Mechanisms of Condition-Specific Regulation of mRNA Stability by Puf Proteins:  From Yeast to Humans by Russo, Joseph
University of Missouri, St. Louis
IRL @ UMSL
Dissertations UMSL Graduate Works
12-17-2014
Mechanisms of Condition-Specific Regulation of
mRNA Stability by Puf Proteins: From Yeast to
Humans
Joseph Russo
University of Missouri-St. Louis
Follow this and additional works at: https://irl.umsl.edu/dissertation
Part of the Biology Commons
This Dissertation is brought to you for free and open access by the UMSL Graduate Works at IRL @ UMSL. It has been accepted for inclusion in
Dissertations by an authorized administrator of IRL @ UMSL. For more information, please contact marvinh@umsl.edu.
Recommended Citation
Russo, Joseph, "Mechanisms of Condition-Specific Regulation of mRNA Stability by Puf Proteins: From Yeast to Humans" (2014).
Dissertations. 6.
https://irl.umsl.edu/dissertation/6
Russo, Joseph, UMSL  p.1 
 
 
 
Mechanisms of Condition-Specific Regulation 
of mRNA Stability by Puf Proteins: From Yeast 
to Humans 
 
Joseph Russo 
B.S., Biology, University of Missouri-Saint Louis, 2008 
 
 
Submitted to the Graduate School at the University of Missouri-Saint Louis in Partial 
Fulfillment of the Requirements for the Degree 
 
 
Doctor of Philosophy in Biology 
With an Emphasis in Cell and Molecular Biology 
 
 
December, 2014 
  
Advisory Committee 
 
Wendy M. Olivas, Ph.D. 
Chairperson 
 
Bethany K. Zolman, Ph.D. 
 
Mindy M. Steiniger, Ph.D. 
 
Ambrose Kidd, Ph.D. 
 
 
 
 
Russo, Joseph, UMSL  p.2 
 
ABSTRACT 
   Regulation of gene expression is critical to properly functioning cells.  In 
addition to the well understood transcriptional control, post transcriptional control of 
gene expression expands our understanding of a multifaceted system that allows for 
precise protein production.  One such mechanism of post transcriptional control of gene 
expression is the regulation of mRNA decay and translation rate facilitated by RNA 
binding proteins.  Controlling mRNA metabolism allows the cell to make rapid changes 
in expression patterns by utilizing already available mRNA, bypassing the wait for newly 
transcribed mRNA.   The Puf family of RNA binding proteins bind specific mRNAs 
through interactions with cis-regulatory elements located in the 3’ untranslated region 
(UTR) consisting of a core UGU sequence.  Puf proteins are conserved throughout 
eukaryotes and have diverse roles including stem cell maintenance, neuronal 
development, stress response and organelle biogenesis.  Concomitant with their cellular 
roles, Puf proteins bind a variety of target mRNAs containing divergent binding 
sequences downstream of the core UGU.  This work focuses on the recent discovery of 
Puf proteins role in stress response.  In Saccharomyces cerevisiae, Puf proteins have 
been shown to be conditionally active in response to the metabolic state of the cell.  
Specifically, in fermentative growth Puf proteins stimulate decay of target mRNAs; 
however, during respiration, Puf proteins are inactive resulting is the stabilization of 
target mRNAs.  Presented herein, I show that in addition to Puf3p, the activity of Puf1p, 
Puf4p and Puf5p in yeast is conditionally regulated.  I establish YHB1 mRNA as a bona 
fide target of Puf1p, Puf4p and Puf5p regulation through one unique binding site 
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located in its 3’ UTR.  YHB1 encodes the only known defense gene against nitric oxide 
stress in yeast.  Growth studies show that Puf proteins regulate YHB1 mRNA in response 
to nitric oxide stress allowing for an adaptive response.  This establishes a model for Puf 
protein regulation of target mRNAs where transcripts are rapidly turned over in the 
absence of stress; however, in the presence of stress transcripts are stabilized to 
increase protein production and combat the stress.  Much of the mechanistic detail 
underlying Puf regulation remained to be elucidated.  Herein, I show that Puf activity is 
regulated by at least two different mechanisms.  The alteration of Puf activity is not due 
to increased expression or altered localization.  Instead, the RNA binding activity of 
Puf5p is reduced during inactivating conditions providing a mechanism for inactivation; 
however, Puf1p, Puf3p and Puf4p are able to bind target mRNAs in both activating and 
inactivating conditions.  Puf proteins require interactions with decay machinery to 
facilitate mRNA degradation.  The Puf3p interaction with Pop2p is perturbed in 
inactivating conditions and an increase in association with a truncated form of Pop2p is 
observed.  This provides mechanistic insight into how Puf3p is inactivated in stress 
conditions.  Thus I have established two mechanisms of Puf protein inactivation in yeast.  
It is likely that more mechanisms exist given that no clear evidence for either 
mechanism previously described was observed for Puf1p or Puf4p.  In a third project, I 
began to evaluate human Puf proteins, also known as Pumilio proteins.  I sought to 
identify natural targets of Pum regulation in humans.  Large scale studies suggest 
physical association of Pum proteins with mRNAs involved in Parkinson’s disease (PD).  
Utilizing bioinformatic approaches as well as experimental approaches I identified SNCA, 
Russo, Joseph, UMSL  p.4 
 
LRRK2 and SAT1 as targets of Pum regulation in humans.  The implication of this 
discovery may provide a novel therapeutic approach to PD in the future as SNCA and 
LRRK2 are the most commonly associated genes with PD. 
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CHAPTER I:  INTRODUCTION 
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Proper gene expression is critical to the survival of cells.  Cells must express the 
precise amount of protein at specific times to respond to various environmental stimuli.  
Much research has focused on how the cell regulates gene expression using a variety of 
transcriptional and post-transcriptional mechanisms.  Such mechanisms include post-
transcriptional control of messenger RNA (mRNA) stability and translational repression.  
In addition to vast transcriptional control, the cell can use post-transcriptional 
mechanisms to control protein expression rapidly, in response to stimuli, by modulating 
its use of already available mRNA.  This crucial layer of control allows for “fine-tuning” of 
protein expression, providing a rapid response to cellular stress and allowing energy 
conservation in a variety of nutritional states. 
Typically, control elements located in the 3’ untranslated region (UTR) of mRNAs 
recruit regulatory proteins or miRNAs that influence mRNA decay and/or translation 
rates.  These RNA binding proteins bind specific sequences and recruit machinery that 
influences decay/translation.  The cis-elements located in the 3’ UTR of mRNAs often 
dictate what family of RNA binding proteins is recruited.  Examples of these cis-elements 
include AU or GU rich elements which recruit specific proteins to mediate stabilization 
or destabilization of target mRNAs (Adjibade and Mazroui, 2014).  Also, in higher 
eukaryotes, miRNA recruitment to complementary seed regions, located in 3’ UTRS 
facilitate mRNA degradation/translational inhibition through interactions with Agonaute 
and GW182 (Adjibade and Mazroui, 2014).  Furthermore, many additional families of 
RNA binding proteins exist to regulate mRNA decay/translation rates for fine-tuning of 
protein expression. 
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One important family of 3’ UTR regulatory proteins is the Puf family, with 
multiple members in mammals, insects, worms, plants and yeast.  Pumilio from 
Drosophila melanogaster (DmPum) and FBF from Caenorhabditis elegans were the 
founding members of this group providing the Puf family name.  DmPum promotes 
abdominal segmentation in the early embryo by binding the 3’ UTR of hunchback mRNA 
and subsequently repressing its translation (Murata and Wharton, 1995) and promoting 
its deadenylation (Wreden et al., 1997). DmPum also represses translation of cyclin B 
mRNA for regulation of germline stem cell development (Forbes and Lehmann, 1998; 
Asaoka-Taguchi et al., 1999; Parisi and Lin, 1999) and regulates anterior patterning 
(Gamberi et al., 2002). The FBF proteins promote the sperm/oocyte switch by binding 
the 3’ UTR of fem-3 mRNA and repressing its expression (Zhang et al., 1997), and control 
germline stem cell maintenance by repressing gld-1 mRNA expression (Crittenden et al., 
2002).     
Different organisms contain variable numbers of Puf proteins, from one in D. 
melanogaster, to over 20 in Arabidopsis thaliana (Barker et al., 1992; Horan et al., 
2005).  Further examples include Saccharomyces cerevisiae, which expresses six Puf 
proteins and humans which express only two Puf proteins.  Concomitant with variable 
numbers in different organisms, Puf proteins regulate diverse processes including cell 
development, stem cell maintenance, organelle biogenesis and environment stress 
defense by binding to specific sequences of targeted mRNAs and stimulating decay 
and/or suppressing translation (Miller and Olivas, 2011a).  Puf proteins are also involved 
in several aspects of neural function, such as neuronal excitability (Schweers et al., 
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2002), dendrite morphogenesis in peripheral neurons (Ye et al., 2004), and synaptic 
growth and plasticity at the neuromuscular junction (Menon et al., 2004; Marrero et al., 
2011). Puf expression increases during long-term memory formation, and its disruption 
results in defective memory (Dubnau et al., 2003).  
The primary role of Puf proteins is to negatively regulate target mRNAs, although 
there are some cases in which Puf proteins positively regulate target mRNAs (Pique et 
al., 2008; Archer et al., 2009; Suh et al., 2009).  Sequences located in the 3’ UTR of 
target mRNAs allow for dynamic assembly of ribonucleoprotein (mRNP) complexes 
consisting of Puf proteins, functional protein partners, and in some cases micro-RNAs.  
mRNP complex formation leads to functional changes in the mRNA such as decay or 
translational repression. The presence or absence of specific factors in mRNP complexes 
can determine the fate of an mRNA.  Such factors include deadenylation and decapping 
proteins that influence the turnover of an mRNA.  Also, translational repressors are 
assembled into mRNPs and can influence translation rate and efficiency.   Concomitant 
with their function, Puf proteins are typically localized in the cytoplasm (Macdonald, 
1992; Gallegos et al., 1998; Crittenden et al., 2002; Gerber et al., 2004).  In some cases, 
it is thought that Puf proteins localize to stress granules which are sites of mRNA 
turnover and/or mRNA storage during translational repression (Vessey et al., 2006; 
Morris et al., 2008; Balagopal and Parker, 2009).  Other data suggests that Puf proteins 
can localize and repress on polysomes (Hu et al., 2009).  The specific localization of 
mRNA decay/translational repression is still largely debated; however, our research 
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suggests that Puf proteins in yeast are diffuse throughout the cytoplasm (Miller et al., 
2014) (Russo and Olivas, submitted).  
Puf Protein Structure and Function 
The Puf family is characterized by a conserved RNA-binding domain consisting of 
eight imperfect repeats of a 36 amino acid sequence, plus short flanking regions. This 
domain, also known as the Pumilio homology domain (Pum-HD) or the Puf repeat 
domain (PufRD), is located near the protein’s C-terminus and is responsible for binding 
the 3’UTR of specific mRNAs (Goldstrohm et al., 2006; Groban et al., 2006; 
Padmanabhan and Richter, 2006; Deng et al., 2008; Saint-Georges et al., 2008; Ulbricht 
and Olivas, 2008; Kedde et al., 2010; Ota et al., 2011).  For many Puf proteins, the PufRD 
alone is sufficient to regulate mRNA decay and repress translation (Houshmandi and 
Olivas, 2005; Padmanabhan and Richter, 2006; Kedde et al., 2010). Regions outside the 
PufRD are not well conserved, although some Pufs contain glutamine-rich motifs, such 
as yeast Puf3p, which may promote aggregation (Miller and Olivas, 2011a).  Recently, it 
has been shown that unique domains located in the N-terminus of Drosophila and 
human Pumilio proteins possess strong repressive capacity, suggesting a recently 
evolved regulatory function for domains outside of the repeat domain (Weidmann and 
Goldstrohm, 2012).  
Target mRNAs contain a conserved Puf recognition element (PRE) consisting of a 
UGU sequence followed by an AU-rich downstream region (Souza et al., 1999; Nakahata 
et al., 2001; Tadauchi et al., 2001; Wang et al., 2001; White et al., 2001; Wang et al., 
2002; Gerber et al., 2004; Jackson et al., 2004; Gerber et al., 2006; Galgano et al., 2008)  
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Figure 1.1.  Puf protein binding element consensus sequences.  Reprint from Miller and 
Olivas, 2011.  Consensus sequence weight matrices were developed based on sequences in the 3’ 
UTRs of mRNAs associated with human PUM1 and PUM2, Drosophila Pumilio, and S. cerevisiae 
Puf3p, Puf4p and Puf5p.  The height of the nucleotide represents the probability that it will occur 
at that position.  Positions that are conserved across organisms and proteins are highlighted in 
yellow (Gerber et al., 2004; Gerber et al., 2006; Galgano et al., 2008) 
Yeast Puf4p 
Yeast Puf3p 
Human PUM2 
Human PUM1 
Yeast Puf5p 
Drosophila Pumilio 
8nt Consensus PRE 
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Figure 1.2.  Puf protein binding schematics.    Reprint from Miller and Olivas, 2011.  Puf 
proteins bind recognition elements in either a one base to one repeat modular-manner or by 
inclusion of spacer/ﬂipped bases. (a) Co-crystal structure of the canonical human PUM1-RD bound 
to a Nanos Response Element (NRE) from Drosophila hunchback mRNA (Wang et al., 2002).   (b) 
Co-crystal structure of C.elegans FBF-RD bound to a Puf Recognition Element (PRE) in gld-1.  Arrow 
denotes ﬂipped RNA base that does not interact with FBF amino acids (Wang et al., 2009).  (c) Co-
crystal structure of yeast Puf4RDp bound to the HO PRE. Arrow denotes ﬂipped RNA base that 
does not interact with Puf4p amino acids (Miller et al., 2008).  (d) Co-crystal structure of yeast 
Puf3RDp bound to a PRE in COX17. Arrow denotes novel interaction between an upstream 
cytosine base and amino acids of Puf repeat 8’ (Zhu et al., 2009).  (e) Binding interactions between 
RNA bases and amino acids of PufRDs. Conserved interactions are represented in black.  Amino 
acid–RNA base interactions and spacer/ﬂipped bases that are unique to each Puf protein are 
indicated by color: C.elegans FBF (red), human PUM1 (gold), yeast Puf4p (green), and yeast Puf3p 
(orange) (Wang et al., 2009). 
ScPuf3p:COX17b ScPuf4p:HO FBF:gld-1-PREa HsPum1: NRE 
ScPuf4p:HO ScPuf3p:COX17b FBF:gld-1-PREa HsPum1: NRE 
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(Figure 1).  The PRE is typically between 8-10 nucleotides in length.  Crystal structure 
analysis of several Puf-mRNA complexes reveals a primarily modular binding method, 
such that conserved amino acids within each repeat contact and stack with successive 
bases along the RNA in an anti-parallel manner, where bases 1-8 contact repeats 8-1 
(Wang et al., 2001; Wang et al., 2002; Galgano et al., 2008) (Figure 2).  Puf proteins 
show strong binding specificity for targets; however, flexibility can involve RNA bases 
flipping out from the protein binding surface, allowing an increase in target mRNAs and 
possibly altering mRNP complex structure (Valley et al., 2012). By flipping bases the local 
mRNA structure is changed, creating unique surface features that provide specificity.  
An interesting hypothesis is that the flipped bases may be sights of interaction for other 
regulatory proteins, providing another layer of regulation.  An example of this can be 
seen with human Pum1, which can accommodate a 9-base binding site or an 8-base site 
(Miller and Olivas, 2011a).  This feature greatly increases the number of potential target 
mRNAs and possibly offers an increase in protein binding partners.  It is likely that Puf 
proteins are not as limited in their binding sites, aside from the core UGU.  More 
research is needed to determine the binding capacity Pufs have for natural targets.  
Another feature that allows for specificity can be observed with yeast Puf3p.  A cytosine 
at the -2 position from the UGU element is required for Puf3p binding in vitro and Puf3p 
decay regulation in vivo (Zhu et al., 2009) (Figure 2e). Recent discoveries, including 
results presented herein, add to the promiscuity Puf proteins possess for RNA binding.  
Many of the mRNAs that associate with Puf proteins contain a similar binding motif 
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conserved across species; however, the targets themselves are functionally divergent 
between species. 
Biological Roles of Puf Proteins and Their mRNA Targets 
 Puf proteins regulate diverse processes across eukaryotes.  Although the 
recognition of mRNA targets is well conserved throughout eukaryotes, the function of 
the mRNAs is remarkably different.  Considering this, it is hypothesized that the general 
role of Puf proteins is to support stem-cell maintenance and self-renewal (Wickens et 
al., 2002; Miller and Olivas, 2011a).  Included herein are multiple examples of the 
biological roles of Puf proteins and their mRNA targets in multiple organisms.   
 Through analysis of Puf mutant phenotypes across eukaryotes, many biological 
roles for Puf proteins have been elucidated and mRNA targets have been discovered.  In 
Drosophila, Pumilio has been shown to regulate the mRNA paralytic, which controls 
neuron excitability and sodium current regulation.  Pumilio mutant flies show hyper- 
excitability in motor neurons, which is attributed to an increase in paralytic mRNA; 
however, overexpression of Pumilio relieves the phenotype through repression of 
paralytic (Schweers et al., 2002; Mee et al., 2004; Muraro et al., 2008).  Also, through 
regulation of eIF-4E and GluRIIA mRNA, Pumilio regulates presynaptic growth and 
postsynaptic glutamate receptor subunit composition.  An increase in the number of 
eIF-4E aggregates and increased expression of GluRIIA glutamate receptor can be seen 
in Pumilio mutants, suggesting Pumilio acts to repress these targets.  Using gel mobility 
shift assays, the authors were able to validate Pumilio binding to these target RNAs, 
further supporting Pumilio’s regulatory role (Menon et al., 2004).  Pumilio also regulates 
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posterior and anterior patterning through regulation of hunchback and bicoid mRNAs, 
respectively.   
 In C. elegans, FBF-1 regulates the translation of the mRNA egl-4 determining 
plasticity in olfactory sensory neurons (Kaye et al., 2009).  FBF-1 and FBF-2 repress fem-
3 mRNA, which is required to control the spermatogenesis to oogenesis switch (Zhang et 
al., 1997).  Also, FBF-1 and FBF-2 regulate entry into meiosis by promoting gld-1 
expression (Crittenden et al., 2002; Ariz et al., 2009).    PUF-5, PUF-6 and PUF-7 regulate 
egg shell formation/cytokinesis through multiple mechanisms, although the mRNA 
target(s) is/are not known (Lublin and Evans, 2007).  PUF-8 regulates spermatogenesis, 
meiosis, and germline stem cell maintenance through regulation of fog-2 expression, 
which acts upstream in germline sex determination (Subramaniam and Seydoux, 2003; 
Ariz et al., 2009; Nadarajan et al., 2009).   PUF-9 controls hypodermal stem cell 
differentiation through regulation of hbl-1 mRNA, a let-7 miRNA target gene (Nolde et 
al., 2007). 
 In S. cerevisiae, mutant phenotype analysis revealed Puf5p controls repression of 
filamentous-form cell differentiation (Prinz et al., 2007). Puf5p also controls cell wall 
integrity, chronological and replicative life span through regulation of LRG1 mRNA 
(Stewart et al., 2007).  Also, Puf5p controls peroxisome protein localization by regulating 
PEX14 mRNA (Zipor et al., 2009).  puf5 mutants show detergent sensitivity and 
susceptibility to the cell wall stain calcofluor white, suggesting defects in cell wall 
integrity (Kennedy et al., 1995; Kennedy et al., 1997; Kaeberlein and Guarente, 2002; 
Stewart et al., 2007; Zipor et al., 2009).  puf5 mutants also show increased stress 
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tolerance and an increased ability to go through mitosis multiple times before cell death 
(Kennedy et al., 1995; Kennedy et al., 1997).  Puf5p and Puf4p regulate the mating-type 
switch by repressing expression of HO mRNA.  Extensive gel shift study revealed two 
binding sites in the HO 3’ UTR that are used by Puf4p and Puf5p (Hook et al., 2007).  
Also, Puf1p and Puf5p repress TIF1 mRNA, which encodes the translation initiation 
factor eIF4A, in a combinatorial manner (Ulbricht and Olivas, 2008).  Puf1p, Puf4p and 
Puf5p regulate HXK1 mRNA stability through multiple binding sites in the 3’ UTR to 
control the hexokinase Hxk1 protein activity (Ulbricht and Olivas, 2008).  Also, YHB1 
mRNA decay is regulated by Puf1p, Puf4p and Puf5p through one binding site to control 
Yhb1 protein levels for response to cellular nitrogen stress (this work).  Puf3p regulates 
multiple mRNAs involved in mitochondrial biogenesis to respond to respiration 
requirements of the cell (Olivas and Parker, 2000; Eliyahu et al., 2010; Gadir et al., 2011; 
Miller et al., 2013). Puf3 deletion strains show increased levels of many mRNAs 
encoding mitochondrial proteins, increased occurrence of aggregated mitochondria, and 
a decrease in mitochondria movement to the daughter bud tip (Olivas and Parker, 2000; 
Eliyahu et al., 2010; Gadir et al., 2011; Miller et al., 2013).  Overexpression of Puf3p in a 
non-fermentable carbon source also had growth defects, suggesting a disruption in 
respiratory function (Garcia-Rodriguez et al., 2007). 
 In humans, Pum2 controls spermatogenesis through regulation of SDAD1 and 
CEP3 mRNAs (Urano et al., 2005; Spik et al., 2006).  Also, Pum1 and Pum2 control cell 
proliferation by repressing the translation of the E2F3 transcription factor and 
enhancing the activity of E2F3 targeting miRNAs.  PUM-1 also controls the cell cycle by 
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inducing local structure changes in the p27 mRNA, allowing for increased miR-221 and 
miR-222 accessibility to the 3’ UTR for down-regulation.  Pumilio knockdown led to a 
disrupted cell cycle phenotype (Kedde et al., 2010).   
 It is abundantly clear that Puf proteins regulate a vast array of mRNA targets 
involved in many cellular functions among many different organisms.  In any given 
organism there are multiple targets of Puf regulation.  For example, yeast Puf3p alone 
stimulates the decay of at least 10 mRNAs with hundreds more predicted to be bona 
fide targets of Puf3p regulation (Olivas and Parker, 2000; Garcia-Rodriguez et al., 2007; 
Miller et al., 2013).  Alternatively, a target mRNA can be regulated by multiple Puf 
proteins as observed with HO, TIF1, HXK1 and YHB1 mRNAs in yeast (Hook et al., 2007; 
Ulbricht and Olivas, 2008) (this work).  Only one Puf protein can be bound at a binding 
site at a given time thus this combinatorial control allows for redundancy ensuring the 
availability of Pufs to regulate the target. Furthermore, many targets of Puf regulation 
contain multiple binding sites that are separated enough to allow each site to be 
occupied by a Puf, suggesting the importance of combinatorial regulation.  Multiple Puf 
regulation of one target mRNA may also allow control under conditions that inactivate 
particular Pufs or permit use of different mechanisms to regulate the mRNA. 
 Global analysis of mRNAs that co-purify with Puf proteins suggest specific classes 
of functionally related mRNAs are bound by different Pufs (Gerber et al., 2004; Gerber 
et al., 2006; Galgano et al., 2008).  This supports the RNA regulon theory that suggests 
that functionally related RNAs are co-regulated by interactions with specific trans-
factors to allow for post-transcriptional regulation (Keene, 2007; Kanitz and Gerber, 
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2009; Morris et al., 2009).  In a given organism, Puf bound targets are often involved in 
functions in a specific subcellular compartment, organelle or regulatory pathway.  In S. 
cerevisiae, affinity-tagged purification of Puf1p-Puf5p revealed interactions with mRNAs 
that function in distinct subcellular compartments or organelles.  For example, Puf1p 
and Puf2p bind mRNAs coding for membrane-associated proteins, Puf3p binds mRNAs 
that encode mitochondrial proteins, and Puf4p and Puf5p bind mRNAs that function in 
the nucleus (Gerber et al., 2004).  Another example can be found with Trypanosoma. 
brucei, where purified PUF9 was enriched for mRNAs having a role in DNA replication 
(Archer et al., 2009). Finally, C. elegans FBF associates with transcripts involved in 
meiosis, the Ras/MAPK pathway, apoptosis and stem cell maintenance (Kershner and 
Kimble, 2010). 
 Many of the mRNAs that associate with human PUM1 and PUM2, Drosophila 
Pumilio and yeast Puf3p have a very similar binding site; however, these bound mRNAs 
are often not conserved between organisms when homologs exist (Gerber et al., 2006; 
Galgano et al., 2008; Morris et al., 2008).  Although target mRNAs are not well 
conserved across species, Puf-mediated control of some biological processes is 
conserved across species, providing evidence for evolutionary conservation of Puf 
function. 
Mechanisms of mRNA Repression  
There are numerous ways in which Puf proteins could repress protein expression 
of target mRNAs.  Puf proteins may simply be a scaffold for other proteins that are 
active in repression.  Alternatively, Puf proteins themselves could have repressive 
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function by blocking translation or recruiting decay machinery.  Puf proteins could alter 
local structure to allow access to previous inaccessible locations for protein binding or 
miRNA binding.  Research suggests that all of these repression mechanisms can and do 
occur.  Specifically, once bound to a target mRNA, Puf proteins elicit repression either 
through protein interactions that limit cap-binding events to inhibit translation 
initiation, or interactions with mRNA decay machinery to stimulate deadenylation and 
decapping steps of decay (Goldstrohm et al., 2006; Goldstrohm et al., 2007; Miller and 
Olivas, 2011b).   
Several examples of different mechanisms of repression exist in multiple 
organisms.  A conserved Puf mechanism is stimulation of mRNA decay by recruitment of 
the CCR4-POP2-NOT deadenylase complex.  Puf proteins in yeast, Drosophila, C. elegans 
and humans recruit and directly bind Pop2, which acts as a bridge molecule between 
Pufs, CCR4 and the NOT complex (Goldstrohm et al., 2006; Goldstrohm et al., 2007; 
Hook et al., 2007; Lee et al., 2010) (this work) (Figure 1.3(a)).  The presence of Ccr4p, 
the catalytic subunit of the deadenylation complex, results in deadenylation of the 
target mRNA (Goldstrohm et al., 2006; Goldstrohm et al., 2007; Hook et al., 2007).  The 
Puf-Pop2 interaction is conserved in humans, illustrating the importance of this 
mechanism for Puf mediated decay (Van Etten et al., 2012).  The resulting deadenylated 
target mRNA subsequently has its cap removed by decapping factors and is then rapidly 
decayed in the 5’ to 3’ direction by exonucleases (Muhlrad et al., 1994) (Figure 1.3 (a)).  
Recently, Pufs have been shown to use the repeat domain to antagonize poly A binding 
protein (PABP) to accelerate deadenylation (Weidmann et al., 2014).   
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Figure 1.3.  Modes of Puf-mediated regulation. Reprinted for Miller and Olivas, 2011 with 
modifications. Translational repression and decay mechanisms through direct interactions with 
Puf proteins.  (a)  Pufs directly recruit the Pop2p subunit of the Ccr4p-Pop2p-Notp deadenylase 
complex, which in turn binds Ccr4p and presumably the rest of the Not complex.  The Puf protein 
also recruits Dcp1p, which cleaves the 5’ cap, and Dhh1, a regulator of mRNA degradation 
(Kennedy et al., 1995; Kennedy et al., 1997; Goldstrohm et al., 2006; Goldstrohm et al., 2007; 
Hook et al., 2007; Stewart et al., 2007).  After deadenylation and decapping of the transcript, the 
5’→3’ exonuclease Xrn1p rapidly degrades the mRNA (Muhlrad et al., 1994). (b)  Pufs inhibit 
translation by competing with eIF4E for interaction with the mRNA cap or by competing with 
initiation factor eIF4G to disrupt binding to eIF4E (Cao et al., 2010; Blewett and Goldstrohm, 
2012). (c) Pufs can also repress translation of an mRNA by either interacting with specific 
translation factors such as eIF5B or by competing with them for interactions with other 
translation initiation factors.  Pufs can also prevent the formation of the 80s ribosome complex 
(Deng et al., 2008). 
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Puf proteins can also repress protein expression by disrupting translation.  
Removal of the poly-A tail can inhibit translation itself; however, Puf proteins 
accomplish translational inhibition in more direct ways as well.  Pufs can disrupt mRNA 
interactions with the translational initiation machinery. For example, yeast Puf6p 
represses ASH1 mRNA translation by interacting with Fun12p/eIF5B or by competing for 
interactions with different initiation factors (Deng et al., 2008).  In vitro translation 
assays indicate Puf6p also prevents the formation of the 80s ribosome complex during 
translation (Deng et al., 2008) (Figure 1.3 (c).)  Yeast Puf5p requires interactions with 
translational repressor Eap1p to efficiently decap and repress target mRNAs in addition 
to competing with initiation factor eIF4E for cap binding. (Blewett and Goldstrohm, 
2012) (Figure 1.3 (b)).  Also, human Pumilio can repress independent of deadenylation, 
as seen on a target lacking a Poly-A tail, likely through translational repression (Van 
Etten et al., 2012). 
Higher eukaryotes use many auxiliary proteins, such as BRAT, Nanos, CPEB, DAZ 
and DAZL, to function with Puf proteins to accomplish mRNA repression.  The 
requirement for these protein partners depend on the organism and the mRNA target 
because homologs are not conserved across eukaryotes; however,  Nanos homologs 
have been identified in Drosophila, humans, C. elegans, and Xenopus, and are required 
for the repression of many mRNA targets (Sonoda and Wharton, 2001; Cho et al., 2006; 
Kadyrova et al., 2007).  Nanos can interact specifically (Kadyrova et al., 2007) or non-
specifically (Curtis et al., 1997; Kraemer et al., 1999; Sonoda and Wharton, 1999; 
Nakahata et al., 2001; Jaruzelska et al., 2003) with transcripts and directly interact 
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Figure 1.4.  Mode of Pum1 activity in humans.    Reprint from Triboulet and Gregory, 2010.  (a) In 
quiescent fibroblasts, p27 mRNA is actively translated to yield high levels of p27 protein. One of the two 
target sites for miR-221/miR-222 in the p27 3′ UTR is embedded in a stable stem-loop structure together 
with one of the two conserved Pumilio recognition elements (PREs), thus preventing p27 silencing by 
miR-221/miR-222. (b) When cells re-enter the cell cycle on growth-factor stimulation, levels of Pumilio 
protein PUM1 increase and phosphorylation of the Ser 714 enhances its RNA-binding activity. PUM1 
binds to the proximal PRE to induce a local change in the RNA that enables miR-221/miR-222 binding to 
its target site and repression of p27 translation. Ago; Argonaute. (Galgano et al., 2008; Triboulet and 
Gregory, 2010) 
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with PufRD to stabilize repression complexes.  In Drosophila, translational repression of 
some mRNAs, such as hunchback, requires the formation of complexes containing Brat, 
Nanos, Pumilio, and the target mRNA (Wreden et al., 1997; Sonoda and Wharton, 1999, 
2001); however, other complexes exclude Brat to perform repression (Sonoda and 
Wharton, 2001; Kadyrova et al., 2007).  Human PUM2 interacts with several Puf protein 
partners, such as the Deleted in Azoospermia (DAZ), Deleted in Azoospermia-Like 
(DAZL), and the BOULE (BOL) RNA-binding protein family (Urano et al.; Fox et al.)  The 
ability of Puf proteins to bind different partners such as Nanos, DAZ, DAZL, and BOL 
allows for mRNP structure changes that can use different mechanisms for mRNA 
repression, increasing the complexity of regulation by Puf proteins.  
Recently, Puf proteins have also been found to act cooperatively with the miRNA 
regulatory system.  Global studies to identify mRNAs bound by human Pum1 and Pum2 
determined that 3’ UTRs containing Puf binding sites are enriched in miRNA binding 
sites (Galgano et al., 2008).  In humans, miRNA sites located near Puf binding sites are 
often located in highly structured 3’ UTR regions that are poorly accessible, and the 
distance between the miRNA and Puf sites is typically less than 50 nucleotides 
(Leibovich et al., 2010).  For example, Puf binding sites are often associated with miR-
410 target sites located in highly structured regions (Leibovich et al., 2010).  
Experimentally, binding of human Pum1 to the 3’ UTR of the p27 tumor suppressor 
mRNA was found to alter the local RNA structure and permit binding of miR-221 and 
miR-222 for RNA repression (Figure 1.4)  (Kedde et al., 2010).  Binding of human Puf 
proteins to the 3’ UTR of the E2F3 oncogene also enhanced miRNA-mediated repression 
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of this mRNA, and several types of cancer circumvent miRNA regulation by shortening 
the 3’ UTR, thereby eliminating the Puf binding site (Miles et al., 2012). In addition to 
making miRNA sites more accessible, Pufs may also work coordinately with miRNAs 
through interactions with the miRNA complex protein Argonaute, and these interactions 
have been shown to inhibit translation elongation (Friend et al., 2012). 
Regulation of Puf Protein Activity 
 Puf proteins regulate functionally related mRNAs in a coordinated manner to 
achieve protein expression goals required by the cell.  Although Puf proteins repress 
mRNAs, it is not likely that they repress target mRNAs at all times.  It is more likely that 
Puf protein activity is responsive to environmental stimuli or cellular signaling during 
precise times when a rapid expression control mechanism is needed.  Such control over 
Puf protein activity would allow for use of already existing mRNA pools to respond to 
stimuli.  A model for this hypothesis is to alter Puf protein activity and/or expression 
levels to repress or derepress target mRNAs as needed.   Indeed, eukaryotes have 
developed multiple ways to regulate Puf activity such as modulating expression levels, 
disrupting the ability to interact with target mRNAs, and disrupting interactions with co-
factors.  Puf proteins are controlled at all levels of gene regulation including 
transcription, post-transcription, translation and post-translation, suggesting activity is 
tightly controlled.   
 In C. elegans, it is thought that an autoregulatory mechanism exists for post-
transcriptionally regulating fbf-1 and fbf-2 mRNA levels through binding of FBF proteins 
to their 3’ UTRs.   Also, in humans both Pum1 and Pum2 mRNA bind purified Pum1 
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protein, indicating that this autoregulation may be conserved (Morris et al., 2008).  Puf 
expression is also regulated post-transcriptionally through the miRNA pathway.  In rat, 
PUM2 has been shown to be negatively regulated by miR-134, and interestingly the 3’ 
UTRs of PUM2 homologs in mouse and human also contain miR-134 binding sites, again 
suggesting conservation of this mechanism (Fiore et al., 2009).  Recently, miR-340 has 
been implicated in lung cancer progression through regulation of Pum1 and Pum2 in 
humans, further supporting post-transcriptional control of Puf protein expression and 
activity (Fernandez et al., 2014).         
 Puf protein activity may also be altered at the post-translational level.  In 
budding yeast, phosphorylation of Puf6p by protein kinase CK2 inhibits translational 
repression by Puf6p (Deng et al., 2008).    In humans, Pum1 RNA-binding activity to the 
p27 3’ UTR is dependent on phosphorylation of Pum1 in response to growth factor 
stimulation (Figure 1.4) (Kedde et al., 2010).  Work in the Olivas lab has shown that Puf 
protein activity in yeast in active during cellular fermentation and inactive during cellular 
respiration.  This activation/inactivation occurs rapidly, within two minutes, during 
metabolic changes from fermentation to respiration or vice versa suggesting that a post-
translational modification may be responsible for altered activity.  The binding of yeast 
Puf1p, Puf3p, and Puf4p to their target mRNAs is not disrupted in fermentation verses 
respiration conditions, while Puf5p is less able to bind target mRNAs in respiration 
conditions (Miller et al., 2013) (This Work).   
 A final way Puf protein activity is regulated is through interactions with binding 
partners.  In Drosophila, Bam and Bgcn form a complex with Pumilio where Bam directly 
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interacts with the N-terminal region of Pumilio, and this binding abolishes repressive 
activities of the Pumilio repeat domain (Kim et al., 2010).  In this work, yeast Puf3RD is 
shown to have limited binding capacity for POP2p in inactivating conditions 
(respiration).  Together, this research provides mechanistic details into how Puf protein 
activity is controlled.   
Contribution to the Field of Puf Research 
 The research presented herein provides new insight into Puf protein regulation.  
In one project, I identify YHB1 mRNA as a bona fide target of Puf1p, Puf4p and Puf5p 
regulation in yeast.  This mRNA utilizes a single, highly flexible PRE to bind three 
different Puf proteins to accomplish regulation.  Each individual Puf protein is able to 
regulate YHB1 mRNA in the absence of the other Puf proteins.  Puf1p, Puf4p and Puf5p 
activity is tightly regulated for YHB1 mRNA decay, as alterations in the growth carbon 
source affects Puf activity.  Specifically, growth in dextrose allows for repressive Puf 
activity; however, growth in galactose inhibits Puf activity completely.  This result is also 
seen with a second target of Puf1p, Puf4p and Puf5p regulation, HXK1 mRNA.  
Overexpression of Puf4p or Puf5p in dextrose conditions increases the repression 
capacity beyond that of wild-type, suggesting the amount of Puf proteins is limited in 
the cell.  Overexpression of Pufs in galactose can rescue inactivation of Puf proteins 
suggesting that the inactivation signal is limiting as well.  Furthermore, Puf4p 
overexpression reduces the steady-state levels of YHB1 mRNA during nitric oxide 
exposure, resulting in a growth defect and further illustrating the importance of “fine-
tuned” protein expression control in response to environmental stress.  The differential 
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activity of Puf1p, Puf4p and Puf5p in different carbon sources is not a result of altered 
Puf protein expression levels or changes in localization.  Rather, Puf5p has a reduced 
ability to bind target mRNAs, although this is not the case with Puf1p or Puf4p.   I also 
identified a Puf5p mutant that has increased repressive capacity compared to wild-type, 
potentially offering mechanistic insight into Puf protein regulation.   
 In a second project, I will present mechanistic information on Puf3p condition-
specific activity in yeast.  Puf3p was the first Puf identified in the lab as being inactivated 
in respiratory conditions such as galactose and ethanol.  I determined that Puf3p’s 
altered activity in galactose is not due to altered localization or differential mRNA 
binding.  In fact, binding to Puf3p target mRNA COX17 was enhanced in galactose. 
Instead, a potential mechanism for altered Puf3p activity is to change the local mRNP 
complex.  Indeed, during growth in galactose conditions Puf3RD was limited in its ability 
to bind Pop2p.  Further evaluation of Puf3p decay complex formation in a POP2Δ strain 
revealed that cofactors such as Ccr4p, Dhh1p and Dcp1p are no longer able to bind in 
the absence of Pop2p, further supporting Pop2p as a crucial cofactor for Puf3p activity.  
His-repression assays further support the notion that Puf3p repression is disabled in the 
absence of Pop2p.  Also, I identified the mechanism by which a Puf3RD mutant is unable 
to accomplish mRNA decay. This mutant has a loop structure disrupted between repeats 
7 and 8 such that it can still bind target mRNAs but cannot accomplish mRNA decay.  
Interactions with full-length Pop2p are disrupted with this Puf3RD loop mutant, instead 
binding to a truncated form of Pop2p occurs.  The nature of this smaller Pop2p is yet to 
be elucidated; however, it is clear that the mutant Puf3RD cannot bind the functional, 
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full-length Pop2p.  Mass-spectra comparison between the two protein forms will 
provide critical information on how repression is affected by these two Pop2p species.  I 
am performing research into Pop2p mutants that block or mimic a known 
phosphorylation state to determine if this post-translational modification is responsible 
for altered binding to Puf3RD.  Yak1p phosphorylates Pop2p in the absence of dextrose, 
(Moriya et al., 2001) and we show that Puf3p activity is retained in a YAK1Δ strain in the 
presence of galactose.  This data suggests that galactose provides an inactivating signal 
to Puf3p through Pop2p phosphorylation, wherein phosphorylation of Pop2p may 
inhibit the ability of Puf3RD to interact with Pop2p.  Furthermore, this data provides a 
potential mechanism for carbon-source dependent regulation of mRNA decay by Puf3p. 
 Finally, I have used my knowledge of Puf proteins in yeast to move into research 
on human Pumilio proteins.  The Olivas lab has previously focused on using yeast as a 
model organism for studying Puf proteins.  I have transitioned the lab into using human 
cell culture for studies of Pumilio proteins.   
  My third project presented herein discusses the discovery of novel targets of 
Pum1 and Pum2 regulation in humans.  I have discovered that several genes implicated 
in Parkinson’s disease are targets of Pumilio regulation.  Specifically, SAT1, SNCA, and 
LRRK2 are identified as targets of Pumilio regulation.  In doing so, I have established 
protein knockdown protocols for the lab as well as standard cell culture methods for 
two different cell lines.  Also new to the lab are methods for transfection of reporter 
plasmids for luciferase-based assays.  Establishing these techniques indicates that our 
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lab is capable of performing these types of experiments and is critical for future funding 
opportunities.      
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INTRODUCTION 
 Precise control of protein production is critical to proper cellular function and is 
needed to respond to a variety of environmental stimuli.  Cells control protein 
production in a variety of ways including transcriptional regulation, post-transcriptional 
regulation, translational regulation and post-translational regulation.  One such post-
transcriptional mechanism is regulation of mRNA decay.  Precise regulation of mRNA 
decay offers a mechanism to respond rapidly to environmental stresses by altering the 
use of already available mRNA (Shim and Karin, 2002).  Regulation of mRNA decay is 
often accomplished by RNA binding proteins that recognize cis-elements located in the 
3’ untranslated region (3’ UTR) of mRNAs.   
 The Puf family of RNA binding proteins regulate target mRNAs by binding cis-
acting regulatory elements contained within the 3’ UTR.  Typically, Puf proteins bind 
conserved UGU elements, leading to recruitment of factors that disrupt translation 
initiation and/or promote mRNA degradation (Miller and Olivas, 2011). Puf proteins 
regulate assorted cellular processes including memory formation, embryonic 
development, organelle biogenesis and stress response (Barker et al., 1992; Wickens et 
al., 2002; Spassov and Jurecic, 2003; Wharton and Aggarwal, 2006; Miller et al., 2014). 
Although the binding sequence is conserved in eukaryotes, target mRNAs can vary 
between organisms and particular mRNAs may not be conserved between organisms 
even when orthologs exist (Gerber et al., 2006; Galgano et al., 2008; Morris et al., 2008).  
However, targets of specific Puf proteins are often mRNAs that are functionally related 
Russo, Joseph, UMSL  p.48 
 
and therefore are functionally regulated (Foat et al., 2005).  This can be observed with 
Saccharomyces cerevisiae Puf3p, which binds target mRNAs that encode mitochondrial 
proteins (Gerber et al., 2004; Miller et al., 2014).   
 Although Puf proteins such as S. cerevisiae Puf3p act to stimulate decay of their 
target mRNAs, these mRNAs are not repressed at all times.  Target mRNAs are likely 
repressed when the cell needs a limited amount of protein product; however, when an 
increase in protein product is required, target mRNAs are derepressed.   Puf protein 
activity is altered to accommodate cellular protein requirements.  For example, human 
Pum1 RNA-binding activity to the p27 3’ UTR is dependent on phosphorylation of Pum1 
in response to growth factor stimulation (Kedde et al., 2010).  In C. elegans, current 
models suggest an autoregulatory mechanism for post-transcriptionally regulating fbf-1 
and fbf-2 mRNA levels by binding of the FBF proteins to their own 3’ UTRs (Lamont et 
al., 2004) and this mechanism may be conserved in humans (Morris et al., 2008).  In 
budding yeast, Puf6p N-terminal phosphorylation by CK2 causes translational 
derepression (Deng et al., 2008).  mRNAs that are targeted for decay by Puf1p, Puf3p, 
Puf4p and Puf5p in glucose conditions are stabilized in response to glucose deprivation 
(Miller et al., 2014) (Russo and Olivas, submitted).  Specifically, Puf3p regulates 
mitochondrial biogenesis and function by promoting rapid degradation of target mRNAs 
in fermentable conditions (glucose/dextrose-these are synonymous) where the need for 
mitochondria is low; however, in respiration conditions such as galactose where 
mitochondria production is needed, Puf3p decay activity is inhibited allowing for 
increased protein production for mitochondria biogenesis.  Additionally, Puf1p, Puf4p 
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and Puf5p stimulated decay of YHB1 mRNA in glucose conditions, but YHB1 mRNA is 
stabilized in response to increased accumulation of toxic nitric oxide from respiration 
(Russo and Olivas, submitted).  Altered mRNA binding is at least partially responsible for 
the reduction in Puf5p activity (Russo and Olivas, submitted); however, the mechanism 
for reduced activity in Puf1p, Puf3p and Puf4p has remained elusive.  Our research 
indicates that reduced activity is not a result of altered protein expression, localization 
or RNA binding.  In fact, Puf3p enhances its binding capacity in galactose conditions 
(Miller et al., 2014), further supporting a dual role for Puf3p in localizing target mRNAs 
for localized protein synthesis (Eliyahu et al., 2010; Gadir et al., 2011).  Thus, the 
observed inactivation of Pufs in yeast may be due to altered interactions with decay 
machinery or other inhibitory factors. Precedent for this mechanism comes from C. 
elegans and Drosophila where GLD3, Bam and Bgcn proteins bind Puf proteins to inhibit 
their repressive activity (Eckmann et al., 2002; Kim et al., 2010). 
 Puf proteins in yeast utilize the recruitment of mRNA decay machinery to 
facilitate degradation.  Key members of the decay machinery include the deadenylation 
complex consisting of Pop2p, Ccr4p and the NOT complex.  Also included is the 
decapping complex consisting of Dcp1p/Dcp2p and the enhancer Dhh1p.  Puf proteins 
directly bind Pop2p, which likely acts as a bridge for binding other decay factors 
including Ccr4p, Dcp1, Dhh1 and the NOT complex (Goldstrohm et al., 2006; Goldstrohm 
et al., 2007; Hook et al., 2007; Lee et al., 2010) (this work).  Recruitment of the 
catalytically active subunit of the deadenylation complex, Ccr4p, by Puf proteins results 
in deadenylation of the mRNA (Goldstrohm et al., 2007; Lee et al., 2010).  The mRNA is 
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then decapped by Dcp1p/Dcp2p and subjected to 5’ to 3’ exonuclease degradation by 
Xrn1p.   
 In this work I have identified a condition-specific mechanism for control of Puf3p 
activity.  We identified deadenylation as the key regulatory step that is inhibited in 
respiration conditions.  Furthermore, Puf3p interactions with Pop2p are greatly reduced 
during respiration, supporting inhibition of deadenylation as a key regulatory step.  We 
provide in vivo evidence of the requirement of Pop2p for bridging protein interactions 
with Ccr4p, Dhh1p and Dcp1p.  Additionally, the kinase Yak1p has been shown to rapidly 
phosphorylate Pop2p in response to glucose deprivation, and this modification is 
removed rapidly (within 1 minute) upon glucose addition (Moriya et al., 2001).  
Transcriptional shut-off assays in a yak1Δ strain revealed that Puf3p remains active for 
decay of COX17 mRNA in galactose suggesting that phosphorylation of Pop2p disrupts 
binding with Puf3p and/or function for Puf3p mediated decay stimulation.  Finally we 
identified a truncated form of Pop2p that interacts with Puf3RD more predominantly 
than the wild-type Pop2p in respiration conditions.  Furthermore, the smaller Pop2p 
almost exclusively interacts with our Puf3RD loop 7a mutant in fermentation conditions.  
This Puf3RD loop 7a mutant is capable of binding target mRNAs; however, it is unable to 
facilitate decay (Houshmandi and Olivas, 2005).  This exclusive binding of the mutant 
Puf3RD with the truncated form of Pop2p further supports the hypothesis that this 
interaction inhibits mRNA decay.  Finally, mass spectrometry analysis of the two species 
of Pop2p suggests an N-terminal truncation of the full length Pop2p for formation of the 
smaller version of Pop2p.  These results define a condition-specific mechanism by which 
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altered Puf3p interactions with Pop2p results in inactivation of Puf-mediated mRNA 
decay.    
RESULTS AND DISCUSSION FROM PREVIOUS STUDY (MILLER ET AL, NAR 
2014) 
 I was a second author on a paper from our lab entitled “Carbon source-
dependent alteration of Puf3p activity mediates rapid changes in the stabilities of 
mRNAs involved in mitochondrial function”.  Together with Anthony Fischer, I 
performed the analysis of Puf3p conditional localization as well as in vivo RNA-
immunoprecipitation studies to evaluate conditional mRNA binding capacity.  The 
following describes and discusses that work. 
Condition-specific inactivation of Puf3p is not due to altered localization 
 To analyze Puf3p localization under different conditions, endogenously GFP-
tagged Puf3p was visualized in cells grown in dextrose, galactose or ethanol conditions. 
Similar to the results seen by western analysis, Puf3p-GFP levels detected 
microscopically were increased >1.5-fold in galactose and ethanol as compared with 
dextrose (Figure 2.1). Despite differences in expression levels, Puf3p-GFP was diffusely 
localized across the cytoplasm with multiple small foci in all conditions, demonstrating 
that localization is not markedly altered by inactivating conditions (Figure 2.1). Previous 
work has shown a similar localization pattern in dextrose (Garcia-Rodriguez et al., 2007).  
Specifically, Puf3p does not exclusively localize to mitochondria in galactose or ethanol, 
though some Puf3p does appear to localize to the perimeter of mitochondria as seen by 
the yellow rings surrounding the red mitochondrial foci in the merged images between  
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Figure 2.1.  Ethanol and galactose do not decrease PUF3 expression levels or alter 
localization.  Yeast expressing endogenously GFP-tagged Puf3p were grown in YEP media 
supplemented with 2% dextrose, galactose or ethanol. Each image represents 10 ﬂattened Z 
plane slices through ﬁxed cells using a confocal ﬂuorescence microsope. Puf3p-GFP is shown in 
green, while mitochondria stained with Mitotracker Deep Red are shown in red. Merge indicates 
merger of the Puf3p-GFP and Mitotracker windows. Bright ﬁeld images of each cell ﬁeld are 
shown. The bar equals 5mm. Fluorescence levels of Puf3p-GFP, quantiﬁed across cell ﬁelds and 
normalized to levels in dextrose, are graphically represented. 
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Puf3p-GFP and Mitotracker red (Figure 2.1). This result supports previous studies 
indicating that Puf3p localizes to the cytosolic face of mitochondria (Garcia-Rodriguez et 
al., 2007). 
Condition-specific inactivation of Puf3p does not disrupt Puf3p-mRNA 
interactions 
 The condition-specific regulation of Puf3p could be altering its ability to associate 
with its mRNA targets or its ability to functionally stimulate decay of the targets. To 
address whether Puf3p-mRNA interactions are disrupted under inactivating conditions, 
qPCR was used to quantitate the amount of mRNA that copuriﬁed with endogenously 
TAP-tagged Puf3p from cells grown in dextrose or galactose. We tested COX17 mRNA as 
a positive target of Puf3p regulation, as well as CBS1 and STE3 mRNAs as negative 
controls to ensure we specifically enriched for Puf3p binding targets after the IP process. 
As shown in Figure 2.2 A and B, COX17 mRNA was enriched 200- to 800-fold following 
Puf3p IP from both galactose and dextrose conditions as compared with input mRNA 
levels, while there was no enrichment of either CBS1 or STE3 mRNA. Having 
demonstrated specificity of Puf3p binding, we next compared levels of COX17 that 
copuriﬁed with Puf3p from dextrose and galactose conditions. COX17 mRNA levels from 
the IP were >2-fold higher in galactose versus dextrose, indicating that Puf3p-mRNA 
interactions are not disrupted under conditions that inactivate Puf3p-medicated decay 
stimulation (Figure 2.2C). The higher level of COX17 mRNA that copuriﬁed with Puf3p in 
galactose likely reflects the increased amount of Puf3p expressed in galactose 
conditions (Figure 2.2 D). These results support the hypothesis from previous studies 
that Puf3p binds and traffics its mRNA targets to the mitochondria (Saint-Georges et al.,  
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Figure 2.2.  Puf3p binds its target mRNAs in both activating and inactivating conditions. 
Endogenously TAP-tagged Puf3p was immunoprecipitated (IP) from yeast grown in YEP media 
supplemented with 2% dextrose or galactose using IgG-Sepharose, and RNAs associated with Puf3p 
were analyzed by qPCR. Fold mRNA enrichment after IP from dextrose (A) or galactose (B) 
conditions was calculated by comparing average Cq values of mRNAs isolated after IP versus 
average Cq values of the respective mRNAs isolated from total cell lysate before IP. (C) Average Cq 
values of mRNAs isolated after IP were compared between dextrose and galactose conditions, with 
levels normalized to that found in dextrose. (D) Puf3p- TAP protein levels from dextrose and 
galactose conditions in total cell lysates (Input) and after IP were assessed by western blot using 
anti-TAP antibodies. A strain expressing nontagged Puf3p (-lane) is also shown. 
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2008; Gadir et al., 2011), and our results demonstrate that such binding occurs 
regardless of the conditions. In contrast, the inactivation of Puf3p is likely disrupting its 
ability to stimulate decay of the bound targets. 
Discussion of possible mechanisms of Puf3p inactivation in respiration 
conditions 
 Our data showing rapid changes in Puf3p activity upon carbon source shift 
without carbon source-dependent changes in Puf3p expression suggest that changes in 
Puf3p decay activity are regulated posttranslationally. One possibility is that Puf3p is 
sequestered into aggregates or its localization is otherwise altered to render it inactive. 
However, our results indicate that localization is not significantly altered between 
conditions, being diffusely localized with multiple small foci throughout the cytoplasm 
(Figure 2.1). A second possibility is that phosphorylation modulates Puf3p activity, as 
Puf6p-mediated translational repression is regulated by CK2 phosphorylation (Deng et 
al., 2008) .  Mass spectrometry analysis of condition-dependent Puf3p phosphorylation 
has to date been inconclusive (Anthony Fischer, unpublished data).   Activity may also be 
altered by changes in proteins that interact with Puf3p. In addition to its role in 
stimulating mRNA decay, Puf3p stimulates mitochondrial localization of nuclear-
transcribed mRNAs containing Puf3p binding sites. In a puf3Δ strain grown in galactose 
(Saint-Georges et al., 2008) or glucose (Gadir et al., 2011), these transcripts have 
decreased association with the mitochondria. It is hypothesized that Puf3p shuttles 
mRNA targets to the mitochondrial outer membrane surface, where they are locally 
translated and imported into the mitochondria. This hypothesis is supported by physical 
interactions between Puf3p and Mdm12p, a mitochondrial outer membrane protein 
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(Garcia-Rodriguez et al., 2007). Tom20p, a component of the translocase of the 
mitochondrial outer membrane complex, is also required for mitochondrial localization 
of Puf3p target mRNAs (Eliyahu et al., 2010). Our results demonstrating that Puf3p 
physically associates with its target mRNA in both dextrose and galactose conditions 
further supports the shuttling hypothesis (Figure 2.2). The following model accounts for 
the dual condition-specific functions of Puf3p. In dextrose conditions, yeast cells can 
readily perform fermentation, so mitochondria are not required and are in low 
abundance. To limit mitochondria, expression of mitochondrial proteins is 
downregulated. One mechanism of such repression involves Puf3p binding to mRNAs 
such as COX17, TUF1 and CYT2 and acting to mediate rapid degradation of the 
transcripts, presumably by recruiting deadenylase and decapping factors. In ethanol, 
galactose and raffinose conditions when yeast require additional metabolism via the 
mitochondria, Puf3p’s ability to stimulate decay is turned off, but its ability to bind its 
target mRNAs remains. With the bound mRNA now stabilized, Puf3p can increasingly 
shuttle the mRNA to the mitochondria for translation and import, though mRNAs could 
also be shuttled in dextrose conditions before degradation. This role of Puf3p in mRNA 
localization explains why Puf3p is not downregulated in nonfermenting conditions. 
Posttranslational modifications such as phosphorylation of either Puf3p or Puf3p 
binding partners may serve as the molecular switch that inhibits the decay activity of 
Puf3p.  Future work will elucidate the mechanism of these activity changes. 
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RESULTS 
Deadenylation of Puf3p regulated mRNAs is inhibited in galactose 
conditions 
All of the experiments in this section were performed together with Anthony Fischer. 
 Our previous work began to evaluate the mechanism by which Puf proteins 
derepress target mRNAs during stress conditions such as respiration (growth in 
galactose).  Our work with Puf3p demonstrated that altered Puf3p activity is not a result 
of changes in expression, localization or mRNA binding (Miller et al., 2014).  In fact, 
mRNA binding by Puf3p was increased two fold in the inactivating condition galactose 
(Miller et al., 2014).  Furthermore, I evaluated Puf1p, Puf4p and Puf5p using the same 
criteria as Puf3p and determined that only Puf5p showed a significant reduction in 
target mRNA binding during stress (Russo and Olivas, see chapter 3).  Thus, one 
mechanism by which Puf5p alters its activity on target mRNAs is through disrupted 
mRNA binding, as is the case with human Pumilio (Kedde et al., 2010).  The mechanism 
by which Puf1p, Puf3p and Puf4p inactivate decay of target mRNAs in stress conditions 
remains elusive.  To understand the mechanism of Puf3p inactivation, we evaluated 
which step of decay is being affected by stress.  We performed transcriptional pulse-
chase experiments to determine if deadenylation is inhibited by galactose conditions.  
Utilizing our COX17 reporter mRNA under the control of the inducible/repressible GAL 
UAS (upstream activating sequence) we were able to create a pulse of newly transcribed 
COX17 mRNA, then monitor deadenylation after transcriptional repression.  
Transcription was repressed by shifting the culture to a non-permissive temperature of 
37°C that inactivates RNA polymerase II (rpb1-1 allele) in this strain.  Accomplishing 
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repression in this manner allowed for deadenylation analysis in both dextrose and 
galactose conditions as the cells were either maintained in galactose after 
transcriptional induction or placed in dextrose after transcriptional induction.  Utilizing 
temperature sensitive repression allows for inactivation of transcription regardless of 
the GAL UAS in the construct. (Russo and Olivas, see chapter 3).  As shown in figure 
2.3A, deadenylation proceeds rapidly in dextrose, with removal of the poly-adenosine 
tail within 4-6 minutes (as noted by the smear of products in the lanes) and complete 
degradation of the mRNA within 6-8 minutes (Figure 2.3A), which is in agreement with 
previous transcriptional shut-off data for COX17 mRNA (Olivas and Parker, 2000; Jackson 
et al., 2004; Houshmandi and Olivas, 2005; Miller et al., 2014).  In contrast, in galactose 
conditions deadenylation is severely inhibited, as mRNAs with at least a partial poly-A 
tail persist through 40 minutes (Figure 2.3B).  These data indicate that carbon-source 
dependent inactivation of Puf proteins works through the deadenylation step of mRNA 
decay.   
Binding of Pop2p to Puf3p is reduced in galactose 
 A possible mechanism by which Puf3p is inactivated for mRNA decay stimulation 
in stress conditions could be differential binding to decay factors.  Previous in vitro 
studies have shown that Puf proteins bind many of the core mRNA decay factors 
including Dcp1p, Dhh1p, Ccr4p and Pop2p (Goldstrohm et al., 2006; Hook et al., 2007; 
Lee et al., 2010; Quenault et al., 2011).  To examine these interactions under stress 
conditions we performed co-immunoprecipitation (co-ip) studies in dextrose and 
galactose conditions.  Utilizing our puf3Δ strain, we individually inserted a C-terminal  
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A B 
Figure 2.3.  Deadenylation rate of COX17 mRNA during growth in Dextrose or Galactose.  
Shown are Northern blot analyses of transcriptional pulse-chase experiments examining decay of 
COX17 mRNA during growth in either Dextrose of Galactose.  Minutes following transcriptional 
repression are indicated above each blot.  The -8 lane in each blot corresponds to background levels 
of RNA expression before galactose induction of COX17 RNA transcription.  The 0dt lanes in A and B 
correspond to RNA from the 0-min time point in which the poly(A) tail was removed by RNase H 
cleavage with oligo(dT).  The sugar used in the growth of the cells is indicated below each blot.   
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Myc-tag into the endogenous genes encoding components of the decay machinery 
including Dcp1p, Dhh1p, Ccr4p and Pop2p.  This resulted in four new strains, each with a 
single Myc-tagged gene.  We then expressed our FLAG-tagged Puf3 repeat domain (RD) 
construct in each strain.  Co-ips were performed to capture Puf3RD from cells grown in 
either dextrose or galactose conditions, then Myc-tagged factors that co-purified with 
Puf3RD were evaluated by Western blot.  Puf3RD co-purified with Dcp1p, Dhh1p and 
Ccr4p in both dextrose and galactose to equal levels; however, Pop2p binding was 
significantly decreased in galactose as compared to dextrose conditions (Figure 2.4, left 
panel).  As a control, Puf3RD was shown to equally purify from both conditions (Figure 
2.4, right panel).   Furthermore, in galactose Puf3RD increases binding to a smaller form 
of Pop2p.  This smaller form of Pop2p has been previously observed in stationary cells 
grown in dextrose as well as galactose growth conditions (Norbeck, 2008).  These two 
species of Pop2p have been thoroughly evaluated by cycloheximide (inhibitor of protein 
synthesis) treatment to ensure that the smaller species is not simply a degradation 
product (Norbeck, 2008).  Thus, a decrease in binding to full-length Pop2p by Puf3RD 
and an increase in binding to a truncated Pop2p in galactose conditions is likely 
contributing to Puf3p inactivation. 
Pop2p acts as a bridging molecule for Puf3RD interactions with Dcp1p, 
Dhh1p and Ccr4p in vivo 
 Using in vitro binding assays, previous groups have implicated Pop2p as a 
bridging molecule responsible for interactions of Puf4p and Puf5p with other 
components of the decay machinery (Goldstrohm et al., 2006; Hook et al., 2007).  We  
Russo, Joseph, UMSL  p.61 
 
  
Figure 2.4.  Interactions between Puf3p and Pop2p are reduced during growth in 
galactose. Western blot analysis of co-immunoprecipitation assays performed with FLAG-Puf3RDp 
in dextrose or galactose conditions.  Myc-DCP1, Myc-DHH1, Myc-CCR4 and Myc-POP2 were co-
immunoprecipitated with Puf3RDp or empty vector (EV) from dextrose or galactose conditions.  
Myc-tagged decay factors that co-purified with Puf3RDp were detected using anti-Myc antibody 
(left panel).  As a control, FLAG-Puf3RDp was detected using anti-FLAG antibody to determine equal 
purification between conditions (right panel).  Experiments were performed in triplicate with similar 
results observed.   
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 provide further support for this hypothesis for Puf3RD binding in vivo.  Utilizing our 
puf3Δ strain, we created a puf3Δ/ Pop2Δ double deletion strain.  We then endogenously 
Myc-tagged Dcp1p, Dhh1p or Ccr4p in this strain to create three new strains.  Co-ip 
experiments were performed to capture Puf3RD and eluates were evaluated by 
Western blot to ascertain if binding to cofactors was dependent on Pop2p.  Puf3RD 
purified equally from both wild-type and pop2Δ strains (Figure 2.5, right panel).  
However, Puf3RD interactions with Dcp1p, Dhh1p and Ccr4p were all disrupted in the 
absence of Pop2p, supporting the hypothesis that Pop2p acts a bridge between Puf 
proteins and other decay machinery factors (Figure 2.5, left panel).    
Yak1p kinase inactivates Puf proteins in galactose 
 We next sought to identify the signal for Puf3p inactivation in galactose 
conditions.  Yak1p kinase rapidly phosphorylates (within 2 minutes) Pop2p at Thr97 
under glucose deprivation, and this modification is removed within 1 minute upon the 
addition of glucose (Moriya et al., 2001).  Pufp condition-specific regulation of mRNA 
decay is also rapid, as switching carbon sources can activate or inactivate Pufs within 2 
minutes (Miller et al., 2014) (Russo and Olivas, submitted).  To determine if Yak1p is 
responsible for inactivation of Puf3p in galactose, we knocked out YAK1 in our 
temperature sensitive strain used to perform RNA decay analysis.  Such transcriptional 
shut-off assays were performed in both dextrose and galactose in the wild-type strain 
and the yak1Δ strain.  In contrast to the wild-type strain, COX17 mRNA was rapidly 
degraded in galactose in the absence of Yak1p, supporting the hypothesis that the 
presence of Yak1p is involved in inactivation of Puf3p (Figure 2.6).  This data supports  
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Figure 2.5.  Interactions between Puf3p and Dcp1p, Dhh1p and Ccr4p are bridged 
by Pop2p. Western blot analysis of co-immunoprecipitation assays performed with FLAG-
Puf3RDp in a PUF3Δ/POP2Δ strain.  Myc-DCP1, Myc-DHH1, and Myc-CCR4 were co-
immunoprecipitated with Puf3RDp or empty vector (EV).  Myc-tagged decay factors that 
co-purified with Puf3RDp were detected using anti-Myc antibody (left panel).  As a control, 
FLAG-Puf3RDp was detected using anti-FLAG antibody to determine equal purification 
between conditions (right panel).  Experiments were performed in triplicate.   
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Figure 2.6.  Condition-specific activity of Puf3p is dependent on Yak1p.  Decay of COX17 
mRNA in wild-type or yak1Δ strains during growth in dextrose or galactose is shown.  
Representative Northern blots are presented in the left panel, with average half-life (T1/2) listed to 
the right of each blot.  Graphical representation of average half-life is presented in the right panel.  
Minutes following transcriptional shut-off are indicated above blots and along the X-axis of the 
graph.  The error for each T1/2 is the SEM (n≥3). 
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the hypothesis that Pop2p phosphorylation by Yak1p inhibits Puf3p activity, likely 
through disruption of Puf3p binding to Pop2p.   
Puf3RD-R7A cannot bind full length Pop2p in dextrose conditions 
 Previous work from our lab described a Puf3RD mutant, Puf3RD-R7A, which has 
four amino acids deleted from the outer surface of the Puf repeat 7 (Houshmandi and 
Olivas, 2005).  This mutant is able to bind COX17 mRNA; however, it is not able to 
stimulate its decay (Houshmandi and Olivas, 2005).  We sought to further characterize 
the mechanism by which this mutant cannot stimulate decay.  Based on our discovery 
that Pop2p is differentially bound to Puf3p in inactivating conditions, we performed 
similar co-ips with our Puf3RD-R7A mutant.  Again, wild-type Puf3RD preferentially 
bound full length Pop2p in dextrose; however, Puf3RD-7A nearly exclusively binds the 
smaller form of Pop2p (Figure 2.7, left panel). In fact, the full length Pop2p is often 
undetectable even in the original input when Puf3RD-R7A is expressed, suggesting that 
the interaction between the full length Pop2p and Puf3p may stabilize full length Pop2p 
(Figure 2.7, left panel).    Dcp1p, Dhh1p and Ccr4p were all able to bind both wild-type 
and the mutant equally (Figure 2.7, left panel).  As a control, Western blot analysis using 
α-FLAG antibody illustrates equal purification levels of Puf3RD and Puf3RD-R7A (Figure 
2.7, right panel).   We hypothesize that the lower form of Pop2p bound to Puf3RD-7A is 
not functional to mediate decay, and is therefore responsible for the previously 
observed stabilization of COX17 mRNA (Houshmandi and Olivas, 2005).   
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Figure 2.7.  Mutant Puf3RD-R7A binds a truncated version of Pop2p. Western blot 
analysis of co-immunoprecipitation assays performed with FLAG-Puf3RDp or FLAG-Puf3RD-
R7A in dextrose conditions.  Myc-DCP1, Myc-DHH1, Myc-CCR4 and Myc-POP2 were co-
immunoprecipitated with Puf3RDp, Puf3RD-R7A (7A) or empty vector (EV) from dextrose 
conditions.  Myc-tagged decay factors that co-purified with Puf3RDp or Puf3RD-R7A were 
detected using anti-Myc antibody (left panel).  As a control, FLAG-Puf3RDp was detected 
using anti-FLAG antibody to determine equal purification between conditions (right panel).  
Experiments were performed in triplicate.   
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The lower form of Pop2p is an N-terminal truncation 
 Previous studies have also observed two forms of Pop2p that exist in S. 
cerevisiae, suggesting biological relevance (Norbeck, 2008).  We have shown that the 
truncated form of Pop2p may be a dominant negative form that cannot stimulate decay 
of Puf3p target mRNAs.  To further characterize the truncated form of Pop2p, we 
purified our FLAG-Puf3RD and FLAG-Puf3RD-R7A in dextrose conditions.  These two 
proteins showed the strongest differential binding of the two forms of Pop2p.  We then 
coomassie stained and excised the two Pop2p bands using a western blot of the same 
sample for reference.  The two species were subjected to mass spectrometry.  The 
results showed that peptide fragments consisting of the first 140 residues were not 
detectable in the lower Pop2p band, supporting the hypothesis that the smaller Pop2p 
is an N-terminal truncation.  
  DISCUSSION 
 The biological role of the Puf family of RNA binding proteins in eukaryotes 
continues to expand.  Recently, Puf proteins in yeast have been implicated in stress 
response (Miller et al., 2014) (Russo and Olivas, submitted).  In response to respiration, 
Puf1p, Puf3p, Puf4p and Puf5p are inactivated and target mRNAs are derepressed 
allowing translation of many stress response genes including YHB1(Miller et al., 2014) 
(Russo and Olivas, submitted).  The inactivation of Puf proteins is rapid and can be 
observed within 2 minutes upon carbon source change from dextrose to galactose 
(Miller et al., 2014) (Russo and Olivas, submitted).  Thorough evaluation of differential 
expression, localization and mRNA binding of Puf proteins in yeast revealed only Puf5p 
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exhibits reduced target mRNA binding.  Thus, the mechanism of inactivation of Puf 
proteins is still unrefined (Miller et al., 2014) (Russo and Olivas, submitted).  Based on 
the rapid activation/inactivation switch for Puf proteins, we hypothesize that the signal 
responsible is likely post-translational.   
Puf proteins provide target specificity by binding to specific mRNAs and direct 
interactions with Pop2p bridge interactions with decay machinery including Dcp1p, 
Dhh1p and Ccr4p ( Goldstrohm et al., 2006; Hook et al., 2007; Lee et al., 2010; Miller 
and Olivas, 2011; Quenault et al., 2011).  Furthermore, Pop2p is phosphorylated by 
Yak1p in response to glucose deprivation and this modification is rapidly removed upon 
glucose addition (Moriya et al., 2001). Therefore, it is plausible that the interaction 
between Pop2p and Puf proteins acts as a switch for repression of target mRNAs.  We 
discovered that the deadenylation step of decay is inhibited in respiration conditions 
and Puf3p binding to Pop2p is reduced in respiration conditions compared to 
fermentation conditions, supporting the hypothesis that interactions between Pop2p 
and Puf3p control repressive activity.  Perhaps phosphorylation of Pop2p upon glucose 
deprivation disrupts specific interactions with Puf3p; however, interactions with other 
proteins are unperturbed.  This hypothesis is further supported by transcriptional shut-
off data in a YAK1Δ strain grown in respiration conditions where repression was 
maintained despite stress conditions.    In addition, Puf3p interaction with a smaller 
form of Pop2p is increased in respiration conditions and a mutant form of Puf3RD with a 
four amino acid deletion of an outer surface binding loop nearly exclusively binds the 
smaller form.  In fact, the full length Pop2p levels in lysate were often reduced in 
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respiration conditions and nearly non-detectable during Puf3RD-R7A expression.  These 
data provide strong support for the smaller version of Pop2p having a biological role as a 
dominant negative inhibitor of repression.  Further support comes from cycloheximide 
treatment of cells followed by a time course evaluation of Pop2p degradation which 
showed that the two species are present at steady state and are stable throughout the 
30 minute time course (Norbeck, 2008).  We have begun to characterize the smaller 
version of Pop2p by mass spectrometry and the limited coverage obtained suggests it is 
an N-terminal truncation.  Further research will biochemically characterize the 
truncated form of Pop2p.   
 We propose a model for carbon source-mediated Pufp inactivation.  In 
response to glucose deprivation Pop2p is phosphorylated by Yak1p.  The modified 
version of Pop2p has reduced binding to Puf proteins; however, binding to other protein 
partners is maintained.  An increase in binding of the truncated Pop2p to Puf proteins 
results in decreased repression of the mRNA target.  This allows an increase in protein 
products derived from Puf target mRNAs to combat stress conditions presented to the 
cell.   
MATERIAL AND METHODS 
Yeast strains 
 Yeast strains used in this study are listed in table 1.2.  For construction of 
yWO270, yWO271 and yWO272 TRP1 was replaced with KanMX by homologous 
recombination using pWO182, a marker swap vector (Voth et al., 2003).  For 
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construction of Myc-tagged cofactor strains, primers containing sequence homologous 
to the C-terminus of each protein and a common Myc region were used to amplify 
Myc9-TRP1 from pCH985 (C.F.J. Hardy).  The Myc9 inserts with homologous ends to the 
gene of choice were transformed into yWO18, yWO270, yWO271, yWO272 and selected 
on –trp media.  Colonies were verified for C-terminus Myc-tag insertion by PCR 
verification using genomic DNA and Western blot analysis.   
Plasmids 
 Plasmids used in this study are listed in table 2.2.  For construction of mutant 
POP2 plasmids, site-directed mutagenesis was used in accordance with manufacturers 
protocol (Stratagene).  All constructs were verified by sequencing.  For construction of 
the HIS-reporter plasmids  
In vivo decay analysis 
Decay of reporter mRNAs was monitored in strains harboring the temperature-
sensitive rbp1-1 RNA polymerase II allele, in which transcription is rapidly halted 
following a shift from 24°C to 37°C.  All yeast transformations were performed by LiOAc 
high-efficiency transformation (Gietz et al., 1995). 
Transcriptional shut-offs were performed as described (Caponigro et al., 1993) in 
the yeast strain yWO7 (rpb1-1), yWO294(rpb1-1, pop2Δ) and yWO292(rpb1-1, yak1Δ).  
pWO224, pWO225 or empty vector was transformed into yWO290.  Strains were grown 
as 200 mL cultures in Yeast extract peptone (YEP) containing 2% dextrose or 2% 
galactose and 100mg/mL Zeocin (excluding yWO7 and yWO292) at 24°C to an OD600 of 
0.4.  The culture was harvested and resuspended in 20 mL YEP containing 8% dextrose 
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or galactose at 37°C, effectively shutting off transcription by the temperature-sensitive 
inactivation of RNA pol II.  Time course samples were taken over a 40 minute time 
period at 37°C.  Total RNA was isolated from yeast samples as described (Caponigro et 
al., 1993), followed by northern blot analysis (Biobond plus nylon membrane-Sigma).  
Northern blots were probed with 32P-end-labeled oWO2, to detect COX17 mRNA.  
Loading was normalized using scRI RNA, a constitutively expressed RNA polymerase III 
transcript, and all imaging and quantification of half-lives were determined by 
ImageQuant software (Molecular Dynamics). 
Transcriptional pulse chase experiments were performed essentially as described 
(Decker and Parker, 1993) on strains yWO52(cox17Δ, rpb1-1) and yWO269(yhb1Δ, rpb1-
1).  Condition regulated expression of COX17 or YHB1 RNA was accomplished by 
transformation of yWO52 or yWO269 with pWO5(Beers et al., 1997) or pWO128(Russo 
and Olivas), respectively in which the expression of the RNA is under the control of 
the GAL UAS. Cultures were grown in 2% raffinose, which does not induce transcription 
of the RNA, to an OD600 of 0.4 or 1.0 for COX17 or YHB1, respectively. Cultures were 
then incubated with galactose to induce transcription of this RNA for 8 min to create a 
pulse of newly transcribed RNAs. Finally, pre-warmed dextrose or galactose was added 
to the media raising the temperature to 37°C effectively repressing transcription of the 
RNAs. Poly(A) tail lengths were monitored using RNaseH reactions as previously 
described (Muhlrad and Parker, 1992)with an oligo complementary to a sequence just 
upstream of the COX17 or YHB1 stop codon (oWO1or oWO894, respectively). Total RNA 
was separated on 6% denaturing polyacrylamide gels at 300V for 6 h, then transferred 
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to nylon membrane for probing with a radiolabeled oligo to COX17 or YHB1 (oWO2 or 
oWO895). 
Puf protein co-immunoprecipitation analysis 
Condition-specific Puf3 repeat domain (RD) co-immunoprecipitation (co-ip) studies were 
performed as follows.  pWO16 (Puf3RD) or pWO15 (empty vector) were transformed 
into yWO187 (Myc-CCR4), yWO188 (Myc-DCP1), yWO189 (Myc-DHH1) or yWO191 
(Myc-POP2).  Cells were grown as 200mL cultures of selective minimal media 
supplemented with 2% dextrose or 2% galactose to an OD600 of 0.4.  Cells were 
harvested and frozen in a 2mL eppendorf tube at -80°C until co-ip was performed.  Cell 
pellets were resuspended in 500µL of co-ip binding buffer containing 50mM Tris-HCl pH 
7.5, 50mM NaCl, 2mM MgCl2, 0.1% NP-40 and 10% glycerol.  Immediately before 
resuspension, 2-mercaptoethanol (0.01%v/v), 1 protease inhibitor tablet per 10mL 
(Roche) and RNASE A (40µg/mL) were added.  100µL of FLAG affinity resin (Sigma) per 
co-ip was equilibrated in 1mL of co-ip binding buffer supplemented with 1mM PMSF 
and 1%BSA for ≥ 1 hour at 4°C.  Resuspended cells were subjected to manual lysing 
using glass beads and vortexing for 1 minute followed by 1 minute on ice (5X).  Lysate 
was quantitated using Bradford reagent (Bio-Rad) and equal amounts of total protein 
were loaded onto the FLAG resin.  A portion of the lysate was saved for input analysis.  
The lysate was allowed to bind to the FLAG resin for 1 hour at 4°C on an end over end 
rocker.  After 1 hour, the beads were spun down and lysate was removed.  The beads 
were then subjected to 3, 5 minute washes with co-ip wash buffer consisting of 50mM 
Tris-HCl pH 7.5, 150mM NaCl, 2mM MgCl2, 0.5% NP-40, and 1mM PMSF.  After the final 
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wash, FLAG-Puf3RD was eluted by competition using 3X FLAG peptide (Sigma).  4µL of a 
5mg/mL 3X FLAG peptide solution was added to 96µL of wash buffer for a final volume 
of 100µL per co-ip sample.  Elution was allowed to proceed for 20 minutes at 4°C with 
end over end rocking.  The beads were separated out by pipetting the co-ip/bead 
mixture into a Spin-X column and centrifuging in a table top centrifuge for 1 minute at 
4°C.  The eluted protein is captured in the flow-through.  Equal volumes of lysate and 
co-ip were loaded onto a 7.5% SDS-PAGE gel for separation and then subjected to 
western blotting.  Often, 2 identical gels were run simultaneously for probing with α-
FLAG (Sigma) for detection of the Puf3RD and α-MYC for detection of co-factors.   
 Condition-specific Puf1, Puf4 and Puf5 co-ips were performed similar to the 
Puf3RD co-ips with the following modifications.  Endogenously TAP-tagged Puf1p, Puf4p, 
Puf5p strains containing an endogenously Myc-tagged POP2 were grown in a 100mL 
culture of YEP in the presence of 2% dextrose or 2% galactose to an OD600 of 1.0.  The 
lysate was allowed to bind to the IGG sepharose 6 fastflow (GE healthcare) or Sepharose 
6B resin for 1 hour at 4°C on an end over end rocker.  TAP-Puf proteins were eluted 
from the beads using 4µL of a 5mg/mL Protein A solution added to 96µL of wash buffer 
for a final volume of 100µL per co-ip sample.  During blocking of the membranes for 
western blotting, a non-specific antibody (α-LRRK2, human) was used to block Protein A 
signal.   
 Puf3RD co-ip was performed in the absence of POP2.    The co-ip experiments 
were performed as described above with the following modifications.  yWO285, 
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yWO290 and yWO291 were transformed with pWO15 (empty vector) or pWO15 
(Puf3RD).    
  Puf3RD co-ip was performed in the presence of POP2 WT (pWO135), pop2 T97A 
(pWO224), pop2 T97D (pWO225) in yWO290 (puf3Δpop2Δ).  Cultures were grown as 
described for the Puf3RD co-ip with the addition of 100mg/mL Zeocin.  Plasmid encoded 
Pop2p was detected using α-His antibody during Western blotting. 
 Puf3RD R7A loop mutant co-ip was performed as described for Puf3RD.  pWO86 
(Puf3RD R7A) was transformed into yWO187 (Myc-CCR4), yWO188 (Myc-DCP1), 
yWO189 (Myc-DHH1) or yWO191 (Myc-POP2).   
Repression assays 
The HIS-COX17 3’ UTR reporter gene contains the MET25 promoter driving the HIS3 
coding region and the COX17 3’ UTR downstream.    The cox17 mt has both canonical 
PREs mutated from UGUA to ACAC by site-directed mutagenesis.  yWO211 (WT), 
yWO212 (pop2Δ) and yWO213 (ccr4Δ) were transformed with each reporter RNA and 
Puf3FL (pWO226).  Additionally, yWO212 was transformed with pWO135, pWO224 or 
pWO225.  For growth assay, colonies were isolated and grown to an OD600 of 0.4-0.6 at 
30 °C and plated on minimal medium with or without Histidine. The HIS3 competitive 
inhibitor 3-aminotriazole was added to increase stringency where indicated. 
Mass spectrum analysis 
For mass spectrum analysis of two isoforms of POP2p, 4 liter cultures were grown using 
yWO191 transformed with pWO16(isolation of full length Pop2p) or pWO86(isolation of 
truncated Pop2p).  Co-ip was performed as described above after appropriate scaling for 
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the larger culture volume.  Total IP was run on a SDS-PAGE gel and coomassie stained 
for band visualization.  The appropriate bands were excised from the gel and frozen.  A 
small portion of the IP was saved for western blot analysis and as a reference for 
excision of POP2p bands.  The gel bands were sent to the University of Missouri-
Colombia for analysis.   
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Table 1.2.  Oligos used in this chapter 
 
 
  
oWO Sequence Use 
1 gccataacccttcatgcactc COX17 cutter 
2 ggttgtcggcagactgtcag COX17 probe 
21 gtctagccgcgaggaagg 7Sr  RNA probe 
834 ccagtcattccaaacggaattcggtccttacccgctgctcgctccacatacgatttaggtgacac POP2::NAT up 
835 gaccgctaactatacgggaataacgcatcaatctcctgtggaagagtgcaatacgactcacta
tagggag 
POP2::NAT down 
875 cagcagccatttaatataggagatcctgtttcggtggctagtttg POP2 T97D up 
876 aaactagccaccgaaacaggatctcctatattaaatggctgctg POP2 T97D down 
877 cagcagccatttaatataggagctcctgtttcggtggctagtttg POP2 T97A up 
878 caaactagccaccgaaacaggagctcctatattaaatggctgctg POP2 T97A down 
879 caatctatgaatgtacaaccg POP2 sequence 
primer 
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Table 2.2.  Plasmids Used in This Study 
Plasmid Description Marker(s) Source 
pWO5 pST 30 pGAL-COX17 Amp
R, LEU2 Olivas and Parker, 
2000 
pWO15 pG-1 derivative/FLAG tag Amp
R
, URA3, TRP1 Schena and 
Yamamoto, 1988 
pWO16 FLAG-PUF3RD Amp
R, URA3, TRP1 Olivas and Russo, 
2014 
pWO135 pACG NT POP2 Zeo
R
 Goldstrohm et al. 
2007 
pWO166 TRP1→URA3 marker swap Amp
R ATCC 87550 
pWO224 pACG NT POP2 T97A Zeo
R This study 
pWO225 pACG NT POP2 T97D Zeo
R This study 
pWO226 pG-1 PUF3 TRP1→URA3 Amp
R, URA3 This study 
pWO227 pMET-HIS3-COX17 3’ UTR Amp
R
, LEU2 This study 
pWO228 pMET-HIS3-COX17 3’ UTR mt Amp
R
, LEU2 This study 
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Table 3.2. Strains used in this study 
Description Strain Genotype Source 
Wild-type yWO7 MATα, leu2-3,ura3-52, rpb1-1 Caponigro et al. 1993 
puf3Δ yWO18 MATa, trp1, ura3-52, leu2-3, his4-539, 
cup1::LEU2(PM), PUF3::NEO 
Olivas and Parker, 2000 
cox17Δ yWO52 MATa, trp1, leu2-3, ura3-52, his3-1, his4-539, 
rpb1-1, COX17::TRP1 
Wendy Olivas 
Myc-CCR4 yWO187 MATa, trp1, ura3-52, leu2-3, his4-539, 
cup1::LEU2(PM), PUF3::NEO, Myc-CCR4,TRP1 
This study 
Myc-DCP1 yWO188 MATa, trp1, ura3-52, leu2-3, his4-539, 
cup1::LEU2(PM), PUF3::NEO, Myc-DCP1,TRP1 
This study 
Myc-DHH1 yWO189 MATa, trp1, ura3-52, leu2-3, his4-539, 
cup1::LEU2(PM), PUF3::NEO Myc-DHH1,TRP1 
This study 
Myc-POP2 yWO191 MATa, trp1, ura3-52, leu2-3, his4-539, 
cup1::LEU2(PM), PUF3::NEO Myc-POP2, TRP1 
This study 
Myc-DHH1, 
POP2Δ 
yWO285 MATa, trp1, ura3-52, leu2-3, his4-539, 
cup1::LEU2(PM), PUF3::NEO, Myc-
DHH1,TRP1,POP2::NTC 
This study 
Myc-DCP1, 
POP2Δ 
yWO290 MATa, trp1, ura3-52, leu2-3, his4-539, 
cup1::LEU2(PM), PUF3::NEO, Myc-
DCP1,TRP1, POP2::NTC 
This study 
Myc-CCR4, 
POP2Δ 
yWO291 MATa, trp1, ura3-52, leu2-3, his4-539, 
cup1::LEU2(PM), PUF3::NEO, Myc-
CCR4,TRP1, POP2:NTC 
This study 
YAK1Δ yWO292 MATα, leu2-3,ura3-52, rpb1-1, YAK1::NTC This study 
POP2Δ yWO294 MATα, leu2-3,ura3-52, rpb1-1, POP2::NTC This study 
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CHAPTER 3:  CONDITIONAL REGULATION OF PUF1P, PUF4P AND 
PUF5P ACTIVITY ALTERS YHB1 MRNA STABILITY FOR A RAPID 
RESPONSE TO TOXIC NITRIC OXIDE STRESS IN YEAST. 
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INTRODUCTION 
 Cells must rapidly adapt to various types of environmental signals and stresses.  
Efficient methods to rapidly alter gene expression in response to such signals include the 
post-transcriptional regulation of mRNA translation and decay rates.  Some of the most 
familiar cases of decay control come from mammalian proto-oncogenes, cytokines, and 
transcription factors, whose mRNAs are targeted for rapid decay in response to 
environmental stimuli (Shim and Karin, 2002). Changes in decay rates of specific 
transcripts are also involved in circadian clock control (Lidder et al., 2005), the cell cycle 
(Penelova et al., 2005), oxidant stress response by CFTR (Cantin et al., 2006) and 
differentiation (Jack and Wabl, 1988).  The regulatory elements for these changes are 
often found within the 3’ untranslated region (UTR) where regulatory RNA-binding 
proteins attach and perform repressive functions. 
 The Puf protein family is a largely conserved class of RNA-binding proteins across 
eukaryotes (Wickens et al., 2002; Miller and Olivas, 2011).  Puf proteins have a diverse 
set of roles including stem cell maintenance, (Forbes and Lehmann, 1998; Parisi and Lin, 
1999; Crittenden et al., 2002; Moore et al., 2003), development and differentiation, 
(Murata and Wharton, 1995), neuronal plasticity (Menon et al., 2004) and stress 
response  (Foat et al., 2005; Miller et al., 2014).  At the molecular level, Puf proteins 
repress mRNAs by interacting with sequence elements typically located in the 3’ UTR of 
target mRNAs.  Once bound to an mRNA, Puf proteins elicit repression either through 
protein interactions that inhibit cap-binding events of translation initiation, or 
interactions with mRNA decay machinery to stimulate deadenylation and decapping 
steps of decay (Goldstrohm et al., 2006; Goldstrohm et al., 2007; Lee et al., 2010; Miller 
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and Olivas, 2011).   
 The Puf family is characterized by a conserved RNA-binding domain consisting of 
eight imperfect repeats of a 36 amino acid sequence, plus short flanking regions. Crystal 
structure analysis of multiple Puf-mRNA complexes has revealed a primarily modular 
binding method wherein conserved amino acids within each repeat contact and stack 
with successive bases along the RNA, though binding specificity and flexibility involves 
some RNA bases flipping out from the protein binding surface (Edwards et al., 2001; 
Wang et al., 2001; Wang et al., 2002; Miller et al., 2008; Wang et al., 2009; Zhu et al., 
2009).  The conserved Puf recognition element (PRE) contains a UGU sequence followed 
by an AU-rich region, though different Pufs bind specific variants of the AU-rich region 
(Murata and Wharton, 1995; Wreden et al., 1997; Zamore et al., 1997; Souza et al., 
1999; Zamore et al., 1999; Nakahata et al., 2001; Tadauchi et al., 2001; Wang et al., 
2001; Wang et al., 2002; Gerber et al., 2004; Jackson et al., 2004).   
 Saccharomyces cerevisiae contains six Puf proteins (Puf1p-Puf6p).  All except 
Puf2p have been shown to stimulate mRNA decay and/or repress translation via 3’UTR 
interaction (Olivas and Parker, 2000; Tadauchi et al., 2001; Gu et al., 2004; Goldstrohm 
et al., 2006; Hook et al., 2007; Ulbricht and Olivas, 2008).  The function of several bona 
fide and putative targets of Puf regulation in yeast relates to stress response (Foat et al., 
2005; Garcia-Rodriguez et al., 2007; Miller et al., 2014). In this work we evaluate YHB1 
mRNA as a putative target of Puf-mediated decay stimulation in yeast.  YHB1 was 
originally identified in a microarray analyzing altered RNA levels in a yeast strain deleted 
of PUFs 1-5 (Olivas & Parker 2000).  The YHB1 3’ UTR contains two overlapping PREs that 
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can potentially be utilized by multiple Puf proteins, though not simultaneously.   
 YHB1 encodes the only known defense protein against nitric oxide (NO) stress in 
S. cerevisiae (Liu et al., 2000).  To counteract the toxic effects of NO, expression of the 
flavohemoglobin Yhb1p is induced, which metabolizes NO into nitrate or dinitrogen 
oxide depending on the aerobic or anaerobic conditions (Foster et al., 2009).  
Concomitant with its function, Yhb1p is localized to both the cytosol and the 
mitochondrial matrix (Cassanova et al., 2005).  The absence of YHB1 causes growth 
inhibition when cells are treated with the aerobic NO donor, Deta-NO (Liu et al., 2000; 
Foster et al., 2009).  The regulation of YHB1 expression occurs at both transcriptional 
and post-transcriptional levels, and by multiple environmental signals.  Transcriptional 
upregulation occurs in response to both NO exposure and the available sugar source 
through independent transcription factor mechanisms, and Yhb1p levels have been 
shown to immediately decrease upon the addition of glucose (Zhu et al., 2006). Within 
yeast cells, mitochondrial cytochrome oxidase produces NO, and the amount of NO 
production is dependent on the amount of respiration in the cell (Li et al., 2011).  The 
addition of glucose limits the need for respiration in yeast cells, which limits NO 
production and the need for Yhb1p.  In addition to transcriptional control, regulation of 
mRNA decay and/or translation rates offers a rapid response to such environmental 
stresses. 
 Our previous work demonstrated that Puf3p stimulates mRNA decay of nuclear-
encoded mitochondrial transcripts in fermentative growth conditions (in glucose) when 
mitochondrial respiration is not required.  However, Puf3p activity is inhibited in 
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ethanol, galactose and raffinose conditions that use mitochondria, thereby stabilizing 
the mitochondrial transcripts for increased translation.  The response to carbon source 
by Puf3p is rapid and not due to altered Puf3p expression (Miller et al., 2014).  The 
ability of other Pufs to respond to stress by altering regulatory capacity for target 
mRNAs is unknown. 
 To further our understanding of condition-specific mRNA decay stimulation by 
Puf proteins, we evaluated the YHB1 3’UTR for the ability to confer Puf regulation.  We 
determined that Puf1p, Puf4p and Puf5p all play a role in stimulating YHB1 mRNA decay 
through binding two overlapping PREs in the YHB1 3’ UTR.  This Puf-mediated decay 
stimulation is inhibited under stress conditions when Yhp1p production is required, with 
reduced Puf5p binding activity contributing to decay inhibition.  However, 
overexpression of Pufs can override such inactivation, and Puf overexpression during NO 
exposure can destabilize YHB1 mRNA, resulting in decreased cell growth.  Together, this 
work advances our understanding of the multifaceted mechanisms of controlling YHB1 
mRNA stability and cell fitness in rapid response to stress. 
RESULTS 
All of the results presented in this section were complete by me. 
YHB1 mRNA is destabilized by multiple Puf proteins 
The yeast YHB1 transcript was first identified as a potential target of Puf protein-
mediated decay stimulation based on its increased expression in a Puf deletion strain 
(Δpuf1-5) verses a wild-type strain (Olivas and Parker, 2000). YHB1 mRNA contains two 
overlapping candidate PREs located in its 3’ UTR (Figure 3.1A). To evaluate YHB1 mRNA 
for control by Puf proteins, decay analysis was performed in a wild-type PUF strain (WT), 
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strains deleted of individual PUFs 1-5, or a quintuple mutant (Δpuf1-5).   To ascertain the 
direct role of Puf protein regulation through the YHB1 3’ UTR, we created a reporter 
vector in which the 3’ UTR of YHB1 is cloned downstream of the stable coding region of 
PGK1.  Prior studies have shown that the 3’ UTRs of Puf-regulated targets are sufficient 
to confer rapid decay to otherwise stable mRNAs (Jackson et al., 2004).  Half-lives were 
determined following transcriptional repression by two simultaneous methods.  First, 
strains containing the temperature-sensitive RNA polymerase II allele (rpb1-1) were 
used to inhibit transcription by shifting to a non-permissive temperature (Herrick et al., 
1990).  Second, promoter-specific transcriptional repression of the PGK1/YHB1 3’UTR 
reporter under the control of the GAL UAS was achieved by shifting from galactose to 
dextrose in the media (Decker and Parker, 1993). 
 In WT yeast the PGK1/YHB1 3’ UTR reporter mRNA decayed with a half-life of 
10.7 ± 1.3 min (Figure 3.1B).  In the puf2Δ and puf3Δ strains the reporter half-life was 
similar to that of WT; however, in the puf1Δ, puf4Δ and puf5Δ strains the reporter half-
life was significantly extended by 1.5 to 2 fold, suggesting Pufs 1, 4 and 5 all contribute 
to the destabilization of YHB1 mRNA (Figure 3.1B).  To evaluate the full extent of Puf 
destabilization on our reporter, we determined the half-life in the Δpuf1-5 strain to be 
24.3 ± 2.2 min (Figure 3.1B).  Both the puf4Δ and puf5Δ strains showed shorter half-lives 
compared to the Δpuf1-5, suggesting that Puf4p and Puf5p do not act redundantly, and 
the level of active Pufs may be limiting the decay rate of YHB1 mRNA.  These data also 
indicate that Puf4p and Puf5p contribute equally to decay stimulation of YHB1 mRNA, 
while Puf1p plays less of a role.  
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A single flexible binding site is required for Puf1p, Puf4p and Puf5p destabilization of 
YHB1 mRNA. 
Previously identified targets of multiple Puf regulation such as HO, HXK1 and TIF1 
mRNAs contain multiple, non-overlapping PREs in their 3’ UTRs (Hook et al., 2007; 
Ulbricht and Olivas, 2008).  In contrast, while the YHB1 mRNA 3’ UTR is also regulated by 
multiple Pufs, it potentially contains two overlapping PREs, such that only one Puf 
protein could bind this region at one time.  To determine if one or both PREs are 
necessary for Puf-mediated decay, we mutated the conserved UGU element within each 
PRE, which has been shown to be required for Puf binding (Jackson et al., 2004; Ulbricht 
and Olivas, 2008).  If a particular UGU element is necessary for Puf-mediated decay, its 
mutation will extend the mRNA’s half-life in a wild-type PUF strain.  To test this 
hypothesis, we either mutated the first UG in the first PRE while leaving the second PRE 
intact (site #1 mutant) or mutated the UGU elements in both PREs (site #2 mutant) 
(Figure 3.2A).  We did not make mutations in the second UGU alone because this would 
also disrupt the first PRE.  The site #1 mutant mRNA, PGK1/yhb1-1, decayed with a half-
life 1.5 fold longer than the WT mRNA, suggesting that disruption of the first PRE 
inhibits optimal regulation of the reporter, although the second PRE can still function to 
mediate decay in the absence of the first PRE (Figure 3.2B).  The site #2 mutant mRNA, 
PGK1/yhb1-2, decayed with a half-life 2.4 fold longer than the WT mRNA, similar to the 
half-life in the Δpuf1-5 strain, indicating that all Puf-mediated decay stimulation acts 
through these overlapping PREs.  Unlike other known targets of multiple Puf decay  
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regulation, YHB1 mRNA is unique because only one binding site containing overlapping 
PREs is necessary and sufficient to confer destabilization by three Puf proteins. To 
evaluate whether differential RNA binding contributes to the differential roles of Puf1p, 
Puf4p and Puf5p in decay stimulation, as well as the decreased decay stimulation with 
the mutant sites, we performed in vitro binding and gel mobility shift assays.  
Glutathione S-transferase (GST)-tagged Puf proteins were purified from Escherichia coli 
and incubated with radiolabeled RNA encompassing the YHB1 3’ UTR PRE region (33 nt) 
with either the wild-type, site #1 mutant or site #2 mutant sequence (Figure 3.2A).  The 
resulting complexes were separated on a native polyacrylamide gel.  As shown in Figure 
3.2C and graphically in Figure 3.2D, Pufp+RNA complex formation was reduced with the 
site #1 mutant RNA relative to wild-type, and even further reduced with the site #2 
mutant RNA for all three Puf proteins, with Puf5p binding being most dramatically 
reduced.  Thus, decreased decay stimulation of the mutant sites correlates with 
decreased binding capacity of the Puf proteins.  To compare binding between the Puf 
proteins, increasing concentrations of Puf proteins were incubated with either the wild-
type or site #1 radiolabeled RNA sequence, and complexes were analyzed on native 
polyacrylamide gels.  As shown in Figure 3.2E, relative levels of Puf5p binding with wild-
type RNA was significantly larger than with Puf1p or Puf4p, with Puf1p showing the least 
levels of binding.  This pattern of differential binding was also seen with the site #1 RNA, 
but the relative differences between the Pufs were not as large.  These experiments 
support the idea that differential binding capacity between Puf1p, Puf4p and Puf5p 
likely contributes to their differential roles in decay stimulation, especially for the lesser  
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role of Puf1p, though Puf4p appears to have a greater role in decay than its binding 
capacity would suggest. 
Overexpression of Puf4p or Puf5p enhances decay of YHB1 mRNA 
To determine if overexpression of Puf proteins can increase the decay rate of 
PGK1/YHB1 3’UTR mRNA, we co-expressed our reporter construct with Puf 
overexpression constructs consisting of either the repeat domain (RD) or full length (FL) 
Puf protein in the WT strain.  All FLAG-tagged constructs were validated for expression 
by western blot analysis (Figure 3.3).  As expected from the deletion analysis, 
overexpression of Puf2p or Puf3p had no effect on the decay of our reporter (Figure 
3.4).  Unexpectedly, overexpression of either Puf1RD or Puf1FL had no effect on decay 
(Figure 3.5A), suggesting that Puf1p cannot enhance the normal decay stimulation by 
Pufs on this mRNA, likely due to its inferior binding.  In contrast, overexpression of 
Puf4FL, Puf4FL/CEN vector, Puf5FL, or Puf5RD enhanced decay of the reporter, with 
Puf4FL/CEN having the greatest effect by decreasing the half-life >2 fold (Figure 3.5A).  
These data indicate that the levels of Puf4p and Puf5p are normally limiting the decay 
rate of YHB1 mRNA, and/or these Pufs can out-compete wild-type levels of Puf1p for 
binding/decay stimulation.  It is unclear why the Puf4RD did not enhance decay.  It is 
possible that sequences outside the repeat domain are important for activity.  
Alternatively, all over-expression constructs were made in a 2µ vector except the 
Puf4FL/CEN made in a CEN vector, and this Puf4FL/CEN showed greater activity in 
enhancing decay than Puf4FL from the 2µ vector.  While both the CEN and 2µ vectors 
utilize the constitutive GPD promoter to express Puf4FL, it is possible that expression 
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from the high-copy 2µ vector adversely affects Puf activity, perhaps through aggregation 
of the larger pool of Puf proteins.  In contrast, the low-copy CEN vector may overexpress 
enough Puf4FL to enhance decay, but not so much as to aggregate.  Moreover, Puf4RD 
is expressed ~7-fold higher than Puf4FL from the 2µ vector (and ~3-fold higher than 
Puf5RD), which may contribute to its further aggregation and loss of activity (Figure 3.3).  
During the construction of the Puf5RD overexpression vector, a mutant was randomly 
generated during PCR at residue 177 of Puf5p, with asparagine changed to aspartic acid.  
This residue is directly downstream of a known phosphorylated residue at 176 
(Bodenmiller et al., 2010) (PhosphoPep).  Overexpression of this Puf5RD mutant 
decreased the half-life of our reporter >2 fold, showing stronger activity than the wild-
type Puf5RD protein (Figure 3.5A).  Since expression of this mutant was not significantly 
different from the wild-type Puf5RD (Figure 3.3), this result suggests that the local 
charge and perhaps phosphorylation in this region enhances Puf5 activity. 
Overexpression of Puf4p requires a functional PRE to enhance decay 
We next sought to determine if the enhanced decay resulting from the overexpression 
of Puf proteins specifically acts through a functional PRE.  Using our mutant reporter 
constructs, we performed transcriptional repression assays in the presence of Puf1FL, 
Puf4FL/CEN or Puf5FL overexpression and evaluated reporter half-life.  With the site #1 
mutant (yhb1-1), which normally decays with a half-life of 17.0 +/- 1.5 min (Figure 3.2B), 
both Puf4FL/CEN and Puf5FL could stimulate rapid decay to the same extent as with the 
wild-type YHB1 3’UTR (Figure 3.5B).  These results indicate that Puf4p or Puf5p 
overexpression facilitates enhanced decay by using the second UGU element.  Puf1FL 
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overexpression also rescued decay of the yhb1-1 mRNA to near WT YHB1 levels.  Thus, 
while Puf1FL overexpression cannot enhance decay beyond the endogenous rate, it can 
facilitate decay of the mutant through the second UGU site.  In contrast, when both 
UGU sites are mutated (yhb1-2), Puf4FL/CEN overexpression could not fully rescue 
decay, as the mutant yhb1-2 showed a nearly 3-fold increase in half-life compared to 
WT (Figure 3.5B).  These data suggest that the enhanced decay mediated by Puf 
overexpression depends on binding to a functional PRE.  We also examined HXK1 mRNA, 
a second known target destabilized by Puf1p, Puf4p and Puf5p (Ulbricht and Olivas, 
2008).  In the presence of Puf4FL/CEN overexpression, the half-life of the PGK1/HXK1 
3’UTR construct was decreased 2-fold, indicating that the enhanced decay facilitated by 
overexpression of Puf4p is not limited to a single target mRNA (Figure 3.5C). While 
Puf4FL/CEN overexpression was unable to enhance decay of the yhb1-2 mutant to the 
level of the WT construct, the decay of the yhb1-2 mutant was still faster in the 
presence of Puf4FL/CEN overexpression as compared to endogenous levels of Puf 
proteins.  It is possible that increased levels of Puf4p may allow for utilization of other 
UGU elements in the YHB1 3’UTR that are not consensus PREs (Figure 3.1A).  To 
examine off-target effects of Puf4FL/CEN overexpression, we examined the decay rate 
of a PGK1/PGK1 3’UTR construct that is not under Puf protein regulation and contains 
no 3’ UTR UGU elements (Ulbricht and Olivas, 2008).  Puf4FL/CEN overexpression did 
not substantially decrease the half-life of this non-specific target, indicating that 
enhanced decay by Puf overexpression is specific to target mRNAs (Figure 3.5D).  
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Expression of Puf1p, Puf4p or Puf5p rescues decay of YHB1 mRNA in the absence of 
other Pufs 
To evaluate the ability of individual Puf proteins to stimulate YHB1 mRNA decay in the 
absence of other Puf proteins, we performed individual Puf rescue studies in the Δpuf1-
5 strain by co-expressing our reporter construct with constructs containing the full-
length or repeat domain of Pufs 1, 4 or 5.  In the absence of PUFS 1-5, exogenous 
overexpression of Puf1FL or its RD was able to rescue decay to levels similar to the 10.7 
+/- 1.3 min half-life seen in the wild-type PUF strain (Figure 3.6A).  Thus, while Puf1p 
overexpression was not able to enhance decay faster than wild-type rates when other 
Puf proteins are present, it is able to facilitate decay of YHB1 on its own.  Moreover, the 
repeat domain of Puf1p is sufficient for this activity.  Exogenous expression of either 
Puf4FL or its RD, or Puf5FL or its RD was able to rescue decay to levels faster than that 
seen in the wild-type PUF strain (Figure 3.6A, B).  These data illustrate that either the 
full-length or the repeat domain of Puf4p or Puf5p is individually sufficient to facilitate 
enhanced decay of YHB1, demonstrating no need for different Pufs to act synergistically 
when overexpressed, and further supporting the idea that endogenous levels of Puf 
proteins are limiting YHB1 decay.  Even alone, Puf4p and Puf5p are more active than 
Puf1p, likely due to their enhanced binding capacity.  It is interesting that the Puf4RD 
facilitated enhanced decay in the absence of other Pufs, while it did not enhance the 
endogenous rate of decay in the presence of other Pufs.  The Puf4RD that is available for 
binding (and not potentially aggregated) may be less able to compete with endogenous 
Puf4p and Puf5p for RNA binding.  
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Stimulation of YHB1 mRNA decay by Puf proteins is dependent on the available 
carbon source 
Steady-state expression profiles of mRNAs containing putative PREs show altered 
expression levels in response to carbon source, suggesting that Puf protein regulation of  
these mRNAs is dependent on the available carbon source (Foat et al., 2005).  Yhb1p 
levels have been shown to decrease immediately upon glucose addition (Zhu et al., 
2006).  This result is consistent with reduced mitochondrial respiration in the presence 
of glucose, which would decrease the production of NO and the need for Yhb1p.  Post-
transcriptional regulation of YHB1 mRNA decay could contribute to such rapid changes 
in protein production.  To assess the effects of carbon source on Puf-mediated decay of 
YHB1 mRNA, we performed transcriptional repression assays of our reporter constructs 
using only temperature-shift to mediate repression in the continual presence of 
galactose, as compared to all of our prior analyses of YHB1 decay in which dextrose was 
added at the time of transcriptional repression.  In the presence of continual galactose, 
the YHB1 half-life was extended 3-fold from that found in dextrose (Figure 3.7A), similar 
to the half-life of the Δpuf1-5 strain.  This result suggests that Puf-mediated decay is 
inhibited in galactose.  To further examine the effect of carbon source on a target of 
Puf1p, Puf4p and Puf5p destabilization, we examined our HXK1 reporter. Similar to 
YHB1, the HXK1 reporter showed a 4-fold extension of half-life in the presence of 
galactose as compared to dextrose (Figure 3.7B).  To verify that this extension is not a 
global effect on mRNA decay and confirm that transcriptional repression of the GAL UAS 
is complete with only temperature-shift, we evaluated the MFA2/MFA2pG 3’UTR 
reporter, which is not under the control of Puf proteins.  This reporter decayed similarly 
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in both dextrose and galactose conditions, suggesting that changes in carbon source do 
not affect global mRNA decay (Figure 3.7C).  This negative control also eliminates the 
possibility that the GAL UAS promoter is leaky when performing temperature-mediated 
transcriptional repression in the presence of galactose.  Additionally, the YHB1 half-life 
was similar in the Δpuf1-5 strain in galactose or dextrose conditions, mirroring galactose 
conditions in a WT strain (Figure 3.4).  These data suggest that decay stimulation by 
Puf1p, Puf4p and Puf5p is inhibited in respiration conditions (galactose) and active in 
fermentation conditions (dextrose).  The results also imply that the switch from 
galactose to dextrose performed in all of our prior transcriptional repression assays 
leads to a very rapid activation of Puf-mediated decay.  Given the rapid activation of Puf 
activity upon dextrose addition at the time of transcriptional repression, we hypothesize 
that a post-translational mechanism such as phosphorylation is responsible for changes 
in Puf activity. Such mechanisms may affect protein localization or mRNA binding 
affinity. 
Stimulation of YHB1 mRNA decay by Puf proteins is dependent on the culture density 
 Global expression studies suggest that culture density may also alter Puf 
regulation (Foat et al., 2005).  To test this possibility, transcriptional repression assays 
were performed at elevated OD600 values as compared to an OD600 of 1, which was used 
in our prior analyses.  In cell density conditions of OD600=2 and OD600=3, we observed an 
extension of half- life ≥ 3 fold, similar to that observed in galactose conditions (Figure 
3.7D).  To control for any global effects of elevated OD600 on mRNA decay, we examined 
the MFA2/MFA2pG reporter and observed identical half-lives at OD600=1 and OD600=2,  
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indicating that the increase in mRNA stability is specific to targets under the control of 
Puf proteins (Figure 3.7E). 
Overexpression of Puf proteins abrogates condition-specific inhibition of mRNA 
decay 
To investigate whether overexpression of Puf protein levels can rescue Puf-
mediated decay of target mRNAs in normally inactivating conditions, we first performed 
transcriptional repression assays in continual galactose in the presence of Puf4FL/CEN 
overexpression.  The YHB1 reporter decayed rapidly, resulting in a half-life 6-fold shorter 
than without Puf4FL/CEN overexpression (Figure 3.8A).  Similar results were observed 
for Puf5RD overexpression (Figure 3.4).  To validate this phenomenon with other Puf 
targets, we analyzed decay of our HXK1 reporter.  Again, rapid decay was rescued in 
continual galactose when Puf4FL/CEN was overexpressed (Figure 3.8B).  We next 
examined if the inhibition of Puf-mediated decay at elevated culture density could be 
overcome by Puf overexpression.  At the elevated OD600=2, Puf4FL/CEN overexpression 
resulted in a 5-fold shorter half-life than without overexpression.  These results suggest 
that the condition-specific Puf inactivation signal is limiting in cells (Figure 3.8C).The 
regulation of YHB1 expression occurs at both transcriptional and post-transcriptional 
levels, and by multiple environmental signals.  Transcriptional upregulation occurs in 
response to both NO exposure and the available carbon source through independent 
transcription factor mechanisms (Zhu et al., 2006).  We have shown that Puf1p, Puf4p 
and Puf5p destabilize YHB1 mRNA post-transcriptionally in a carbon source and culture 
density dependent manner.  To evaluate biological relevance of Puf regulation, we 
examined the effects of altering YHB1 mRNA decay on cell fitness when exposed to 
exogenous NO.  Previous studies have shown that a yhb1Δ strain exhibits severe growth 
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defects when exposed to 3mM DETA NONOate (Liu et al., 2000).  We hypothesized that 
overexpression of Puf4p would lead to a decrease in the pool of Yhb1p needed to 
combat exogenous NO stress, resulting in a growth defect.  We first recapitulated the 
severe growth defect observed by Liu et al. in a yhb1Δ strain when exposed to 3mM 
DETA NONOate (Figure 3.8D).  As predicted, overexpression of Puf4FL/CEN resulted in a 
significant reduction in growth upon DETA NONOate exposure (Figure 3.8D).  Analysis of 
steady-state levels of endogenous YHB1 mRNA showed reduced levels with Puf4FL/CEN 
overexpression and increased levels in a puf4Δ or Δpuf1-5 strain compared to wild-type 
(Figure 3.8D).  Finally, we evaluated endogenous YHB1 mRNA decay in response to Puf 
overexpression.  In a wild-type strain with empty vector, the half-life of endogenous 
YHB1 mRNA was >40 minutes (Figure 3.8E).  In contrast, Puf4FL/CEN overexpression in 
the wild-type strain showed a half-life of 13.5 ± 2 minutes.  Overexpression of Puf5RD in 
the Δpuf1-5 strain similarly increased decay from a >40 minute half-life to 14.6 ± .34 
minutes.  To gain insight into our hyperactive Puf5RD mutant, we overexpressed it in 
the Δpuf1-5 strain and observed a 3-fold decrease in half-life beyond that observed with 
the wild-type Puf5RD (Figure 3.8E). These data demonstrate that altered mRNA levels 
resulting from changes to YHB1 decay by Puf proteins influences the cell’s response to 
toxic NO.  
Puf protein inactivating conditions alters Puf5p mRNA binding. 
To begin to dissect the mechanism by which Puf1p, Puf4p and Puf5p activity is 
altered by conditions, we first examined whether the expression levels of these Puf 
proteins are altered in different carbon sources.  We utilized endogenously TAP-tagged 
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Puf strains to evaluate steady-state Puf protein levels in cells grown in dextrose and 
galactose.  Puf1p, Puf4p and Puf5p levels did not change between dextrose and 
galactose conditions, eliminating the possibility that decreased Puf activity in galactose 
is due to decreased protein levels (Figure 3.9A).  This result supports our hypothesis that 
changes in Puf activity are due to a post-translational mechanism.  Next, we investigated 
condition-specific localization of Puf1p-GFP, Puf4p-GFP and Puf5-GFP.  No changes in 
localization of Puf1p, Puf4p or Puf5p were observed between dextrose and galactose 
conditions, eliminating altered localization as being responsible for Puf inactivation in 
galactose (Figure 3.9B).  Finally, we assessed if mRNA binding was inhibited in galactose 
conditions.  We used qPCR to quantitate the amount of mRNA that co-purified with TAP-
tagged Puf1p, Puf4p and Puf5p from cells grown in dextrose or galactose.  Both YHB1 
and HXK1 mRNAs were analyzed as positive binding targets, while CBS1 mRNA was 
analyzed as a negative control target to ensure we enriched for specific targets after Puf 
protein immunoprecipitation (IP).  As shown in Figure 3.9C (top graphs), YHB1 and HXK1 
were both enriched following IP with Puf1p, Puf4p and Puf5p from both dextrose and 
galactose conditions as compared to –RT control reactions (albeit to different levels), 
while there was no enrichment of CBS1 mRNA.  We next directly compared levels of 
YHB1 and HXK1 mRNAs that copurified with Puf proteins from dextrose or galactose 
conditions after normalizing for differences in IP efficiency of the Puf proteins and 
setting the levels found in galactose arbitrarily to 1 (Figures 3.9C bottom graphs, 9.3D).  
For both Puf1p and Puf4p, no significant changes in binding to either target mRNA could 
be detected between conditions, especially given the large difference in values obtained 
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from the two trials with YHB1 mRNA as shown by the large error bars.  In contrast, 
Puf5p binding to each target mRNA was consistently decreased in galactose conditions.  
Thus, condition-dependent binding to target mRNAs by Puf5p may contribute to its 
altered decay activity.    
DISCUSSION   
The flexibility of Puf proteins to regulate target mRNAs is increasingly evident.  
Systematic analyses identified 90 yeast transcripts that co-purified with more than one 
Puf protein (Gerber et al., 2004).  Several established targets of multiple Puf regulation 
contain multiple, nonoverlapping PREs, allowing simultaneous Puf binding (Hook et al., 
2007; Ulbricht and Olivas, 2008).  Some of these PREs are also flexible enough to bind 
two different Puf proteins, including Puf1p and Puf5p alternatively binding a single site 
in TIF1 mRNA (Ulbricht and Olivas, 2008), and Puf4p and Puf5p alternatively binding a 
single site in HO mRNA (Hook et al., 2007).  Since different Puf proteins favor binding to 
distinct PREs, the basis for this flexibility derives from the ability of Puf proteins to flip 
out one or more bases from the binding surface to accommodate non-canonical/extra 
bases within the 8 nucleotide binding site (Gupta et al., 2008; Miller et al., 2008; Koh et 
al., 2009; Lu et al., 2009; Valley et al., 2012). This work investigates a novel target of 
multiple Puf regulation, YHB1 mRNA, containing two overlapping PREs in its 3’ UTR such 
that only one Puf protein can bind at one time.  The first PRE in YHB1 does not conform 
to either a Puf4p or Puf5p binding site, while the second PRE conforms to the canonical 
binding site for Puf5p (UGUANNNNUA) (Gerber et al., 2004).  Yet, YHB1 is destabilized 
by Puf1p, Puf4p and Puf5p (Figure 3.1).  Specifically, all three Pufs can bind and act  
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through the second PRE, though both PREs contribute to full Puf-mediated decay 
stimulation (Figure 3.2, 3.5).  It is proposed that Puf4p and Puf5p both bind to the 
sequence (UGUANNAUA), where the N bases at nucleotides 5 and 6 flip out from the 
Puf binding surface, while only Puf4pbinds the sequence (UGUANANUA), where 
nucleotides 5 and 7 flip out (Valley et al., 2012).  However, neither overlapping PRE in 
YHB1 conforms to either of these sequences, illustrating the uniqueness of YHB1 as a 
target of multiple Puf regulation and implicating additional modes of base recognition 
and base flipping by Puf1p, Puf4p and Puf5p than previously described. 
 The binding and destabilization of YHB1 mRNA by Puf1p, Puf4p and Puf5p 
indicate competition between Pufs.  The extension of half-life in the puf1Δ strain was 
smaller than in the puf4Δ or puf5Δ strains, implying different binding and/or regulatory 
properties between Pufs.  Our in vitro binding data suggest that inferior binding of 
Puf1p to the YHB1 PREs likely contributes to its lesser role in decay stimulation, while 
the superior binding of Puf5p likely contributes to its larger role in decay.  We also 
demonstrate that endogenous levels of Puf proteins are limiting, as overexpression of 
Puf4p or Puf5p in a wild-type strain facilitates more rapid decay of YHB1 mRNA 
compared to wild-type (Figure 3.5A).  In contrast, Puf1p overexpression in a wild-type 
strain had no effect on YHB1 mRNA decay, which is likely a result of its inferior binding 
activity.  However, any single deletion of PUF1, PUF4, or PUF5 results in a decay 
phenotype, demonstrating that each Puf is important for fine-tuned regulation of YHB1. 
Overexpression of a mutant form of the Puf5RD enhanced YHB1 decay better 
than WT Puf5RD (Figure 3.5).  This N→D mutation at residue 177 neighbors a known 
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phosphorylated serine at 176 (Bodenmiller et al., 2010) (PhosphoPep).  We hypothesize 
that the increased activity is due to the constitutive charge mimic in this region.  
Phosphorylation of Puf proteins has been shown to either stimulate activity, such as the 
case for human Pum1 (Kedde et al., 2010), or inhibit activity as seen with yeast Puf6 
(Deng et al., 2008).  Future research will evaluate the potential role of Puf5p 
phosphorylation in activity.  Differential phosphorylation could lead to altered RNA 
binding or altered interactions with other proteins. 
In the absence of other Pufs, overexpression of Puf1p, Puf4p or Puf5p is 
sufficient to rescue decay of YHB1 mRNA (Figure 3.6).  Thus, in the absence of 
competition from other Pufs, Puf1p is capable of binding and stimulating decay, even 
though it is not normally as active as Puf4p or Puf5p.  The repeat domains of Puf1p, 
Puf4p and Puf5p are also sufficient to rescue decay of YHB1 mRNA, demonstrating that 
all sequences necessary for both binding and decay stimulation are present (Figure 3.6). 
 Yhb1p is the only known defense against NO stress in Saccharomyces cerevisiae 
(Liu et al., 2000).  Upon exposure to NO, YHB1 expression is increased due to 
transcriptional activation as well as post-transcriptional regulation (Foster et al., 2009).  
Here we demonstrate that inhibition of Puf-mediated decay contributes to the 
stabilization and increased levels of YHB1 mRNA in respiratory conditions (Figure 3.7).  
During respiration, mitochondrial cytochrome oxidase produces NO proportional to the 
cellular respiration level (Li et al., 2011)).  We have previously shown that decay 
stimulation by Puf3p, but not mRNA binding, is inhibited by respiratory conditions such 
as galactose (Miller et al., 2014).  This inactivation allows stabilization of Puf3p target 
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mRNAs encoding mitochondrial proteins, therefore increasing mitochondrial production 
under respiratory conditions (Figure 3.10).  Like Puf3p, we propose that Puf1p, Puf4p 
and Puf5p are also inactivated in respiratory conditions.  Such inactivation would allow 
for the increased production of Yhb1p to rapidly combat toxic NO levels accumulating in 
the cell (Figure 3.10).  The stress of high cell density also inactivates Puf1p, Puf4p and 
Puf5p, resulting in stabilization of YHB1 mRNA to combat this otherwise toxic event 
(Figure 3.7).  In fermentation conditions or without exogenous stress, Puf1p, Puf3p, 
Puf4p and Puf5p are active to stimulate rapid turnover of their target mRNAs, whose 
protein products are not needed under these conditions. 
We further demonstrate the biological relevance of this mechanism by 
increasing the decay rate of endogenous YHB1 mRNA by Puf4p overexpression during 
exposure to exogenous NO, which resulted in decreased cell growth (Figure 3.8).  To 
correlate this growth phenotype with levels of YHB1 mRNA, we determined that steady-
state levels of endogenous YHB1 mRNA increase in puf4Δ and Δpuf1-5 strains, but 
decrease with Puf4p overexpression (Figure 3.8).  Overexpression of Puf4p could 
stimulate rapid decay of YHB1 mRNA even in galactose and high cell density, suggesting 
that the high levels of Puf4p were overwhelming normal inactivation of Puf regulatory 
function (Figure 3.8).  These results highlight the importance of the precise balance of 
Puf proteins normally in the cell to promote decay or respond to inactivation signals, 
possibly phosphorylation changes, under stress conditions.   
Condition-specific inhibition of Puf protein activity could be due to decreased Puf 
expression, altered localization, reduced mRNA binding capacity, disruption of  
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interactions with other proteins, or altered activity of protein co-factors.  We found that 
the inhibition of Puf1p, Puf4p and Puf5p activity in galactose is not due to decreased 
expression or altered localization.  Examination of Pufp-mRNA binding interactions in 
vivo demonstrated that Puf1p and Puf4p bind target mRNAs in both activating and 
inactivating conditions.  However, Puf5p showed reduced binding in inactivating 
conditions, which likely contributes to the condition-specific inhibition of Puf-mediated 
decay stimulation of YHB1 given that Puf5p plays the largest role in YHB1 decay.  Such 
reduced binding by Puf5p is a unique mechanism of inactivation, as previous studies 
with Puf3p demonstrated that its mRNA binding was enhanced in galactose conditions 
(Miller et al., 2014).  Further research will dissect the mechanism of Puf5p binding 
inhibition, as well as possible changes to the interactions with or activity of protein co-
factors. 
  In this work, we have elucidated a key role for Puf proteins in response to 
elevated levels of NO whereby stabilization of a specific target mRNA (YHB1) leads to 
increased cell fitness.  Puf proteins may also play a role in translational inhibition of 
YHB1 mRNA.  Previous work has demonstrated that Puf4p acts exclusively through 
stimulation of deadenylation, while Puf5p can repress mRNAs through additional 
mechanisms, including translational inhibition (Hook et al., 2007; Chritton and Wickens, 
2010).  A global study to identify mRNAs whose translation is dependent on Eap1p 
identified YHB1, and Puf activity has been shown to be dependent on Eap1p (Cridge et 
al., 2010; Blewett and Goldstrohm, 2012).  It is plausible that Puf proteins also 
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translationally repress YHB1 mRNA through Eap1p by disrupting interactions with the 
initiation machinery and promoting decapping. 
MATERIALS AND METHODS 
Oligonucleotides, Plasmids and Yeast Strains 
 All yeast strains, plasmids and oligonucleotides are listed in Supplementary 
Tables 1, 2, and 3, respectively.  Strain yWO268 was made by transforming yWO204 
with pWO183 after digestion with BamHI to replace URA3 with KanMX3.  Transformants 
were plated on YPD plates containing 300µg/mL geneticin.  Colonies were isolated and 
back-plated on media lacking uracil to verify loss of URA3.  Strain yWO269 was made by 
replacement of YHB1 with URA3 in yWO7.  URA3 was amplified from pWO15 with YHB1 
flanking regions using primers oWO77 and oWO78.  The PCR product was transformed 
into yWO7, with selection on media lacking uracil.  Deletion of YHB1 was verified by 
colony PCR and northern blot analysis.      
PUF Overexpression Plasmids 
The PUF1 ORF was amplified from genomic DNA using primers oWO466 and 
oWO467.  The PUF1RD was amplified from pWO48 with primers oWO468 and oWO145.  
The PCR products were inserted into the BamHI and SalI sites of pWO15 3’ of the FLAG 
tag and under the control of the constitutive GPD promoter to create pWO114 (PUF1 
full-length) and pWO115 (PUF1RD). 
PUF2RD was amplified from genomic DNA using primers oWO570 and oWO571.  
The PCR product was inserted into the BamHI and SalI sites of pWO15 to create 
pWO192. 
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pWO16 was created by removing the PUF3RD from pWO14 using BamHI and SalI 
and inserting into the respective sites in pWO15. 
 The PUF4 ORF was amplified from genomic DNA using primers oWO610 and 
oWO611.  The PUF4RD was amplified from genomic DNA using primers oWO638 and 
oWO611.  The PCR products were inserted into the BamHI and SalI sites of pWO15 to 
create pWO193 (PUF4RD) and pWO194 (PUF4 full-length).  pWO116 (pRS415-GPD-
PUF4) was a kind gift from Marvin Wickens. 
 The PUF5 ORF was amplified from pWO18 using primers oWO612 and oWO613.  
The PUF5RD was amplified from pWO18 using primers oWO568 and oWO569.  The PCR 
products were inserted into the BamHI and SalI sites of pWO15 to create pWO195 
(PUF5RD), pWO196 (PUF5 full-length) and pWO200 (PUF5RDmut).  All constructs were 
verified by sequencing. 
Protein Expression and Purification 
 The GST-PUF1 fusion construct (pWO201) was made by PCR amplification of 
Puf1 with BamHI and NotI restriction sites from yeast genomic DNA using primers 
oWO865 and oWO866.  The resulting fragment was then inserted into pGEX-3X 
(Amersham Biosciences) and validated by sequencing and western blot.  The GST-PUF4 
fusion construct (pWO202) was made similarly with the modification of using restriction 
sites EcoRI and NotI, and primers oWO867 and oWO868.  The GST-PUF fusion constructs 
pWO18, pWO201, and pWO202 were transformed into the protease-deficient E. coli 
strain BL-21 and GST fusion proteins were purified as recommended by the 
Russo, Joseph, UMSL  p.116 
 
manufacturer.  Protein eluates were dialyzed into 50mM Tris-HCL (pH 8.0), and 
expression products were verified by Western blot analysis with anti-GST antibody. 
PGK1-YHB1 3’ UTR Reporter Plasmids 
pWO127 (URA3 marker) and pWO128 (LEU2 marker) were made by PCR 
amplification of the YHB1 3’ UTR from genomic DNA using primers oWO262 and 
oWO263.  For pWO127, the PCR product was inserted into pRS227 (Heaton et al., 
1992)3’ of the PGK1 ORF between the SacI and HindIII sites.  For pWO128, the PGK1-
YHB1 3’UTR insert was cut from pWO127 and inserted into pWO61 between the PvuII 
sites. 
pWO129 (URA3 marker) was created by PCR-based in vitro site-directed 
mutagenesis of the YHB1 3’ UTR PRE sequence UGUAUGUA to ACAAACAA using primers 
oWO480 and oWO481, in accordance with manufacturers recommendations 
(Stratagene QuikChange XL site-directed mutagenesis kit).  pWO197 (URA3 marker) was 
created by site-directed mutagenesis of the PRE sequence UGUAUGUA to ACUAUGUA 
using primers oWO513 and oWO514.  pWO199 (LEU2 marker) was made by performing 
a URA3 to LEU2 marker swap on pWO197 using pWO162 (ATCC product #87552) 
according to ATCC instructions.  All constructs were verified by sequencing. 
In Vivo YHB1 Decay Analysis of Puf Deletion Mutants 
Decay of reporter mRNAs was monitored in strains harboring the temperature-
sensitive rbp1-1 RNA polymerase II allele, in which transcription is rapidly halted 
following a shift from 24°C to 37°C.  All yeast transformations were performed by LiOAc 
high-efficiency transformation (Gietz et al., 1995). 
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 Transcriptional shut-offs were performed as described (Caponigro et al., 1993) in 
yeast strains containing pWO127 or pWO128, which express a fusion RNA containing 
the PGK1Δ82 ORF and YHB1 3’UTR, with transcription regulated by the GAL UAS.  
pWO127 was transformed into yWO7 (WT), yWO102 (puf1Δ), yWO43 (puf3Δ), yWO105 
(puf4Δ) and yWO268 (Δpuf1-5).  pWO128 was transformed into yWO48 (puf2Δ), yWO49 
(puf5Δ) and yWO204 (Δpuf1-5).  Transcriptional shut-offs of PGK1/yhb1 mRNA mutants 
were performed in yWO7 (WT) containing pWO129 or pWO197.  Strains were grown as 
200 mL cultures in selective minimal media containing 2% galactose at 24°C to an OD600 
of 1.0.  Half of each culture was harvested and resuspended in 20 mL selective media 
containing 8% dextrose at 37°C, effectively shutting off transcription by both the 
temperature-sensitive inactivation of RNA pol II as well as carbon source inactivation of 
the GAL UAS.  Time course samples were taken over a 40 minute time period at 37°C.  
Total RNA was isolated from yeast samples as described (Caponigro et al., 1993), 
followed by northern blot analysis (Biobond plus nylon membrane-Sigma).  Northern 
blots were probed with 32P-end-labeled oWO105, oWO159 or oWO447 to detect HXK1 
3’ UTR, YHB1 3’UTR, or PGK1 3’ UTR, respectively.  Loading was normalized using scRI 
RNA, a constitutively expressed RNA polymerase III transcript, and all imaging and 
quantification of half-lives were determined by ImageQuant software (Molecular 
Dynamics). 
In Vitro Binding Assays 
 RNAs representing the wild-type YHB1 3’UTR, yhb1-1 mutant 3’UTR and yhb1-2 
mutant 3’UTR were purchased from IDT (oWO 898, oWO899, and oWO900, 
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respectively).  The RNAs were subjected to 32P-end-labeling for detection in the binding 
assay.  Binding reactions included radiolabeled RNA (100,000 counts per minute) and 1X 
binding buffer (10 mM HEPES pH 7.5, 50 mM KCl, 1 mM EDTA, 2 mM dithiothreitol 
(DTT), 200 U/ml RNasin ribonuclease inhibitor, 0.1 mg/ml bovine serum albumin, 0.01% 
Tween-20, 0.1 mg/ml poly(rU), and 10 µg/ml yeast tRNA) in the presence or absence of 
GST-Puf1p, GST-Puf4p or GST-Puf5p in a total of 20 µl.  Reactions were incubated for 30 
min at 24˚C, 5 µg of heparin was added and reactions incubated for a further 10 min at 
24˚C, then reactions were electrophoresed on 8% nondenaturing polyacrylamide gels 
for 2.5 h at 200 V at 4˚C.  To calculate relative binding, storage phosphor signals were 
first determined for each bound complex, and background signal from the no protein 
lane was subtracted from each.  For comparison of binding between RNA targets, values 
for each set of Puf+RNA complexes were divided by the corresponding Puf+WT RNA 
value, then normalized values were averaged between trials.  For comparison of binding 
between Puf proteins on a single RNA target, values for each set of Puf-RNA complexes 
were divided by the 2 µM Puf5p+RNA value, then normalized values were averaged 
between trials.   
In Vivo YHB1 Decay Analysis with Puf Overexpression 
Transcriptional shut-offs were performed as described above in yWO7 co-
transformed with plasmids pWO100, pWO102, pWO127, pWO128, pWO129, pWO197 
or pWO199 and Puf overexpression plasmids pWO15, pWO16, pWO58, pWO114, 
pWO115, pWO116, pWO192, pWO193, pWO194, pWO195, pWO196 or pWO200. 
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Transcriptional shut-offs were also performed in yeast strains yWO204 (Δpuf1-5) 
and yWO268 (Δpuf1-5) co-transformed with plasmids pWO127 or pWO128 and Puf 
overexpression plasmids pWO15, pWO16, pWO58, pWO114, pWO115, pWO116, 
pWO192, pWO193, pWO194, pWO195 or pWO196.  Similar detection and quantification 
methods were used as described above. 
  In Vivo Decay Analysis in Alternate Carbon Sources or Culture Densities 
Transcriptional shut-offs were performed in yWO7 (WT) transformed with 
pWO61, pWO100 or pWO127; or yWO204 (Δpuf1-5) transformed with pWO128.  To 
examine decay in cultures grown continuously in galactose, strains were grown as 200 
mL cultures in selective minimal media containing 2% galactose at 24°C to an OD600 of 
1.0.  Half of each culture was harvested and resuspended in 20 mL selective media 
containing 8% galactose at 37°C, effectively shutting off transcription by the 
temperature-sensitive inactivation of RNA pol II.  To examine decay in cultures grown to 
higher cell densities, strains were grown as 200 mL cultures in selective minimal media 
containing 2% galactose at 24°C to an OD600 of 2.0 or 3.0.  50 mL (OD600 2.0) or 25 mL 
(OD600 3.0) of cells were harvested and resuspended in 20 mL selective media containing 
8% dextrose at 37°C, effectively shutting off transcription by both the temperature-
sensitive inactivation of RNA pol II as well as carbon source inactivation of the GAL UAS.  
Similar detection and quantification methods were used as described above.  Northern 
blots were probed with 32P-end-labeled oWO105, oWO159 or oWO238 to detect HXK1 
3’ UTR, YHB1 3’ UTR or MFA2pG 3’ UTR, respectively. 
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In Vivo Endogenous YHB1 mRNA Decay Analysis 
Transcriptional shut-offs were performed in yWO7 or yWO268 transformed with 
over-expression plasmids pWO15, pWO58, pWO116, pWO195 or pWO200. Strains were 
grown as 200 mL cultures in selective minimal media containing 2% galactose at 24°C to 
an OD600 of 1.0.  Half of each culture was harvested and resuspended in 20 mL selective 
media containing 8% dextrose at 37°C, effectively shutting off transcription by the 
temperature-sensitive inactivation of RNA pol II.  Similar detection and quantification 
methods were used as described above.   
Growth inhibition study 
Mid-log phase (OD600 0.4-0.6) cells were diluted to an OD600 of 0.04 and allowed 
to grow at 24°C for 24hrs during exposure to 3mM DETA-NO.  Cell growth was 
monitored every 4hrs by OD600 measurements.  Growth percentage represents growth 
with 3mM DETA-NO exposure normalized against growth with no added DETA-NO for 
each individual strain (yWO7 transformed with pWO58 or pWO116, or yWO269). 
 
Steady-state Detection of Endogenous YHB1 mRNA 
Mid-log phase (OD600 0.4-0.6) cells were harvested and total RNA was extracted 
from yWO7 transformed with pWO58 or pWO116, yWO105, or yWO204.  Northern 
analysis and detection of YHB1 mRNA with oWO159 was performed.  Similar detection 
and quantification methods were used as described above. 
Puf1p, Puf4p and Puf5p Western Analysis 
Protein extracts were prepared from 20 ml yeast cultures of endogenously TAP-
tagged strains TAP-Puf1p, TAP-Puf4p and TAP-Puf5p (Ghaemmaghami et al., 2003) 
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(Thermo-Fischer Scientific) grown in YEP containing 2% dextrose or galactose at 30°C to 
an OD600 of 1.0. Harvested cells were resuspended in 0.25 ml of sample buffer [125 mM 
Tris–HCl, pH 6.8, 1% sodium dodecyl sulphate (SDS), 2% glycerol, 10% beta-
mercaptoethanol (BME)], lysed with glass beads, and extract collected by poking a hole 
in the bottom of the microfuge tube and spinning into a 15-ml centrifuge tube. Equal 
OD600 units of total protein were loaded onto a 10% Tris–glycine polyacrylamide gel 
(Bio-Rad). Resulting gels were blotted to nitrocellulose and probed with anti-TAP 
antibodies. Blots were also probed with anti-GAPDH (Thermo Scientific) antibodies as a 
loading control. 
Confocal Fluorescent Microscopy 
Endogenously green fluorescent protein (GFP)-tagged Puf1p, Puf4p and Puf5p 
(yWO200, yWO203, yWO199) (Huh et al., 2003) were grown at 30°C to an OD600 of 1.0 
in YEP supplemented with 2% dextrose or galactose.  Cells were then fixed with 3.7% 
formaldehyde for 1 hr.  The cells were washed twice with 1x phosphate buffed saline 
(PBS) and resuspended in 1 ml of 1x PBS.  10 milliliters of cells was loaded onto a circular 
glass slide coated with 1% polyethyleneimine (SigmaAldrich Cat# P3143-100ML) and 
cells were allowed to settle for 10 min.  The cell solution was aspirated from the edge of 
the slide, and the slide was then dipped in 1x PBS twice to remove nonadherent cells.  A 
coverslip was applied and the cells were immediately visualized with a Zeiss LSM-700 
confocal microscope on the 100x oil immersion objective for eGFP fluorescence.  Ten 
slices were taken through the Z plane of the cells.  The slices were flatted using Fiji Is 
Just ImageJ (FIJI) Z project at maximum intensity, and the intensity of GFP signal was 
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adjusted such that the maximum signal for cells grown in galactose was set as the 
maximum for cells grown in dextrose. 
Quantitative real-time PCR of RNA associated with Puf1p, Puf4p and Puf5p 
RNA immunoprecipitation (IP) was performed essentially as described (Gerber et 
al., 2004), with minor alterations. Endogenously TAP-tagged Puf1p, Puf4p and Puf5p 
cells (yWO272, yWO271, yWO270) were grown at 30°C in 1L YEP supplemented with 2% 
dextrose or galactose to an OD600 of 1.0. The cells were pelleted, washed twice with 25 
ml of ice-cold Buffer A (20 mM Tris–HCl pH 8.0, 140 mM KCl, 1.8 mM MgCl2, 0.1% 
Nonidet P-40, 0.02 mg/ml heparin) and frozen at −80°C. The following day, cells were 
thawed on ice and resuspended in 5 ml of Buffer B (Buffer A with 0.5 mM DTT, 1× 
Complete Mini Protease Inhibitors [Roche Diagnostics Ref#11-836-153-001], 40 U/ml 
RNasin ribonuclease inhibitor, 0.2 mg/ml heparin). Cells were vortexed in the presence 
of glass beads for 1 min and placed on ice for 1 min for a total of five times. Lysates 
were clarified by centrifuging at 7000g for 5 min. The supernatant was collected and 
protein concentration was measured using a standard Bradford assay. Lysates were 
normalized to contain 1.625 mg in a volume of 5 ml, and bovine serum albumin (BSA) to 
1% and 50 µg yeast tRNA were added. The lysates were incubated with 400 µl of 50% 
IgG Sepharose 6 Fast Flow (GE Healthcare Cat# 17-0969-010) that had been blocked for 
1 h in 1 ml of Buffer B plus 1% BSA and 50 µg of yeast tRNA. Beads were incubated at 
4°C for 2 h, washed once with 5 ml of Buffer B for 15 min and three times with 5 ml of 
Buffer C (20 mM Tris–HCl pH 8.0, 140 mM KCl, 1.8 mM MgCl2, 0.01% Nonidet P-40, 0.5 
mM DTT, 12 U/ml RNasin Ribonuclease Inhibitor) for 15 min each. Beads were 
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resuspended in 400 µl of Buffer C and 80 U ProTEV Plus (Promega Cat#V6101) was 
added. Beads were incubated for 2 h at 16°C. The resultant supernatant was drawn off 
and total RNA was isolated via hot phenol extraction. Glycogen (20 µg) was added to the 
final aqueous phase to assist precipitation of RNA before the addition of one-tenth 
volume 3M NaOAc and 2.5 volumes ethanol. The entirety of immunoprecipitated RNA 
was subjected to DNase treatment via manufacturer’s instructions (Ambion Turbo 
DNase). Reverse transcription of RNA was performed according to manufacturer’s 
specifications (Biorad iScript). Quantitative PCR (qPCR) was optimized and performed on 
a Biorad CFX96 Real-Time system using SYBR Green detection chemistry (Biorad SSO 
advanced). Gene-specific qPCR primers are provided in Supplementary Table S3. All RT-
qPCR experiments were conducted in technical triplicates and biological duplicates.  
RNA fold enrichment after IP was calculated as 2^(No RT – RT), where No RT is the 
reaction performed without reverse transcriptase and RT is the reaction with reverse 
transcriptase.  Normalized mRNA levels between carbon sources were calculated as 
2^(Galactose IP – Dextrose IP), then multiplied by the normalized protein levels after IP. 
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CHAPTER 4:  PUMILIO PROTEINS REGULATE mRNAS ASSOCIATED 
WITH THE PROGRESSION OF PARKINSON’S DISEASE 
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INTRODUCTION 
Parkinson’s disease (PD) is the most common motor system disorder and is 
caused by the loss of dopamine-producing neurons.  The decreased levels of the 
neurotransmitter dopamine, which is required for movement coordination and balance, 
leads to tremors, slowness of movements, rigidity, and impaired balance (Bueler, 2009).  
Within neural cells, Parkinson’s is characterized by aggregation of the α-synuclein 
protein (encoded by the gene SNCA), and this aggregation impairs mitochondrial 
function.  In fact, many genes that are mutated or aberrantly expressed in PD patients 
are involved in maintaining different aspects of proper mitochondrial function. It is 
hypothesized that the loss of dopamine-producing neurons in familial and sporadic PD 
may largely be due to mitochondrial dysfunction (Bueler, 2009). Coding mutations have 
been identified in several PD-associated genes, yet it is often the over-expression of 
these genes that is implicated in the disease.  For example, increased expression of 
SNCA is correlated with increased severity and earlier onset of PD, presumably due to 
the increased levels of α-synuclein protein that promote aggregation (Wood-Kaczmar et 
al., 2006).  Aberrantly high expression of the kinase LRRK2 is also linked to both familial 
and sporadic Parkinson’s cases and causes mitochondrial dysfunction and apoptosis 
(Bueler, 2009); however, the molecular mechanisms that cause aberrant expression of 
these genes are not well understood.  
In addition to the well-studied transcriptional regulation of genes, post-
transcriptional regulation of mRNA stability and translation are increasingly 
acknowledged as key steps in gene expression control.  Typically, control elements 
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located in the 3’ untranslated region (UTR) of mRNAs recruit microRNA (miRNA) 
complexes or regulatory proteins that influence mRNA decay and/or translation rates.  
One important family of 3’ UTR regulatory proteins is the Puf family, with multiple 
members in mammals, insects, worms, plants and yeast.  Pumilio from Drosophila 
melanogaster (DmPum) and FBF from Caenorhabditis elegans were the founding 
members of this group, thus providing the Puf family name.  Puf proteins regulate 
diverse processes such as cell development, stem cell maintenance, and organelle 
biogenesis by binding to specific sequences of targeted mRNAs and stimulating mRNA 
degradation and suppressing translation (Miller and Olivas, 2011).  Puf proteins are also 
involved in several aspects of neural function, such as neuronal excitability (Schweers et 
al., 2002), dendrite morphogenesis in peripheral neurons (Ye et al., 2004), and synaptic 
growth and plasticity at the neuromuscular junction (Menon et al., 2009; Marrero et al., 
2011). Puf expression increases during long-term memory formation, and its disruption 
results in defective memory (Dubnau et al., 2003). In humans, the Puf proteins Pum1 
and Pum2 are expressed widely, including in stem cells and brain tissue (Spassov and 
Jurecic, 2002).  Microarray studies indicate that Pum1 levels decrease ~2-fold in some 
PD patient brain tissue, while Pum2 levels decrease ~1.3 fold (Sutherland et al., 2009); 
however, there is little known about which mRNAs are regulated by Pufs in humans that 
may link Puf function with neural activity and PD. At the molecular level, Puf proteins 
directly elicit translation initiation repression through protein interactions that inhibit 
cap-binding events, or stimulate deadenylation and decapping steps of decay through 
interactions with mRNA decay machinery (Miller and Olivas, 2011).  Recently, Puf 
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proteins have also been found to act cooperatively with the miRNA regulatory system.  
Global studies to identify mRNAs bound by human Pum1 and Pum2 determined that 3’ 
UTRs containing Puf binding sites are enriched in miRNA binding sites (Galgano et al., 
2008).  It was hypothesized that binding of Puf proteins to a 3’ UTR may alter the 
secondary structure of the 3’ UTR such that miRNA sites become more accessible and 
therefore more efficient in RNA repression.  Specifically, miRNA sites located near Puf 
binding sites are often located in highly structured 3’ UTR regions that are poorly 
accessible (Incarnato et al., 2013), and the distance between the miRNA and Puf sites is 
typically less than 50 nt (Jiang et al., 2013).  For example, Puf binding sites are often 
associated with miR-410 target sites located in highly structured regions (Leibovich et 
al., 2010).  Experimentally, binding of human Pum1 to the 3’ UTR of the p27 tumor 
suppressor mRNA altered the local RNA structure and permit binding of miR-221 and 
miR-222 for RNA repression (Kedde et al., 2010).  Moreover, Pum1 RNA-binding activity 
to the p27 3’ UTR was dependent on phosphorylation of Pum1 in response to growth 
factor stimulation (Kedde et al., 2010).  Binding of human Puf proteins to the 3’ UTR of 
the E2F3 oncogene also enhanced miRNA-mediated repression of this mRNA, and 
several types of cancer circumvent miRNA regulation by shortening the 3’ UTR, thereby 
eliminating the Puf binding site (Miles et al., 2012).  In addition to making miRNA sites 
more accessible, Pufs may also work coordinately with miRNAs through interactions 
with the miRNA complex protein Argonaute, and these interactions inhibit translation 
elongation (Friend et al., 2012).  
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The miRNA regulatory system is involved in many diseases, and Parkinson’s is no 
exception.  Elimination of miRNAs in both Drosophila and mice results in a loss of 
dopamine neurons and motor defects similar to PD (Mouradian, 2012).  The SNCA 
mRNA, which contains a highly conserved 3’ UTR, is repressed by at least two miRNAs, 
miR-7 and miR-153 (Mouradian, 2012).  The LRRK2 mRNA is repressed by miRNA- 205, 
and this miRNA is downregulated in patients with PD (Cho et al., 2013).  Bioinformatic 
analysis revealed that many of the known PD-associated genes contain miRNA binding 
sites in their 3’ UTRs (Figure 4.1).  Moreover, we determined that many of these 3’ UTRs 
also contain perfect or near perfect Puf binding sites (UGUA(A/U)AUA) (Figure 4.1).  One 
of the Puf binding sites in SAT1 has been shown to be clinically relevant, as a deletion of 
the UGU was identified as a common mutation in Parkinson’s patients (Lewandowski et 
al., 2010).  Given the cooperative activity of Puf proteins and miRNAs in repressing 
mRNA targets, and the knowledge that many PD genes are aberrantly upregulated in 
the disease state, we hypothesized that Puf proteins bind and regulate multiple mRNA 
targets involved in Parkinson’s disease.  Further support for this hypothesis comes from 
the global study identifying mRNAs physically associated with human Pufs, where the 
SNCA mRNA was pulled down with Pum1 (Galgano et al., 2008).  Since many PD-
associated genes are involved in proper mitochondrial function, Pufs may play a global 
role in regulating mitochondrial function in humans. Such a role may be conserved 
across species, as the yeast Puf3 protein regulates many genes required for 
mitochondrial function (Olivas and Parker, 2000; Gerber et al., 2004; Foat et al.,  
 
Russo, Joseph, UMSL  p.139 
 
  
Figure 4.1.  Bioinformatic analysis of potential Puf binding sites and miRNA binding 
sites in the 3’ UTRs of Parkinson’s associated genes.  Lines represent 3’ UTR regions, not 
drawn to scale.  Perfect Puf binding sequences UGUA(A/U)AUA are shown as filled black boxes 
and imperfect Puf binding sequences (contains the core UGU with variable A/U rich downstream 
nucleotides)  are shown as filled in grey boxes.  miRNA binding sites are noted by red arrows, 
with miRNAs known to be expressed in SH-SY5Y neural cells underlined.  A predicted secondary 
structure example between Puf and miRNA binding site regions is shown in the open boxes, with 
the Puf site lined in blue and the miRNA site lined in red. 
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2005). Herein, I describe key findings that implicate Pufs in regulating PD-associated 
mRNAs, thereby advancing both the Pumilio field and the Parkinson’s disease field.  
Also, I have established the use of human cell lines as model organisms in the Olivas Lab 
for studying Pumilio function during PD progression. The completed and future research 
presented herein will significantly advance the field of Parkinson’s disease by revealing 
the extent to which Puf proteins are directly involved in coordinately regulating several 
mRNAs involved in PD and mitochondria.  Also, valuable information on the interplay 
between miRNA and Puf-mediated repression of these mRNAs will be discussed, as well 
as the mechanisms by which Puf proteins may be inactivated under PD conditions to 
cause upregulation of the target mRNAs.  The knowledge gained from these studies will 
provide a new line of inquiry into Pufs as therapeutic targets for Parkinson’s disease 
treatment. 
MATERIALS AND METHODS 
Plasmids and Oligos Used in this Study 
 All oligos used in this study are listed in Table 2.4.  All plasmids created and used 
in this study are listed in Table 3.4.  qPCR primers were all designed using quantprime 
software.  All plasmids were prepared using the Promega Pure-Yield kit to ensure quality 
during transfection and other downstream applications.  Renilla luciferase reporter 
constructs were made by standard restriction site cloning of 3’ UTR regions PCR-
amplified from SH-SY5Y cDNA.   Standard site-directed mutagenesis protocols were used 
in the creation of mutant reporter constructs. 
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Cell lines Information and Medium for Growth 
Two different cell lines were used to perform the studies presented herein.  The 
neuroblastoma human cell line SH-SY5Y and the human embryonic kidney cell line HEK-
293 were used.  The SH-SY5Y cells were purchased from ATCC, and detailed information 
for this cell line can be found on ATCC’s website.  Briefly, these cells are from a 4 year 
old female brain with metastatic bone cancer.  The growth properties are described as 
mixed.  This term means that the cell line is both suspension and adherent when 
cultured in flasks.  Specifically, when visualizing these cells in the growth flask under a 
microscope, some cells will appear stuck to the plastic while others will be floating 
around in suspension.  Neurites/dendrites are observable as arms extending from the 
cells.  These cells also tend to clump/cluster when they become adherent.  Both 
individual cells as well as large aggregates of cells are observable (Figure 4.2).  Renewal 
of the growth medium is required every 4-7 days and passage is typical every 10-14 days 
at a 1:10 ratio.     The SH-SY5Y cells exhibit moderate levels of dopamine beta 
hydroxylase activity and have a reported saturation density greater than 1 X 106 cells/sq 
cm.  The base cell medium used for this cell line is a 1:1 mixture of ATCC-formulated 
Eagle’s Minimum Essential Medium, Catalog No. 30-2003, and Ham’s F12 Medium 
(DMEM 1:1 with F-12).  This medium is then supplemented with 10% Fetal Bovine 
Serum (HyClone FBS) and 5% Penicillin/ Streptomycin antibiotic mixture (HyClone 
Penicillin-Streptomycin).  The HEK-293 cells were acquired from the Nichols lab in the 
Chemistry department at UMSL.  These cells exhibit an adherent growth phenotype 
(Figure 4.2).  Medium renewal is required every 2-3 days and passaging is performed 
every 7 days at  
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A. 
B. 
Figure 4.2.  Examples of cells used in this study.  (A) Shown are SH-SY5Y human 
neuroblastoma cells at low density (left panel) and at high density (right panel).  Images 
are modified from the ATCC website that the cells were purchased from.  (B)  Shown are 
HEK-293 human embryonic kidney cells at low density (left panel) and at high density 
(right panel).  Images are modified from the ATCC website that the cells were purchased 
from. 
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a 1:10 ratio.  The medium for this cell line is Eagle’s DMEM supplemented with 10% FBS 
and 5% Penicillin/Streptomycin.   
 For basic cell growth and maintenance, the following disposable items are 
required.  Corning culture flasks are used to maintain cell lines.  Specifically, canted, 
75cm2 vent cap flasks were used (10-126-37 Fisher).  In addition, disposable, individually 
wrapped serological pipettes in sizes 5ml, 10ml and 25ml are required.  Nalgene MF75 
sterile filter units (500mL, 0.2µm, aPES, 90mm) are needed for filtering of media.  Other 
required plastics include sterile nalgene cryogenic vials for stocking (2mL), conical tubes 
(15mL and 50mL), and 96 well plates in both clear (Costar, CLS3595) and white (Costar, 
CLS3362) for downstream assays.   
Medium Preparation 
 Sterile preparation of media is required before thawing cells for use.  Media 
preparation, cell culturing, and most experiments are done in sterile hoods in the cell 
culture facility.  Before preparing media, gloves are put on and sprayed with 70% 
ethanol for sterility.  After gloves are sterile, thoroughly wipe down the interior of the 
hood with 70% ethanol and chemwipes to ensure a sterile working area.  Sterility under 
the hood is key to maintaining healthy, contamination-free cells.  Media is purchased in 
either 1 liter or 500mL volumes.  FBS is purchased as a 500mL volume and should be 
thawed and aliquoted into 50mL sterile conical tubes for use in media preparation.  
Freeze unused conicals for future use (-20°C).  Penicillin/Streptomycin arrives as a 100 
mL volume and should be aliquoted into 5mL portions in sterile 15mL conical tubes.  
Freeze remaining conicals for later use.  Using an MF75 500mL sterile filter, add 445mL 
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of base medium, 50 mL of pre-thawed FBS, and 5mL of pre-thawed Pen/Strep and 
vacuum filter under the sterile hood in the cell culture facility.  Once filtered, 
immediately cap bottle and seal with parafilm.  The media is now ready for use in 
culturing cells.  The media is stored in the refrigerator (4°C) until ready for use.  It is a 
good idea to always pay attention to how much media you have remaining and to 
always have media made before getting new cells or passaging currently growing cells.   
Cell Expansion 
 After media has been made, cells can be thawed and expanded for experimental 
use.  First wipe down the hood with 70% ethanol ensuring a sterile working 
environment.  Next, remove previously made media from the 4° fridge, place in the 37°C 
bath and allow to warm so as to not shock the cells (15 minutes at 37°C is sufficient).  
Once the media has been warmed, wipe the entirety of the bottle with 70% ethanol.  
Place the bottle in the hood and wipe further around the cap with 70% ethanol.  
Remove the parafilm around the cap and continue to wipe with 70% ethanol as you 
remove the cap being sure to get the threading.  Now your media is ready for use.  It is a 
good idea to prepare all other equipment needed for cell culture work at this time.  This 
includes wiping down the pipettes and pipette aid that will be used, being sure to wipe 
down the single use 5mL, 10mL and 25mL pipettes in their plastic wrapping (i.e. before 
you unwrap them).  Furthermore, you should label a 75mm flask with the cell type and 
passage number of the cells you wish to expand.  Thorough cleaning of the flask should 
be done, and once placed under the hood, the threads should be cleaned as the cap is 
removed.  Always using sterile pipettes, aliquot the desired amount of media into the 
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flask, in most situations it will be 9mLs of media to 1mL of cells (either from freezer 
stock or passaged cells).  Once the media is in the flask, you can get a vial of cells from 
the liquid nitrogen chamber.  The current liquid nitrogen storage sheet is on the 
computer in the cell culture facility.  With sterile gloves, remove one vial of cells to be 
thawed and expanded.  Note that the tube should describe the cell line and provide the 
passage number for you to write on the flask if the information was not previously 
known.  Using forceps dip the vial into the 37°C water bath and allow the cells to thaw 
being sure not to fully submerge the vial or expose the cap to the bath.  Once the cells 
have thawed, dip the vial in 70% ethanol several times to sterilize.  Place 9mLs of media 
into a 15mL conical tube and add the 1mL of cells from the vial.  Note, any steps 
involving cells are done under the hood when possible.  Spin the 15mL conical tube at 
125xG for 5-7 minutes.  This step allows for the removal of DMSO used in stocking the 
cell line.  After centrifugation, a pellet of cells should be visible in the conical tube.  
Using the vacuum under the hood and a glass pipette (9 inch), carefully aspirate the 
media from the cell pellet.  Resuspend the pellet with 1mL of fresh media and add to the 
flask containing 9mL of media for a total of 10mL.  This provides the 1:10 dilution 
required for both cell lines.  Other cell lines can differ and should be assessed 
accordingly.  The total cells in stocked vials should be ~ 1.6x106.  View the cells under a 
microscope to ensure their presence and then place the flask in the 37° dry incubator 
for growth.  Check the cells every day or two as growth should become visibly evident 
under the microscope.  Also, growth media contains a pH indicator and over time the 
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media becomes more acidic, causing a change in the media color from pink to yellow.  
This is a good sign of healthy growing cells.   
Cell Counting, feeding and Passaging 
 As the cells continue to grow they will eventually reach a growth density that is 
ready for experiments or passaging.  The common term used to describe cell growth is 
confluency.  This term describes how much area of the flask the cells seem to cover 
when viewed under a microscope.  For example, 70% confluency means that about 70% 
of the visible area of the flask is covered with cells, leaving 30% of the bottom of the 
flask visible.  The rate at which cell confluency increases is dependent on the cell line.  
SH-SY5Y cells can take 10 days or more to reach 70% confluency, while HEK-293 cells can 
reach 70% confluency in as little as 5 days.  During the growth of the cells the media 
may need to be switched out.  This is termed feeding the cells.  Growth media will 
change from pink to yellow when feeding is required, or check the information available 
about the cell line for how often to feed.  Before feeding, be sure to warm fresh media 
in the 37° incubator.  Remove the flask and aspirate the old growth media into a 15mL 
conical and save if the cell line is suspension.  Immediately pipette new media onto the 
adherent cells as they will dry quickly.  Spin down the suspension cells as before and 
resuspend in fresh media.  Combine the resuspended suspension cells into the flask with 
the adherent cells and return to the incubator.   
   Once the cells have reached 70-75% confluency they are ready to be passaged.  
Again, retrieve and sterilize all equipment needed for passaging, including a new flask 
labeled with the new passage number.  Also at this time, you should have warmed your 
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growth media as well as the trypsin 1X (0.25%) in HBSS with EDTA.  Trypsin is used to 
remove adherent cells from the flask for counting and passage.  While working under 
the hood, aspirate the growth media into 15mL conical tubes.  Note, if your cells are 
suspension based, this media will be saved and used because it contains cells (SH-SY5Y 
cells); however, if your cells are strictly adherent (HEK-293 cells) this media can be 
disposed of in the proper receptacle.  Ensure that all the media is removed from the 
cells, as growth medium inhibits trypsin activity.  Some people choose to wash the cells 
with PBS to ensure removal of the growth medium; however, I have not found this to be 
necessary.  Next, apply 1.5-2mLs of trypsin to the cells in the flask, being sure to cover 
the entirety of the cells.  Place the flask in the 37° incubator for 5 minutes, checking 
every two minutes to ensure trypsin activity.  The cells on the bottom should become 
visibly removed upon inspection with the naked eye.  After 5 minutes, all the cells 
should appear to be removed from the bottom of the flask.  Return the flask to the hood 
and add media to a final volume of 10mLs to inactivate the trypsin.  Pipette the cells and 
medium into 15mL conical tubes.  You should now have adherent and suspension cells 
(if using SH-SY5Y cells) in 15mL conical tubes.  Spin tubes at 125xG for 10 minutes.  A cell 
pellet should be visible in all tubes.  Aspirate the media from the pellets and resuspend 
the pellet in 5mLs of fresh media.  Now the cells are ready to be counted.  Using the cell 
counter, perform a cell count by pipetting 20µL onto a compatible slide.  Also, at this 
time viability of the cells can be checked by diluting the cells 1:1 with trypan blue and 
then performing a cell count.  Be sure to change the dilution factor to 2 to account for 
the dilution.  A percentage of viable cells will be shown after the count is completed.  
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Manual adjustment is sometimes necessary when the software misses counts.  Be sure 
to check this each time you perform a cell count.  The cell count will be variable, so you 
must adjust your final cell concentration to be near the 1X106 cells per mL for passage.  
After adjusting your cell concentration, you can now add 1mL of cells to the 9mLs of 
fresh media in the new flask, successfully passaging the cells.  At this point, remaining 
cells can be used for experiments or for stocking of more cells.  It is also important to 
note the maximum passage number to use the cells during experiments.  Depending on 
the experiment and observed growth, this is usually at the experimenter’s discretion.     
Stocking Cells 
  In order to stock cells, media must be made containing all the components 
previous described and an additional 5% DMSO.  This will be a separate media used 
exclusively for stocking cells.  Once cells have been counted (should be ~1.5x106 
cells/mL), spin down again for 10 minutes at 125xG.  Remove the media leaving the cell 
pellet behind and resuspend with the same volume of media now containing 5% DMSO.  
Aliquot 1mL of cells into cryogenic vials labeled with cell type, passage number and 
date.  To ensure viability the cells must be frozen slowly overnight.  To do so, use the 
vial freezing holders (isopropanol chamber) in the cell culture facility.  These allow for 
the addition of isopropanol to the bottom layer to evenly freeze the cells.  The cells are 
placed in the holder and inserted into the -80°C freezer overnight.  The following day, 
vials can be arranged in a freezer box in the liquid nitrogen vessel for later use.   
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Pumilio1 and Pumilio2 Knockdown 
 For knockdown in SH-SY5Y cells, special modified siRNA “SMARTpools” were 
ordered from Thermo Scientific Dharmacon.  Five nmol of Accell Human Pum1 (9698) 
siRNA SMARTpool and Accell Human Pum2 (23369) siRNA SMARTpool was purchased.  
The sequences targeted by the SMARTpool for Pum1 and Pum2 are listed in Table 1.4.  
Upon arrival, the 5x siRNA buffer was diluted to 1X using RNase/Dnase-free water.  The 
5nmol of siRNA was resuspended in 50µl of 1X siRNA buffer to a final concentration of 
100µM and stored at -80°C in 4 µl aliquots for use in knockdowns.  Once cells reached 
70-75% confluency, they were trypsin treated and counted.  10,000 cells were plated 
per well in a 96 well cell culture ready plate and allowed to adhere overnight.  The next 
day, the accell delivery media (provided with SMARTpool siRNAs) was warmed to 37°C 
for use in the transfection.  Remove the growth media by careful pipetting.  Cells should 
be adherent to the well and visible with the naked eye under a microscope.  Disregard 
non-adherent cells at this step.  Immediately add 99µL of accell delivery media to the 
wells.  Do not let wells sit without media for long as cells will dry out and die.  Next, add 
1µL of the 100µM siRNA SMARTpool to the well.  If knocking down Pum1 and Pum2 
reduce growth media to 98µL and add 1µL of each SMARTpool.  Use scrambled siRNAs 
as a negative control.  Return 96-well plate to the incubator and allow to sit for 48-72 
hours before assaying.  For maximum knockdown, perform a second “hit” of siRNAs 24 
hours after the first hit.  Simply add an additional 1µL of SMARTpool siRNA and return to 
the incubator.  Perform all assays 72 hours after the first siRNA application. 
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 For knockdown in HEK-293 cells a different protocol was used.  Silencer Pre-
designed siRNAs against PUM1 (AM16708) and PUM2 (4392420) were purchased from 
Ambion.  The sequences of the siRNAs are listed in Table 1.4.  Each 5nmole siRNA was 
resuspended in RNase/Dnase-free water to a final concentration of 5µM.  The working 
concentration for knockdown is 5nM.  Genemute transfection agent was used to 
facilitate knockdown of Pumilio proteins as this reagent has been optimized for delivery 
of siRNAs.  The following example shows how to set up Pum1 and Pum2 knockdown in a 
96 well format.  The day before knockdown is performed, plate 10,000 cells per well as 
described previously.  Create a cocktail for knockdown in each individual well by 
combining 10µL of Pum1 siRNA (5µM), 10µL of Pum2 siRNA (5µM), 10µL of 5X 
genemute reaction buffer, and 20µL RNase/DNase-free water.  This cocktail now has a 
1µM concentration of each Pum.  Utilizing 0.5µL of the cocktail into the 100µL volume in 
the well will provide the 5nM concentration for quality knockdown.  To do this, combine 
0.5µL of the cocktail with 0.3µL of genemute for each well that will have knockdowns.  
For example, if you need to do 20 wells combine 10µL of cocktail with 6µL of genemute 
(see instructions for siRNA:genemute ratios and trouble shooting).  Allow the complex 
to sit for 10-15 minutes to fully form transfection ready complexes.  During this time, 
remove media from wells and replace with 99.2µL of fresh media, allowing 0.8µL of 
room for the transfection complex.  After 10-15 minutes, apply 0.8µL of transfection 
complex to each well, raising the final volume to 100µL per well and a final siRNA 
concentration of 5nM each.  Allow to sit for 24-72 hours before assaying knockdown.  
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Optimal knockdown is typically observed after 48 hours and still very good at 72 hours 
post transfection. 
Quantitative PCR 
 qPCR was used to verify knockdown and to evaluate expression of target genes 
in response to knockdown.  48-72 hours post-transfection of knockdown siRNAs, total 
RNA was prepared using the Direct-Zol RNA preparation kit (Zymo Research).  300µL of 
trizol was added to each well for a total volume of 400µL.  The cells were subjected to 
aggressive pipetting to remove cells from wells.  The 400µL of sample was then moved 
to microcentrifuge tubes and total RNA was extracted as described by the 
manufacturer.  Total RNA was not DNase treated in column; however, DNase treatment 
was done following total RNA preparation using the turbo DNase kit purchased from 
Ambion.  Total RNA was quantified using the nanodrop system.  500ng of total RNA was 
used to create cDNA using Biorad iScript Reverse Transcription Supermix (170-8840) in 
accordance with the protocol.  For each qPCR reaction, 2µL of each primer (100ng) was 
mixed with, 3.5µL of diluted cDNA (5X or 10X dilution) and 7.5µL of SSO Advanced Sybr 
Green (BioRad).  qPCR was performed on a BioRad CFX 96 real-time system.  Cycle 
parameters are as follows:  Initial denature step 95°C for 3 minutes, denature 95°C for 
10 seconds, anneal at 52°C for 10 seconds, and extend at 72°C for 30 seconds.  Data is 
collected after each extension for a total of 40 cycles.   
Protein Analysis 
 Total protein was prepared immediately following the total RNA prep so that 
both the RNA and protein derive from the same sample.  After the sample has been 
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applied to the Direct-Zol column, collect the flow-through containing the protein.  
Protein can then be prepared from the flow-through in accordance with the protocol 
described by trizol reagents.  Once a protein pellet has been obtained, it is solubilized 
using a 1:1 ratio of 8M urea and 1% SDS.  The protein is now ready for analysis by 
western blot.  Proteins were separated on SDS-PAGE gels ranging for 6-10% and western 
blotted.  Proteins of interest were probed with antibodies in accordance with 
manufacturer protocols.  Specifically, primary antibodies were used at 1:2000 dilution 
while α-rabbit secondary antibody was used at 1:5000 for recognition of all primary 
antibodies.  
Luciferase Reporter Construction 
 In order to assay the requirement of the 3’ UTR of target genes to mediate 
regulation by Pumilio proteins, a dual luciferase assay was used.  The system used was 
adapted from a methods paper entitled “A guide to design and optimization of reporter 
assays for 3' untranslated region mediated regulation of mammalian messenger RNAs” 
(Van Etten et al., 2013).  Two vectors were purchased from Promega to perform these 
assays.  The psiCHECK-1 vector contains the renilla luciferase gene driven by a SV40 
enhancer/promoter.  Immediately following the coding sequence of renilla is a multiple 
cloning site (MCS) for inserting 3’ UTRs of genes to be experimentally tested.  Utilizing 
the NotI and XhoI sites in the MCS, I designed primers for amplifying and cloning the 3’ 
UTR of SNCA, LRRK2 (short version), LRRK2 (long version), SAT1, E2F3 (positive control) 
and E2F1 (negative control).  Two variants of the 3’ UTR of LRRK2 were described on 
Pubmed (full length 3’ UTR and a shorter 3’ UTR), thus I cloned both of them for further 
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analysis.  Primers used for amplification and cloning can be found in Table 2.4.  
Amplification of 3’ UTRs was done using cDNA from SH-SY5Y cells.  Basic cloning 
techniques were used and the plasmids were sequenced following construction.  For 
mutations in Pumilio binding sites and other experimental mutations, Stratagene 
QuikChange XL Site-Directed Mutagenesis was used.  Primers used for mutations 
created in 3’ UTRs of target genes can be found in Table 2.4.   
Transfection of Reporter Constructs 
 24 hours post knockdown application, I transfected the reporter constructs.  To 
transfect reporter constructs, Polyjet transfection agent was used.  This is an optimized 
transfection reagent for DNA.  Polyjet works by forming a reagent/DNA complex utilizing 
a 3:1 volume to weight ratio.  For example, if using 100ng of plasmid then 0.3µL of 
Polyjet is required.  For data presented herein, 25ng of the internal reporter (firefly) was 
transfected with 75ng of the experimental reporters (renilla).  The total weight of DNA 
was 100ng per well, thus 0.3µL of Polyjet was required per well.  Cocktails of reporter 
transfections were made whenever possible.  Reporters were kept at 50ng/µL for ease 
of use.  The following describes how to apply the reporters to 10,000 cells in a 96 well 
format.  A cocktail must be made for both the DNA plus growth medium (- antibiotics) 
and Polyjet plus growth medium (-antibiotics).  For 10 wells where 10µL of transfection 
complex plus 90µL of fresh media (-antibiotics) is added to the well, two separate 
cocktails are made.  One cocktail contains 5µL of firefly DNA (125ng total), 15µL of 
experimental renilla reporter DNA(375ng total) and 30µL of media (-antibiotics).  Next, a 
second cocktail contains 3µL of Polyjet with 47µL of media.  The two cocktails are then 
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combined mixing the polyjet into the DNA (order is important, do not mix the reverse 
way) and allowed to complex for 10-15 minutes.  During this time remove the media 
from the cells and add back 90µL of fresh media (-antibiotics), allowing 10µL of space for 
the transfection complex.  After 10-15 minutes, add 10µL of the transfection complex to 
each well and mix by gentle pipetting.  There is now the correct final volume of 100µL 
per well.  Allow to sit 24-48 hours before assaying reporters by the Dual-Glo assay.    
Dual-Glo Luciferase Assay 
 In order to measure luciferase, white cell culture plates must be used.  Also, all 
edge wells should be filled with medium to reduce background and misreading during 
data acquisition on a luminometer.  Do not use the edge wells for experiments as they 
tend to evaporate and cause issues with luminescence.  The Dual-Glo luciferase assay 
was performed using the manufactures protocol.  In brief, an equal volume of Dual-Glo 
reagent (100µL) was added to each well and pipetted to mix.  The mixture was allowed 
to sit at least 10 minutes and firefly luminescence was measured using the Victor 2 plate 
reader.  Alternatively, the nano drop could be used; however, I did not use it and do not 
have the appropriate protocol.  After the control firefly readings have been acquired, 
add a volume of Dual-Glo Stop and Glo reagent equal to the original well volume 
(100µL) and mix.  Again, allow to sit at least 10 minutes and then assay using the Victor 
2 plate reader.  Background readings of the media alone are important for normalization 
as well as analysis of a control reporter (no added 3’ UTR) on each plate.  All 
normalization and presentation of data was done as described (Van Etten et al., 2013).   
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Overexpression of Pumilio Proteins 
 Overexpression of Pum1 and Pum2 or empty vector was accomplished using 
Polyjet transfection reagent.  Transfection of Pumilio expression constructs with 
reporter constructs was done in the same manner as previously described.  In order to 
get to 100ng total DNA weight, the internal reporter and experimental reporter were 
dropped down to 10ng and 30ng, respectively.  The remaining 60ng was occupied by 
Pum expression vectors (a kind gift from the Dyson Lab (Miles et al., 2012)) or empty 
vector controls.   Luciferase assays were done 24-48 hours post reporter/Pumilio 
overexpression transfection.    
Overexpression of miRNAs 
 Overexpression of miRNAs was done in the same manner as the siRNA 
knockdowns.  In brief, the treatment was done the day after plating 10,000 cells as was 
done with siRNA knockdowns.  If knockdown and miRNA overexpression are to be done 
together, simply use the same concentration of siRNA/miRNA (5nM final) in a cocktail as 
previously described.  24 hours after siRNA or miRNA transfection, transfect the 
reporter constructs and perform luciferase assays 24-48 hours later.   
RESULTS 
All of the results in this chapter were completed by me. 
Knockdown of Pumilio proteins results in up regulation of genes involved in 
Parkinson’s disease progression. 
 Examination of the 3’ UTRs of Parkinson’s associated genes SNCA, LRRK2 and 
SAT1 revealed that there are one or more putative PREs present in each (Figure 4.1).  To 
begin to elucidate if these mRNAs are regulated by Pumilio proteins, I performed RNAi 
knockdown of both Pum1 and Pum2 by transfecting SH-SY5y cells with “SMARTpools” of  
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Figure 4.3.  Knockdown of Pum1 and Pum2 results in up-regulation of SNCA mRNA and 
LRRK2 protein levels.  Shown are quantitative PCR analyses of PUM1 (A), PUM2 (B) and 
SNCA (C) mRNA levels extracted from SH-SY5Y cells transfected with either scrambled 
siRNAs (blue) or siRNA SMARTpools against both Pum1 and Pum2 (red).  Expression levels 
were normalized to GAPDH mRNA levels in each experimental set.  Data are averages of 
biological triplicates performed in technical triplicate.  (D)  Shown are representative 
Western blot analyses of protein extracted from SH-SY5Y cells transfected with either 
scrambled siRNAs (lane1) or siRNA SMARTpools against both Pum1 and Pum2 (lane2).  
The top three panels derive from a single blot, while the bottom two panels derive from a 
separate blot, although still the same protein samples.  Results were observed in 
triplicate. 
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small interfering RNAs (siRNAs) against both Pum1 and Pum2 sequences.  Specifically, 
10,000 cells were plated per well and treated with siRNAs in triplicate wells.  Cells were 
allowed to sit for 48 hours to maximize protein knockdown.  I chose to knockdown both 
Pufs simultaneously since Pum1 and Pum2 are thought to be partially redundant and I 
wanted to achieve the maximum effect in a single experiment.  Cells were alternatively 
transfected with scrambled siRNAs as a negative control.  Following knockdown, total 
RNA and protein were prepared from each well.  500ng of total RNA from each well was 
then subjected to reverse transcription and cDNA was diluted for use in qRT-PCR.  As 
shown in Figure 4.3 A & B, qRT-PCR analysis demonstrated ~60% reduction in Pum1 and 
Pum2 mRNA levels, with a corresponding 80-90% reduction in Pum1 and Pum2 proteins 
levels as measured by Western blot (Figure 4.3D).  The larger reduction in protein levels 
is expected as siRNAs can affect both stability and translation of bound mRNAs.  Having 
established successful knockdown of both Pum1 and Pum2, I performed qPCR analysis 
of SNCA mRNA, a key Parkinson’s mRNA encoding α-synuclein and whose 3’ UTR 
contains a perfect PRE (Figure 4.1).  SNCA levels increased >2-fold in response to 
Pum1/Pum2 knockdown (Figure 4.3C).  This data supports the hypothesis that the Puf 
proteins act to repress SNCA mRNA levels.  I attempted to assay LRRK2 mRNA levels by 
qPCR; however, the two primer sets attempted did not work consistently.  To determine 
if LRRK2 is a target of Pumilio regulation, I analyzed LRRK2 protein levels by Western 
blot using anti-LRRK2 antibody.  The LRRK2 3’ UTR contains three perfect PREs and five 
imperfect PREs (Figure 4.1).  LRRK2 levels are barely detectable in control lanes when 
treated with scrambled siRNA (Figure 4.3D, lane 1); however, with Pum1/Pum2  
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Figure 4.4.  3’ UTRs of PD mRNAs are sufficient to confer regulation.  Shown are relative 
luciferase levels of reporters containing either a minimal 3’ UTR (Unregulated reporter) or 3’ 
UTRs from PD mRNAs (SNCA, SAT1 or LRRK2).   The 3’ UTRs of both SNCA and SAT1 reduced 
luciferase levels compared to the unregulated reporter.  The 3’ UTR of LRRK2 increased 
luciferase levels compared to the unregulated reporter.  
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knockdown, LRRK2 levels significantly increased (Figure 4.3D, lane 2).  This data further 
supports the role of Puf proteins in repressing levels of Parkinson’s associated proteins.  
I was not able to successfully assay SAT1 mRNA or protein due to technical challenges. 
Pumilio Proteins regulate Parkinson’s disease associated genes through their 3’ 
UTRS. 
 I hypothesized that SNCA, LRRK2 and SAT1 are targeted for repression because 
the Pumilio proteins are binding to recognition sequences in the 3’ UTRs, as opposed to 
nonspecific effects or because regulation of the PD genes is downstream of a direct 
Pumilio target.  To test the role of Pumilio binding to the 3’ UTR for regulation of PD 
genes, I first examined the sufficiency of the 3’ UTRs to confer Pumilio regulation.  
Specifically, the commercially available Renilla Luciferase reporter plasmid pGl4 
(Promega) was used in which I cloned the 3’ UTRs of either SNCA, SAT1 and LRRK2 
downstream of the luciferase coding region.  The constructed Renilla Luceriferase/3’ 
UTR plasmids were transfected into HEK293 cells, along with a Firefly Luciferase 
reporter plasmid to control for transfection.  The transfection and subsequent luciferase 
reporter analysis/quantification were performed according to established protocols 
(Van Etten et al., 2013).  Both the SNCA and SAT1 3’ UTR vectors resulted in repressed 
expression as compared to the unregulated Renilla Luciferase reporter lacking a 3’ UTR 
insertion, indicating that the SNCA and SAT1 3’ UTRs contain repressive cis- elements 
(Figure 4.4).  Expression of the LRRK2 3’ UTR vector was similar to the unregulated 
control; however, LRRK2 may have both positive and negative cis-elements that balance 
expression (Figure 4.4).  
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Figure 4.5.  Mutation of PREs in the SNCA 3’ UTR increases reporter luciferase levels.  
Wild type (WT) luciferase levels were normalized to 1.  Shown are various mutations in the 
3’ UTR of SNCA. mut-1 represents a mutation of the first canonical PRE (UGUA to ACAC), 
SNP represents a previously described mutation affecting SNCA luciferase level (Sotiriou et 
al., 2009), mut-1 + mut-1np represents a mutation to the canonical site as well as a 
mutation to the most similar non-perfect site, mut-1nt represents a 1 nucleotide mutation 
of the canonical PRE (UGUA to UCUA).  
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 To further validate the 3’ UTRs of SNCA, LRRK2 and SAT1 as bona fide targets of 
Pumilio regulation, I mutated putative PREs.  If a PRE is functioning in a repressive 
manner, I would observe an increase in luciferase levels coming from the mutant 
construct when compared to wild-type.  Using site-directed mutagenesis, several 
mutations were made in the SNCA 3’ UTR.  First, mutation of the first canonical PRE was 
made by changing UGUAUAUA to ACACUAUA (mut-1).  Mutation of the core UGUA has 
been previously shown to be sufficient to abolish Pumilio mediated regulation (Miller 
and Olivas, 2011).  Indeed, upon mutation of the PRE an increase in luciferase levels was 
observed (Figure 4.5).  Furthermore, mutation of the SNCA 3’ UTR to create a relevant 
single nucleotide polymorphism (snp) known to be involved in Parkinson’s disease also 
increased luciferase levels and served as a positive control for my assay (Figure 4.5) 
(Sotiriou et al., 2009).  The effect of the SNP and mut-1 were additive, as the largest 
increase in luciferase levels was observed in this double mutant.  Interestingly, mutation 
of a non-canonical putative PRE in addition to the canonical PRE increased luciferase 
levels even further than the single PRE mutation (mut-1 + mut-1np(non-perfect)).  
Finally, I mutated one nucleotide (mut-1nt) of the canonical PRE (UGUA to UCUA) and 
observed an identical increase in luciferase level to that of the tri-nucleotide mutation 
of mut-1.  Thus, both the canonical PRE and the non-canonical PRE located in the 3’ UTR 
of SNCA are bona fide cis-regulatory elements likely regulated by Pumilio proteins.  
Additionally, the SNP combined with mut-1 had the largest effect, suggesting these cis 
elements may be synergistic.  Similar to mutational analysis of the SNCA 3’ UTR, I 
mutated the LRRK2 3’ UTR and the SAT1 3’ UTR.  Mutation of the first canonical PRE in  
Russo, Joseph, UMSL  p.162 
 
  
Figure 4.6.  Mutation of PREs in the LRRK2 and SAT1 3’ UTRs increases reporter levels.  Wild 
type (WT) luciferase levels were normalized to 1.  Shown are various mutations in the 3’ UTR of  
LRRK2 and SAT1. LRRK2 mut-1 represents a mutation of the first canonical PRE (UGUA to ACAA), 
mut-1 + mut-2 represents mutation to the first two canonical PREs in the LRRK2 3’ UTR.  SAT1 
WT represents the wild type 3’ UTR, SAT1 mut-1 represents mutation of the PD relevant, non-
canonical PRE (UGUA to ACAA).  
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the LRRK2 3’ UTR was made as well as a double mutant consisting of mutations to the 
first two canonical PREs.  Mutation of the first PRE increased luciferase levels compared 
to wild-type, and the double mutation of the first two PREs increased luciferase levels 
even further, suggesting that the first two PREs contribute to Pumilio-mediated 
regulation of LRRK2 (Figure 4.6).  Additional analysis of the remaining canonical PREs as 
well as non-canonical PREs is needed to determine the full extent of Puf regulation.  
Furthermore, mutation of the non-canonical, clinically relevant (Lewandowski et al., 
2010) PRE in the SAT1 3’ UTR increased luciferase levels compared to wild-type, 
indicating that Pumilio functions through this site (Figure 4.6).  These results further 
support the hypothesis that Puf proteins are regulating SNCA, LRRK2 and SAT1 directly, 
through interactions with their 3’ UTR. 
Pumilio overexpression reduces reporter luciferase levels 
   To further validate SNCA, LRRK2 and SAT1 as bona fide targets of Pumilio 
regulation, I obtained Pum 1 and Pum2 overexpression plasmids (14) and co-expressed 
both vectors in HEK-293 cells with the Renilla and Firefly Luciferase reporters. 
Overexpression of Pum1 and Pum2 significantly reduced expression of all three 3’ UTR 
reporters, suggesting that SNCA, SAT1 and LRRK2 are all directly responsive to Puf 
regulation (Figure 4.7).  Overexpression of the empty vector had no effect on reporter 
expression (data not shown).  Similar results have been seen previously for the Puf 
targeted E2F3 3’ UTR in response to Pum1/2 overexpression (14).  We also tested 
whether co-overexpression of Nanos affected the degree of Puf repression, since Nanos 
often works as a complex with Pufs to regulate target mRNAs and its levels may be  
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Figure 4.7.  Overexpression of Pum1/Pum2 decreases Luciferase levels of reporters 
containing SNCA, SAT1 and LRRK2 3’ UTRs.    (A)  Shown are relative Luciferase levels of the 
SNCA reporter during empty vector (SNCA WT) or during Pum1/2 overexpression (OE).  (B)  
Shown are relative Luciferase levels of the SAT1 reporter during empty vector (SAT1) or 
during Pum1/2 overexpression (OE). (C)  Shown is relative Luciferase levels of the LRRK2 
reporter and mutant reporters during empty vector or Pum1/2 overexpression (OE).  (D)  
Western blot displaying HA-Pum1/2 overexpession.  The middle band is HA-Pum1 and the 
lowest band is HA-Pum2. 
 
D. 
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limiting in the cells.  However, we did not see any differences in Puf-mediated 
repression with or without co-overexpression of Nanos (data not shown).  When 
evaluating the mutant reporter constructs, we also observed a decrease in luciferase 
levels upon Pum1/2 overexpression.  Specifically, with the LRRK2 mutant 3’ UTRs (mut-
1, mut-1+mut-2) luciferase levels were reduced similar to that of wild-type (Figure 4.7).  
Also, overexpression of Pum1 and Pum2 on the control reporter (no added 3’ UTR) 
caused a decrease in luciferase levels (data not shown) suggesting that although 
overexpression reduces luciferase levels of reporters, it may be due to non-specific 
effects.  Alternatively, the non-specific effects may be due to the high level of Pum 
overexpression and titration may be needed to limit off-target effects.  Regarding the 
LRRK2 mutant 3’ UTRS, it may be that the additional canonical and non-canonical PREs 
are used during overexpression such that the effect of the mutations are masked.    
Together, this reporter data suggests that Puf regulation of the SNCA, SAT1 and LRRK2 
mRNAs is directly acting through the 3’ UTRs, but more experiments are needed to 
evaluate the overexpression effects. 
Knockdown of Pumilio proteins in HEK-293 cells does not affect reporter luciferase 
levels 
 To further support the hypothesis that Pumilio proteins act directly on SNCA, 
LRRK2 and SAT1 through interactions with the 3’ UTR, I performed Pumilio knockdown 
studies in the HEK-293 cells and evaluated wild-type reporter responses.  If Pumilio 
proteins act through the 3’ UTR of these mRNAs we would expect an increase in 
luciferase levels upon knockdown of Pumilio proteins.  Knockdown of Pum1 and Pum2 
did not increase luciferase levels of the reporters (Figure 4.8A).  These  
A 
C 
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Figure 4.8.  Knockdown of Pum1/2 has no effect on reporters bearing 3’ UTRs of SNCA, 
LRRK2 or SAT1.  (A)  Shown are bar graphs representing relative luciferase levels during 
scrambled siRNA treatment (SNCA WT, LRRK2 short WT, SAT1 WT) or upon knockdown of 
Pum1/2 (PUM1/2 KD).  (B)  Shown is a representative western blot of Pum1/2 knockdown 
during experiments.  
 
A. 
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results were not because of failure to knockdown Pumilio proteins (Figure 4.8B).  Given 
the fact that the 3’ UTRs of target mRNAs were cloned from SH-SY5Y cells, it is possible 
that the response to knockdown I observed on endogenous targets cannot be 
recapitulated with the reporters.  It is of value to perform this assay in the SH-SY5Y cells 
as varying expression levels of Pumilio proteins (increased levels in SH-SY5Y cells) is 
present in the two cell lines as observed by Western blot.   
DISCUSSION 
 Many genes are implicated in the progression of PD, and much research has 
focused on mutations of genes found in PD patients and how they contribute to disease 
progression.  Recent research has begun to evaluate the critical role of aberrant 
expression of PD genes and its contribution to disease progression; however, an area of 
research lacking in the field is the role of post-transcriptional gene regulation of PD 
genes.  Specifically, there is sparse research on the role of RNA binding proteins (RBPs), 
which include the Puf family, and how they may contribute to altered expression of PD 
genes containing no apparent mutations.  By elucidating the role of Puf proteins on 
post-transcriptional control of PD genes, we will provide a novel avenue for therapeutic 
approaches to PD. We will also make significant strides in understanding Puf function in 
human cells and offer new targets of Puf mediated regulation in humans for future 
studies.  Until recently, the understanding of Puf regulation in humans has remained 
elusive.  Strides have been made implicating the dependency of miRNA mechanisms on 
Puf function, yet experimental analyses of Puf targets and regulatory mechanisms are 
few.  In this work, I identify 3 mRNAs, SNCA, LRRK2 and SAT1 as targets of Pumilio 
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regulation in human cell lines.  This discovery provides evidence of post-transcriptional 
control contributing to the regulation of genes involved in PD.  Furthermore, these 
studies implicate Pumilio proteins in the progression of PD.  Further research will 
determine the interplay between the miRNA system and Pumilio proteins through 
evaluation of various mutant 3’ UTRs of the reporter constructs as well as structural 
analysis of target 3’ UTRs using fluorescent resonance energy transfer (FRET).  There will 
be challenges in interpreting the data from 3’UTR mutational studies as a tri-nucleotide 
mutation may disrupt secondary structure and indirectly aid miRNA function.  Thus, it 
was important to establish that a single nucleotide change is sufficient to disrupt 
Pumilio function.  It is more appropriate to perform single mutations as to maintain 
secondary structure as much as possible.  Maintaining secondary structure will be 
critical in understanding the interplay between the miRNA system and the Pumilio 
system.  These studies will further our understanding of Pumilio and miRNA 
interdependency for regulating target mRNAs involved in PD progression.  
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Table 1.4.  siRNAs, miRNAs and antibodies used in this study. 
 
 
  
  
Product Sequence/Target Source 
Silencer  Pre-designed 
siRNA-PUM1 
 
gcuucgguauaauaggucutt 
 
Ambion (4392420) 
 
Silencer Select Pre-designed 
siRNA-PUM2 
 
gcaacuaauucagcuaauctt 
 
Ambion(AM16708) 
 
 
Accell SMARTpool siRNA 
PUM1 
 
gcuucaguuugugacauua 
cuuucagggugguugguuu 
ucaucuagucucaaguaua 
gccaugucuugaagugugu 
 
Thermo Scientific (E-014179-00-
0005) (9698) 
 
Accell SMARTpool siRNA 
PUM2 
 
gccgauugcaaagauuuua 
gcacuaaucugcaaucuaa 
gcaugguucuagauucaua 
guguauaauuaaaaucguu 
 
Thermo Scientific (E-014031-00-
0005) (23369) 
 
Accell Human Control siRNA 
kit 
N/A Thermo Scientific (K-005000-R1-
01) 
hsa-miR-153-3p uugcauagucacaaaagugauc Ambion(MC10122) 
hsa-miR-205-5p uccuucauuccaccggagucug Ambion(MC11015) 
hsa-miR-410-3p aauauaacacagauggccugu Ambion(MC11119) 
hsa-miR—7-5p uggaagacuagugauuuuguugu Ambion(MC10047) 
Anti-GAPDH(in rabbit)  Human GAPDH  Abcam (EPR6256) 
Anti-Pumilio1(in rabbit)  Human/mouse Pum1  Abcam (EPR3795) 
Anti-Pumilio2(in rabbit)  Human/mouse Pum2 Abcam (EPR3813) 
Anti-Synuclein  Human/mouse/rat SNCA Abcam 
Anti-LRRK2  Human/mouse/rat LRRK2 Abcam 
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Table 2.4.  Oligos used in this chapter 
oWO Sequence Use 
614 tgcatggtgtggcaacagtg qPCR SNCA up primer 
615 tccactgtcttctgggctactg qPCR SNCA down primer 
616 agttcatccatggaacgcacctg qPCR PUM1 up primer 
617 agcaaacatcgatggcctactgg qPCR PUM2 up primer 
620 ttgggtgctgctataggctcag qPCR PUM2 down primer 
621 acttgcagaactgccaactgatg qPCR GAPDH up primer 
622 tctcttcctcttgtgctcttgcta qPCR GAPDH downprimer 
623 agctcatttcctggtatgacaacg qPCR LRRK2 up primer 
707 tgatgagaagcaacgcaaagcc qPCR LRRK2 down primer 
708 ggaaccctcgcttattcaggagtc SNCA 3’UTR clone up(xhoI) 
758 ccagctcgagaaatatctttgctcccagtttcttgag SNCA 3’UTR clone dn(notI) 
759 ccaggcggccgcatatttttgcaatgagataacgtttta LRRK2 3’UTR clone up(xhoI) 
760 gcatctcgagagagaaataggaattgtctttgg LRRK2 short clone dn (notI) 
761 gcatgcggccgcttcacataccaacaaaggac LRRK2 full clone dn (notI) 
762 gcatgcggccgcctttattattccatttaaatatggtattc SAT1 3’UTR clone up(xhoI) 
763 gcatctcgagggagtgctgctgtagatgacaacc SAT1 3’UTR clone dn (notI) 
764 gcatgcggccgcaaagagtagtttattaaaaaagaatcaaacag E2F1 3’UTR clone up(xhoI) 
765 gcatctcgagcagggcttggagggacca E2F1 3’UTR clone dn (notI) 
766 gcatgcggccgctggatctgcttttgagttagga E2F3 3’UTR clone up (xhoI) 
767 gcatctcgagttatgcttcgtgtgaactctc E2F3 3’UTR clone dn (notI) 
768 gcatgcggccgcaaattacacccatttgaagtggtaag qPCR firefly up primer 
769 gatcctcaacgtgcaaaagaagc qPCR firefly down primer 
770 tcacgaaggtgtacatgctttgg qPCR renilla up primer 
771 cgcaactacaacgcctaccttc qPCR renilla down primer 
772 ccctcgacaatagcgttggaaaa psiCHECK sequence primer 
773 gacgctccagatgaaatgggtaag psiCHECK rev sequence primer 
774 cgcacatttccccgaaaagtg LRRK2 sequence primer 
775 ctaggaaagacacagaaactctc E2F1 sequence primer 
776 gattgaagctttaatggagcg E2F3 sequence primer #1 
777 cagccttctggatgaagaacctg E2F3 sequence primer #2 
778 ggctctcttacaccgcactc E2F3 sequence primer #3 
779 ccaggtagatttccacaatatg E2F3 sequence primer #4 
780 ggtgtacattaattagatgtcc SNCA SDM up primer perfect site 
798 gcgatgtgttttattcactttgtgttacactataaatggtgagaattaaaataaa
acg 
SNCA SDM dn primer perfect site 
799 cgttttattttaattctcaccatttatagtgtaacacaaagtgaataaaacacatc
gc 
SNCA SDM up primer snp 
804 aaatactaaatatgaaattttaccattttgtgatgtgttttattcacttgtgtttgta
t 
SNCA SDM dn primer snp 
805 atacaaacacaagtgaataaaacacatcacaaaatggtaaaatttcatattta
gtattt 
SNCA SDM up perfect site w/snp 
806 aatactaaatatgaaattttaccattttgtgatgtgttttattcacttgtgttacac SNCA SDM dn perfect site w/snp 
807 gtgtaacacaagtgaataaaacacatcacaaaatggtaaaatttcatatttag
tatt 
SNCA SDM up 1st nonperfect site 
808 agatgttccatccacaccaagtgctcagtt SNCA SDM dn 1st nonperfect site 
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809 aactgagcacttggtgtggatggaacatct SNCA SDM up 2nd nonperfect site 
810 atttctcaaagtttttacagacactctcgaagtcttccatcag SNCA SDM dn 2nd nonperfect site 
811 ctgatggaagacttcgagagtgtctgtaaaaactttgagaaat SNCA SDM up 3rd nonperfect site 
812 gtgattgaagtatcacaccctgcccccact SNCA SDM dn 3rd nonperfect site 
813 agtgggggcagggtgtgatacttcaatcac LRRK2 SDM up 1st  site 
814 gataggaaaattattctctcctctacacaatatttattttaaaaatgttcacatgg
aaag 
LRRK2 SDM dn 1st  site 
815 ctttccatgtgaacatttttaaaataaatattgtgtagaggagagaataattttc
ctatc 
LRRK2 SDM up 2nd  site 
816 ggaatgttattatttttaatttaaatataacacaaaatacttaccagtaaatgtgt
attt 
LRRK2 SDM dn 2nd  site 
817 aaatacacatttactggtaagtattttgtgttatatttaaattaaaaaataataa
catcc 
LRRK2 SDM up 3rd site 
818 acacaaaatacttaccagtaaatgacacttttaaagaactatttaaaacacaat
g 
LRRK2 SDM dn 3rd site 
819 cattgtgttttaaatagttctttaaaagtgtcatttactggtaagtattttgtgt LRRK2 SDM up 4th site 
820 atcgaaatgcactatcatatatgctacacaatattcaaatgaatttgcactaata
aagtc 
LRRK2 SDM dn 4th site 
821 gactttattagtgcaaattcatttgaatattgtgtagcatatatgatagtgcattt
cgat 
SAT1 SDM up 1st site 
822 gagggagtgctgcacacgatgacaacctcca SAT1 SDM dn 1st site 
823 tggaggttgtcatcgtgtgcagcactccctc SAT1 SDM up 2nd site 
824 cccaacttctcttgctttctatgctgttacacgtgaaataatagaatgagcaccca
ttcc 
SAT1 SDM dn 2nd site 
825 ggaatgggtgctcattctattatttcacgtgtaacagcatagaaagcaagaga
agttggg 
SAT1 SDM up 3rd site 
826 cttcattctcgtgagtcatttaaatgacaccaatgtacacactggtacttagag SAT1 SDM dn 3rd site 
827 ctctaagtaccagtgtgtacattggtgtcatttaaatgactcacgagaatgaag SNCA SDM up 1NT 
828 gcgatgtgttttattcactttgtgtttctatataaatggtgagaattaaaataaaa
cg 
SNCA SDM dn 1NT 
829 cgttttattttaattctcaccatttatatagaaacacaaagtgaataaaacacat
cgc 
qPCR PUM2 up primer 
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Table 3.4.  Plasmids Used in This Study 
pWO Description Source 
203 firefly luciferase reporter Promega 
204 renilla luciferase reporter Promega 
205 HA-Pum1 expression vector Dyson Lab (16) 
206 HA-Pum2 expression vector Dyson Lab (16) 
207 renilla-SNCA 3’UTR Joe Russo 
208 renilla-LRRK2 3’UTR (long) Joe Russo 
209 renilla-LRRK2 3’UTR (short) Joe Russo 
210 renilla-SAT1 3’UTR Joe Russo 
211 renilla-E2F1 3’UTR Joe Russo 
212 renilla-E2F3 3’UTR Joe Russo 
213 renilla-SNCA 3’UTR mut-1 Joe Russo 
214 renilla-SNCA 3’UTR snp Joe Russo 
215 renilla-SNCA 3’UTR mut-1, snp Joe Russo 
216 renilla-SNCA 3’UTR mut-1, mut-1st non-perfect site 
(nps) 
Joe Russo 
217 renilla-SNCA 3’UTR mut-1(1 nt), mut-1st non-perfect 
site 
Joe Russo 
218 renilla-LRRK2 3’UTR mut-1 Joe Russo 
219 renilla-LRRK2 3’UTR mut-1, mut-2 Joe Russo 
220 renilla-SAT1 3’UTR mut-1st non-perfect site(ref 20) Joe Russo 
221 renilla-SAT1 3’UTR mut-2nd non-perfect site Joe Russo 
222 renilla-SAT1 3’UTR mut-1st nps, mut-2nd nps Joe Russo 
223 renilla-SNCA 3’UTR mut-1(1nt change at site) Joe Russo 
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Conditional regulation of Puf proteins in yeast 
 Work on Puf proteins over the last decade has revealed a complicated system of 
mRNA regulation and protein surveillance.   The Puf family of RNA binding proteins bind 
target mRNAs and regulate their turnover through interactions with cis-regulatory 
elements located in the 3’ UTR of mRNAs.  Early research revealed the importance of 
the core UGU element for binding of Puf proteins to target mRNAs and this recognition 
mechanism is conserved throughout eukaryotes (Gerber et al., 2004; Bernstein et al., 
2005; Gerber et al., 2006; Galgano et al., 2008; Miller and Olivas, 2011; Campbell et al., 
2012).  Recent research has shown evidence for flexibility of Puf proteins for binding 
target mRNAs with a wide variety of sequences downstream of the UGU (Valley et al., 
2012) (This work, Figure 3.1).  Furthermore, mechanistic details of Puf protein function 
have continued to be elucidated revealing roles in mRNA decay and translational 
repression (Goldstrohm et al., 2006; Goldstrohm et al., 2008; Miller and Olivas, 2011; 
Blewett and Goldstrohm, 2012; Van Etten et al., 2012; Weidmann and Goldstrohm, 
2012; Hrit et al., 2014).  Initially, the Puf repeat domain was shown to be both necessary 
and sufficient for binding and regulating target mRNAs; however, more recent advances 
in the field suggest autonomous repression capabilities outside of the repeat domain as 
well (Weidmann and Goldstrohm, 2012).   
The work presented herein furthers the field of Puf research by identifying an 
activation switch in response to environmental stress.  Specifically, yeast Puf1p, Puf3p, 
Puf4p and Puf5p regulate target mRNAs based on the available carbon source in the 
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growth media.  During fermentation (dextrose conditions) Puf proteins are active to 
stimulate rapid decay of target mRNAs; however, during respiration (galactose, ethanol 
conditions) Puf proteins are inactive and target mRNAs are derepressed.  I show that Puf 
protein activity is not regulated by either altered expression or localization of the Puf 
proteins.  Instead, I show several modes of activation specific for individual Puf proteins 
in yeast.  One hypothesis of how Puf proteins may be inactivated is to eliminate RNA 
binding capacity in inactive conditions as has been observed with human Pum1 (Kedde 
et al., 2010).  Puf1p, Puf3p and Puf4p are all able to bind target mRNAs regardless of the 
carbon source; however, Puf5p binds target mRNAs less efficiently in respiration 
conditions.  Thus, Puf5p likely alters its binding capacity to limit its regulatory effects on 
target mRNAs.  Further support for this hypothesis comes from the identification of a 
mutant Puf5p which contains an aspartic acid mutation directly next to a known 
phosphorylated residue in Puf5p.  This charge mimic greatly increased Puf5p repressive 
capacity compared to wild-type and this may be due to increased and/or more efficient 
binding to target mRNAs (this work).   
A second hypothesis for the activation switch for Puf proteins is to alter 
interactions with known decay machinery during inactivating conditions.  It is possible 
that critical components of the decay machinery are no longer bound to Puf proteins 
during stress, a condition which leads to stabilization of target mRNAs.  Indeed, 
interactions between Puf3p and Pop2p are perturbed in galactose conditions, providing 
a possible mechanism for inactivation of Puf3p.  In fact, Puf3p binding to a smaller 
version of Pop2p was increased in galactose conditions.  Additionally, this smaller 
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version of Pop2p nearly exclusively binds a mutant form of Puf3p that can bind but not 
repress target mRNAs.  It is possible that binding to the smaller version of Pop2p may 
inhibit repression of target mRNAs by affecting the deadenylation step of decay, as 
preliminary data suggests this is the case.  Previous research has identified a 
phosphorylation event of Thr97 of Pop2p by Yak1p in response to glucose deprivation 
(Moriya et al., 2001).  I sought to determine if this modification is responsible for 
disrupted binding between Puf3p and Pop2p, thereby affecting mRNA turnover.  
Transcriptional shut-offs in a yak1Δ revealed a constitutively active Puf3p in galactose 
conditions, further supporting the hypothesis that the phosphorylation of Thr97 on 
Pop2p is required for Puf3p inactivation.  
Human Pumilio proteins regulate mRNAs involved in Parkinson’s 
Disease 
 Much research on Puf proteins has focused on using lower eukaryotes such as S. 
cerevisiae and Drosophila melanogaster.  Although large scale studies have been done 
to identify target mRNAs regulated by human Pumilio (Fox et al., 2005; Galgano et al., 
2008), identification of bona fide targets is sparse (Kedde et al., 2010; Miles et al., 2012; 
Fernandez et al., 2014).  In addition, recent research shows that Pumilio repressive 
function may also include interplay with the miRNA system, although the mechanism 
remains elusive.  Data supports a model in which Pumilio proteins bind target mRNAs 
and relieve secondary structure to free up miRNA seed regions that have otherwise 
been inaccessible (Kedde et al., 2010).  In addition, it has been shown that human 
Pumilio proteins have their own repressive capacity independent of the miRNA system 
(Van Etten et al., 2012) and global miRNA regulation is not dependent on Pumilio 
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proteins as many miRNA targeted mRNAs do not contain PREs (Galgano et al., 2008; 
Incarnato et al., 2013; Jiang et al., 2013).  Thus, it is important to identify bona fide 
targets of Pumilio regulation in humans to begin to understand the multifaceted 
mechanism by which regulation occurs.      
 I have identified several key genes involved in the progression of PD as bona fide 
targets of Pumilio regulation.  Bioinformatic analysis of 3’ UTRs of genes involved in PD 
revealed that SNCA and LRRK2 contain putative PREs, and physical association studies 
revealed that some PD genes are bound to Pum1 (Galgano et al., 2008).  In addition, 
SAT1 contains no canonical PREs; however, it does contain two non-canonical PREs.  In 
fact, the SAT1 PRE has been implicated in post mortem PD brains where a deletion of a 
UGU element was observed (Sotiriou et al.).  My studies reveal that all three genes are 
likely bona fide targets of Pumilio regulation.  Knockdown of Pum1 and Pum2 resulted in 
increased expression of both SNCA and LRRK2 at the mRNA and protein level, 
respectively.  Furthermore, luciferase assays utilizing the 3’ UTRs of SNCA, LRRK2, and 
SAT1 revealed that they are likely Pumilio targets since mutation of the PRE resulted in 
increased expression of a luciferase reporter.  No other regulatory proteins have been 
shown to bind the specific PREs, further supporting these mRNAs as bona fide Pumilio 
targets.  One issue that occurred in validating these targets is that when Pumilio 
proteins were knocked down in HEK-293 cells the reporters did not respond.  Previous 
studies where knockdown showed a phenotype were done in SH-SY5Y cells; however, 
due to technical issues with transfection in SH-SY5Y cells, reporter based assays are 
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done in HEK-293 cells.  This may be the source of inconsistency, as expression of Pumilio 
proteins are higher in SH-SY5Y cells compared to HEK-293 cells. 
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